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4, and 8 days after starting CYCLO, with or without renal ischemia.
Blood urea (mg/dl SEM) at sacrifice was:
Isehemia No ischemia lschemia No ischemia lschemia
Day 2 52 -'- 2 97 16 48 -'- 2 190 42
Day4 48±2 59± 2 40±4 63± 10
Day8 59*4 55-- 3 71±6 65± 5
2 rats died on day 5 and I on day 6 and 8
Food intake was poor, and urea excretion progressively decreased in
CYCLO-treated rats. However, BU rose in CYCLO-treated rats with-
out ischemia, and 24-hr creatinine clearance fell to 1/2 to 1/3 of control
on day 8 in the 50-mg/kg CYCLO group. CYCLO aggravated ischemic
acute renal failure, but this aggravation appeared reversible. Histologic
changes due to ischemic injury were similar in CYCLO-treated and
control rats.
Does captopril prevent renal failure in scleroderma? J. P. Wauters, H.
R. Brunner, and B. Waeber. University Hospital, Lausanne, Switzer-
land. Renal failure in progressive systemic sclerosis (PSS) is most often
due to malignant nephroangiosclerosis initiated by stimulation of the
reninangiotensin system. It has been claimed that an increase in plasma
renin activity (PRA) forecasts the renal crisis and that chronic blockade
of the angiotensin converting enzyme by captopril could prevent the
deterioration of renal function. Three patients with PSS, age 46, 60, and
57 years, were hospitalized with a blood pressure of 160/1 10, 200/100,
and 180/90mm Hg, plasma renin activity of 19.4, 11.5, and 16.6 ng/ml/
hr, and serum creatinine levels of 274, 565, and 884 p.moles/liter,
respectively. Captopril was started at the dose of 100 mg p.o. twice a
day. In all patients, sustained control of blood pressure at 120/80 mm
Hg was obtained immediately. Renal function, however, deteriorated
further, and hemodialysis had to be started 1, 4, and 7 weeks after
captopril was initiated. Despite the control of uremia by hemodialysis
and blood pressure by captopril, patients did not improve clinically. All
3 died of respiratory failure after 3, 8, and 4 weeks, respectively, of
hemodialysis. This course is in contrast with that of another female
patient of 48 years, with PSS, malignant hypertension, and terminal
renal failure. Chronic hemodialysis and antihypertensive therapy with
sodium nitroprusside and subsequently beta-blockade were instituted.
Twenty months later, due to recovery of renal function, hemodialysis
could be discontinued; 3 years later serum creatinine is at 275 p.moles/
liter. Conclusions. In patients with PSS: (1) chronic blockade of the
renin-angiotensin system by captopril, despite blood pressure control,
does not always prevent the deterioration of renal function. This
suggests that the renin-angiotensin system is not the sole factor leading
to renal failure. (2) On the other hand, even in the face of advanced
renal failure, spontaneous improvement of kidney function can occur.
Therefore, bilateral nephrectomy should be avoided.
Massive fluid retention with pericardial effusion in minoxidil treatment.
K. Záruba, M. Rohacek, W. Grauer. Nierenstation u.Inst.f.Rontgen-
diagnostik Stadtspital Waid Zurich, Switzerland. Minoxidil, a piperi-
dino-pyrimidine derivative, is one of the most effective hypotensive
drugs. It is particularly suitable for the treatment of refractory hyper-
tension and can successfully be instituted in patients with end-stage
renal failure. The drug's direct effect on arteriolar smooth muscle
causes peripheral vasodilatation. Minoxidil, like other vasodilator
drugs, induces a marked tendency to sodium and fluid retention,
consecutive to increased sodium reabsorption in the proximal tubule. A
45-year-old patient with chronic glomerulonephritis was treated with
minoxidil for severe hypertension during the year preceding the start of
hemodialysis. He developed severe fluid retention in spite of simulta-
neous treatment with furosemid and diuresis > 2 liters in 24 hours. On
admission for hemodialysis in our center, there was extensive edema;
X-rays and echocardiography showed a massive pericardial effusion.
With forced ultrafiltration-hemodialysis (UF-HD), we succeeded in
reducing the body weight by 17 kg within 4 weeks. During this time the
peripheral edema as well as the pericardial effusion were gradually
reabsorbed, and the blood pressure returned to normal without the use
of hypotensive drugs. Patients on minoxidil, especially those with renal
failure, should regularly be checked for fluid retention and pericardial
effusion. Early increase in diuretic therapy or institution of UF-HD in
end-stage renal failure can prevent the formation of a potentially
dangerous pericardial effusion.
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Subcutaneous heparin therapy in renal insufficiency. K. Andrassy, W.
Salzmann, J. Bommer, and J. Koderisch. Medizinische Universitäts-
klinik Heidelberg, FRG. It is often necessary to treat uremic patients
with low doses of heparin, for example, for prophylaxis or Cimino-
fistula thrombosis. However, little information is available on heparin
pharmacokinetics and heparin action in uremic patients. In the present
study, plasma activity-time profiles during low-dose heparin therapy
were investigated in control individuals and in uremic patients. Meth-
ods. Heparin levels at 0, 3, 8, 10, 12, 24, 27, 32, 34, and 36 hr after s.c.
injection of various doses of heparin (2 x 7, 500 I.U./day for 2 days, 3
x 5,000 I.U. for 2 days and 2 x 5,000 I.U. for 2 days) were measured in
9 control individuals and in 11 uremic patients (Ce. < 10 mI/mm).
Heparin activity was determined by measurements of (1) neutralization
of factor Xa-activity (Denson and Bonnar); (2) neutralization of Xa
measuring amidolytic activity (Teien and Lie); (3) plasma prothrombin
and thrombin time. Heparin-cofactor concentrations were measured
with immunodiffusion and by measuring amidolytic activity. Results.
With the dose of 2 x 5,000 I.U. of heparin s.c., no difference between
control individuals and uremic individuals was found. In contrast, peak
concentrations of heparin were significantly lower in uremic patients
after 7,500 I.U. heparin s.c. After repeated administration of heparin,
trough concentration (24 hr) had fallen to 0 in uremic patients, whereas
in controls, a measurable residual activity was still demonstrable. The
difference between uremic patients and control individuals was particu-
larly marked at higher doses. Conclusion. The results show that to
reach a given profile of heparin activity, higher s.c. doses of heparin
must be administered in uremic patients than in nonuremic control
persons.
Reversible resistance to the phosphaturic effect of parathyroid hormone
and db-cAMP in lithium-treated rats. S. Angielski, K. Drewnowska, M.
Szczepaiiska-Konkel, and A. Rybczyiska. Department of Clinical Bio-
chemistry, Institute of Pathology, Medical Academy Gdañsk, Poland.
It has been shown that acute lithium (Li) administration to rats induces
extracellular acidosis, probably due to the transport of Li into the cells
as LiCO3 with consequent and perhaps organ-selective alkalinization of
the intracellular space. Unresponsiveness to the phosphaturic effect of
parathormone (PTH) and db-cAMP in parathyroidectomized (PTX) Li-










treated rats was also observed. This study was designed to investigate
the effect of intracellular acidosis on PTH responsiveness in Li-treated
rats. Acute Li administration (5 mmoles/kg of body wt) to PTX rats
increased phosphate (Pi) reabsorption accompanied by hypophosphate-
mia and marked urinary excretion of 2-oxoglutarate (Oxg) and citrate.
Fractional excretion (FE) of Oxg rose from 2 to 250% and citrate from 3
to 100%. PTH and db-cAMP were not phosphaturic in the PTX Li-
treated rats or in the rats loaded with Pi. In contrast, the administration
of PTH or db-cAMP to PTX Li-treated rats which were pretreated with
NH4CI or hypercapnic rats resulted in a marked phosphaturic effect of
PTH or db-cAMP. The administration of Li to PTX rats that were
pretreated with NH4CI did not increase the excretion of Oxg and
citrate. In contrast, FE of these metabolites were markedly increased in
hypercapnic Li-treated rats. We examined the effect of Li and metabol-
ic alkalosis on renal and muscle levels of metabolites. The treatments
produced similar patterns of metabolite changes in the kidney: Oxg and
citrate rose, whereas Pi and ATP levels fell in both groups. In the
muscle of the same rats, treatments produced different patterns: Pi level
rose and ATP level was not changed. We conclude that: (1) the
decreased serum and kidney Pi after Li treatment is secondary to the
increased muscle Pi concentration, which could be due to an acid-base
disturbance caused by transport mechanisms to carry Li across plasma
membranes; (2) renal intracellular bicarbonate concentration, but not
pH, affects renal citrate and Oxg handling, whereas the phosphaturic
responsiveness to PTH or db-cAMP is dependent, at least in part, on
intracellular pH or the transcellular pH gradient.
Prevention of maleate effects on tubular transport by acetoacetate. S.
Angielski, M. Szczepañska-Konkel, P. Gmaj, and Nguyen Thi Hong
Que. Department of Clinical Biochemistry, Inst itute of Pathology,
Medical Academy Gdañsk, Poland. The selective toxicity of maleate
(MA) on the kidney is the result of its high accumulation in the tissue
and its metabolism by both the MA hydratase and succinyl-CoA
transferase (ST) pathways, giving rise to maleyl-CoA. We examined the
effect of acetoacetate (AcAc), the natural substrate of ST, on MA-
treated rats using clearances techniques and isolated brush-border
membrane vesicles (BBMV). MA (100 mg/kg of body wt) was phospha-
turic, glucosuric, and aminoaciduric. Administration of AM to the rats
infused with AcAc (90 moles/kg/min) did not induce phosphaturia,
glucosuria, oraminoaciduria. To assess the specificity of AcAc, propio-
nate was chosen as monocarboxylic anion and also CoA-dependent
metabolite. Propionate had no effect on maleate-induced phosphaturia,
glucosuria, and aminoaciduria. The addition of MA to the BBMV after
the isolation of membrane from normal rats did not change the uptake of
glucose and phosphate. Although the BBMV isolated after 10 mm
incubation of the slices with MA took up less glucose than control
vesicles, the initial rate of glucose uptake was not affected. This
suggests that glucose transport is not directly affected by MA, but the
coupling between glucose and Na transport becomes less tight due to
increased permeability of the membrane to Na. Phosphate transport, on
the contrary, was significantly stimulated after incubation with MA:
both the initial rate and overshoot were higher than in control. When
AcAc (10 mM) and MA (5 mM) were together in the incubation medium
containing kidney slices, under the conditions when maleyl-CoA forma-
tion is reduced or completely prevented, Na-dependent glucose and
phosphate uptake by BBMV isolated from these slices was not inhibit-
ed. We conclude that: (1) maleyl-CoA but not MA exerts its action on
glucose and phosphate reabsorption; (2) maleyl-CoA increases perme-
ability of BBMV to Na, which is closely interrelated with decreased
glucose transport, whereas its action on Pi transport may be due to
interaction with phosphorylation of BBMV.
Hemodynamic characterization of hypertension in interstitial and
glomerular kidney disease. J. Bahlmann, J. Brod, D. Pretschner, and U.
W. Müller-Barthél. Dept. of Medicine, Medical School Hannover,
Hannover, W. Germany. Thirty-nine patients with renal hypertension
(type I and II, WHO) were hemodynamically examined. Eighteen had
pyelonephritis (PN) and 21 had glomerulonephritis (GN). Their GFR's
were not significantly reduced, and there was no anemia or nephrotic
syndrome. By dividing these patients into groups according to their
cardiac index (CI) (limited between normal and increased to 3.56 liters/
min/m2; measured by cardiogreen dilution), it was shown that 12
patients with PN and 12 patients with GN belong to the group with
normal CI. There was no significant difference in cardiac output, mean
blood pressure, total peripheral vascular resistance, venous distensibil-
ity, and blood volume between both diagnostic groups. Patients with
GN had a significantly increased exchangeable sodium. The group with
increased CI comprised 9 patients with GN and 6 with PN. Patients with
GN showed a significant higher cardiac output of 7.32 liters/mm and
increased stroke volume of 107 ml compared to PN with 6.29 liters/mm
and 78 ml, respectively. Mean blood pressure, total peripheral resist-
ance, and blood volume were not different. The total peripheral
vascular resistance is lower in the groups with the increased cardiac
output because of the similar mean blood pressure.
Secondary hyperoxalemia in chronic renal failure. P. Balcke, P.
Schmidt, J. Zazgornik, H. Kopsa, and E. Deutsch. 1st Medical Clinic,
University of Vienna, Austria. Oxalic acid is an end product of amino
acid metabolism and normally excreted by the urine. In renal failure,
therefore, cumulation of oxalic acid can be expected. The aim of the
study was to investigate the behavior of serum oxalic acid in patients
with advanced renal failure under regular dialysis treatment (RDT).
Oxalic acid concentrations were measured after ultrafiltration by the
photometrical method described by Dagneaux et al (1976). Determina-
tions were performed prior to and after 36 hemodialyses in 17 patients
on RDT. In no case was basic renal disease due to primary oxalosis.
Mean predialysis value of serum oxalic acid was l37.5 + 56.0 i.moIes/
liter, all concentrations being markedly higher than the normal range (13
to 28 ij.moles/liter). There was a statistically significant correlation
between serum oxalic acid and serum creatinine levels (r = 0.47, P <
0.01); however, no correlation was noted with the concentrations of
BUN. During 12 hemodialyses, mean serum oxalic acid concentration
fell from 154.2 50.5 to 74.2 28.2 p.moles/liter. Corresponding
creatinine level was 12.8 2.0 and 5.5 1.3 mg/dl, respectively, The
data show that oxalic acid accumulates in renal failure. The results are
in agreement with the findings of Gratama et al (1980) who recently
described oxalate depositions in different organs of patients with
chronic renal failure. We assume that adequate removal of oxalic acid
during dialysis is an important aspect of chronic dialysis treatment in
end-stage renal failure.
Enhanced purine nucleotide synthesis in erythrocytes of uremic pa-
tients. H. J. Becher, W. Wachter, P. Schollmeyer. Med. Klinik IV,
Freiburg, FRG. Studies were performed that suggest that the increased
red cell levels of ATP and adenine nucleotides in uremic patients may
be secondary to an increased biosynthetic rate of adenine nucleotides
via salvage pathway by the predominance of younger red cells. Both
normal and uremic red cells were separated in three groups according to
their age by centrifugation in a discontinuous density gradient using
phthalate esters as separating liquids. (I) The uremic subjects have a
substantial reduction of the older (more dense) red cells with a 3- to 4-
fold increase of the younger red cells. (2) The specific activity of the
salvage pathway enzymes phosphoribosyl- I -pyrophosphate (PRPP)
synthetase, adenine phosphoribosyltransferase, and the red cell PRPP
levels are strictly age-dependent and substantially increased in the
uremic erythrocytes. No definite alterations of enzyme half-lives of
both enzymes could be discerned. (3) Red cell methylene-blue-stimulat-
ed pentose phosphate pathway (PPS) wasn't significantly lower in
patients with chronic uremia than in controls, as could be shown by the
determination of red cell ribose-5-phosphate concentration. There was
no difference of the steady-state levels of ribose-5-phosphate in the age-
dependent red cell fractions of both normal and uremic subjects. (4) The
results support the assumption that the elevated ATP levels in the
uremic red cells may be related to their higher intrinsic ATP synthetic
capacity via salvage pathway. (5) The enzymatic alterations in the
uremic red cells are independent of extracorpuscular factors including
phosphate, and it was concluded that most of the described abnormali-
ties in the uremic red cell metabolism reflect only the hypermetabolic
state of a young red cell population. The conflicting results concerning
red cell metabolism of uremic patients could be caused by an inconstant
percentage of younger red cells in various uremic patients.
Clearances and SDS-PAA-electrophoresis pattern of micromolecular
urinary proteins: Selectivity of tubular resorption? W. H. Boesken, B.
Wacker, E. 0. Blachnitzky, and A. Mamier. Med. Universitätsklinik,
Nephrolog. Labor, Freiburg, FRG. Under physiologic conditions, the
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glomerular ultrafiltrate contains serum proteins of a mol wt ranging
from 10,000 to 100,000 daltons, which are resorbed completely. A
micromolecular proteinuria (MP) may be detected when the tubular
resorption is disturbed. SDS-PAA-e of urinary proteins distinguishes
two forms of MP: first the "classical" tubular proteinuria, containing all
proteins with mol wt of 10,000 to 70,000 daltons, and second, the
"partial" MP, containing the larger microproteins with mol wt of 40,000
to 70,000 daltons (type IV resp. VI according to Gutensohn et al). These
findings lead to the hypothesis of a selective resorption of micromolecu-
lar proteins, In 6 patients with type-IV, 6 with type-VT proteinuria, and
2 with Ig-light chain-paraproteinuria, the clearances of 8 microproteins
ranging from 3-2-microglobulin (11,800) to a-l-antitrypsin (54,000 dal-
tons) were determined and the results expressed in relation to a-i-acid
glycoprotein (44,000 daltons) (C-protein/C-cre/C-alacGP = 1). The
slope of the regression line 'r, calculated from the 8 clearances, was
taken to measure the different tubular resorption: (a) r-IV = 113 67
was significantly different from 'r-VI = 9.6 5.6; (b) Serial analyses of
individual urine samples after transient tubular damage revealed a
gradual decrease of 'r; (c) Clearances of micromolecular paraproteins
were significantly higher compared to 7 of the secondary tubular
proteinuria. We conclude that the microproteins of the glomerular
ultraflitrate are not resorbed unselectively according to their concentra-
tion, but selectively according to their molecular size or form. Classical
tubular proteinuria type IV is associated to interstitial nephritis and
early stages of acute kidney failure; the partial MP may be found in
patients with vascular nephrosclerosis (diabetes, hypertension) and
during late stages of acute kidney failure.
Hepatosplenomegaly secondary to foreign body reaction in patients on
maintenance hemodialysis. J. Bommer, B. Krempien, and E. Ritz. Dept.
Intern. Med. & Dept. Pathology, Univ. of Heidelberg, FRG. Although
the blood of hemodialyzed patients is exposed to plastic material,
clinically relevant complications resulting from such exposure have
rarely been observed. This is surprising since large amounts of plasticiz-
er (100 to 150 mg/treatment period) leach from PVC tubing into the
blood of dialyzed patients. So far, an acute hepatitis-like syndrome with
elevation of transaminases was described when certain PVC tubing
materials were used. Furthermore, cutaneous necrotizing angiltis sec-
ondary to the use of PVC tubing was observed. The present communi-
cation describes another complication resulting from the use of plastic
material in dialyzed patients. Case report. A 60-yr-old female patient
with reflux nephropathy, terminal renal failure since 1971, HbS-Ag
positive hepatitis since 1972, with normalization of all laboratory
parameters within one year, progressive hepatosplenomegaly since
1976 with leukopenia and thrombocytopenia (thrombocyte elimination
kinetics: sequestration in the spleen) died because of hemorrhagic
diathesis, splenectomy in 1979; postoperatively exitus from gastrointes-
tinal bleeding. Autopsy findings were 2,500-g liver; 1 ,500-g spleen,
histologically numerous foreign body giant cells with inclusion bodies of
irregular shape, up to 100 g in size, which consisted of nonpolarizing,
colorless material. Such cells were seen in liver, lung, and particularly
in spleen. There was no granuloma formation. In the liver, gaschroma-
tography revealed phthalate derivatives which were not demonstrable
in livers of nonuremic control persons. Conclusion. The present case
suggests that nongranulomatous foreign body reactions in parenchyma-
tous organs with symptomatic hepatosplenomegaly may constitute a
complication of the use of plastic material in dialyzed patients. Plasti-
cizers and possibly plasticizer metabolites, which are presumably
excreted in the urine in healthy individuals may accumulate in paren-
chymatous organs of uremic patients on maintenance hemodialysis.
Increased testosterone in dialyzed men undergoing bromocriptine
treatment. J. Bommer, E. Ritz, G. Bommer, and E. del Pozo. Dept.
Intern. Med., Heidelberg, FRG, and Sandoz Co., Basle, Switzerland.
Recently we reported a single-blind random crossover placebo con-
trolled study which showed that bromocriptine favorably influences
sexual activity in male hemodialysis patients. Prolactin (PRL) is known
to act both on CNS neurons involved in sexual function and on the
gonads. Characteristically in uremia, hPRL levels are high and testos-
terone levels are normal or low. Since hyperprolactinemia is corrected
by the dopaminergic agonist bromocriptine in uremic men, it appeared
of interest to examine whether plasma testosterone also increases in
parallel with sexual activity. Methods. Before and after 8 weeks of
treatment with bromocriptine (2 x 2.5 mg/day), 5 hemodialyzed male
patients were studied. Before and during bromocriptine treatment,
LHRH and TRF stimulation tests were performed. Serum testosterone,
SHBG, prolactin (RIA), hLH (RIA), and hFSH (RIA) were analyzed.
Specimens were kept deep frozen; all analyses were performed simulta-
neously after conclusion of the study. Results. In hemodialyzed men,
mean serum hPRL (22.1 16.1 ng/ml), hLH (3.8 2.8 ng/ml) and
hFSH (1.8 1.5 ng/ml) were high. Elevated hLH and hFSH were
incompletely feedback suppressed by testosterone (after 100 mg of
testosterone proprionate hLH, — 33%; hFSH, — 47%; normal men >
99%). Under bromocriptine, hPRL levels fell to the low normal range,
but elevated hLH and hFSH levels remained unchanged. However,
serum testosterone levels increased in all men studied (before treat-
ment: 7.9 4.04 ng/ml; during treatment: 10.7 5.38 ng/ml). Conclu-
sion. In uremic men, LH levels are elevated and the hypothalamic
feedback mechanism is disturbed. Administration of bromocriptine
lowers hPRL and raises testosterone levels with no change of LH
levels. The findings are suggestive, but not conclusive, evidence of a
direct gonadai action of hyperprolactinemia in renal insufficiency which
responds to bromocriptine.
Changes in the activity of the renal kallikrein-kinin system in renal
hypertensive rats. G. BOnner, M. Marin-Grez, G. Speck, B. Rastetter,
and F. Gross. Department of Pharmacology, University of Heidelberg,
FRG. In renal hypertensive rats, the relationship between the renal
kallikrein-kinin system and the renin-angiotensin-aldosterone system
was studied. Hypertension was induced in male Sprague Dawley rats,
weighing about 250 g, by ligation of the aorta between the origin of the
renal arteries. Another group of rats were unilaterally nephrectomized
to investigate the effect of reduction in renal mass. Control rats were
sham-operated. Kallikrein in the urine (UKAL) and in the renal cortex
(RKAL) was determined by a bradykinin (BK) radioimmunoassay mea-
suring the kinins released from partially purified kininogen of dog
plasma (UKAL, g BK ' min"/24 hr; RKAL, ng BK ' mm_A/mg of
protein). Renin activity in the renal cortex (RRA) was determined by an
angiotensin I (Al) radioimmunoassay (RRA, pmoles AT min'/mg of
protein). Eight days after aortic ligation, systolic blood pressure was
160.0 9.8 mm Hg, whereas, in control rats it was 109.3 3.5 mm Hg
(P < 0.001). At this time, UKAL was significantly reduced (11.6 1.2
vs. 26.7 3.4, P < .02). In contrast, RKAL was increased in both
kidneys of the hypertensive rats. This increase was more pronounced in
the ischemic kidney (RKAL right, 12.74 1.92 vs. 8.03 1.10, P <
0.05; RKAL left, 62.17 6.38 vs. 8.68 0.74, P < 0.001). RRA was
elevated in the ischemic kidney and decreased in the nonischemic
kidney (RRA right, 2.44 0.16 vs. 4.18 0.48, P < 0.001; RRA left,
18.68 2.57 vs. 3.78 0.47, P < 0.001). Unilateral nephrectomy
caused a reduction of UKAL to about 60% of that of the controls (11 .8
0.8 vs. 20.3 3.3, P < 0.005). The increase in kallikrein activity found
in both kidneys after aortic ligation is not correlated with changes in
renin activity observed after unilateral renal ischemia. It is presumed
that the enhanced aldosterone secretion in renal hypertensive rats has
contributed to the elevated kallikrein activity in both kidneys of the
hypertensive rats, but it cannot be excluded that the much higher
kallikrein activity in the cortex of the ischemic kidney is the conse-
quence of cessation of urine flow and urinary kallikrein excretion.
Familial Mediteranean fever with amyloidosis and its treatment. H.
Brass, H. LOffler, R. P. Linke, W. Thoenes. Med. Klinik II, Stàdt,
Krankenanstalten Ludwigshafen, Inst ituif. Immunol., Univ. München,
Patholog. Institut Univ. Mainz. Familial Mediteranean fever is regard-
ed as a heredofamilial disease, with a high incidence of severe amyloid-
osis. It is characterized by feverish bouts, abdominal pain (attacks), and
subileus symptoms, joint involvement, nephrotic syndrome, and the
development of renal insufficiency. Case report. A 34-yr-old Turkish
patient showed all the above mentioned symptoms. The diagnosis was
established by two rectal biopsies (green birefrigence in polarisation
microscopy after congored staining), microscopical, immunhistological,
and electronmicroscopic evidence of renal amyloidosis. Serum levels of
amyloid-A-protein (SAA) were increased. We could not find amyloid
fibrils in urinary sediment either by light or by electron-microscopy.
Under treatment with colchicine, the fever, the abdominal attacks, and
the arthritis disappeared. Neither proteinuria (5 to 25 g/day) nor the
development of progressive renal insufficiency could be decreased.
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Within 4 months, the serum creatinine levels rose from 1.7 to 5.1 mg/dl,
and the creatinine-clearance fell from 41 to 6 mI/mm. In the literature
there are a few reports about positive therapeutical effects of dimethyl-
sulfoxide (DMSO) treatment. Therefore, we decided on an additional
therapy with DMSO under which the serum creatinine fell from 5. 1 to
3.3 mgldl. The creatinine clearance rose from 6.0 to 15.5 mllmin. The
pharmacologic effects of choichicine and DMSO as well as the behavior
of SAA protein are discussed.
A new combination of methods for the isolation of uremic toxins. H.
Brunner, H. Mann, U. Essers, T. Byrne. Abteilung Innere Medizin II
der RWTH Aachen, W. Germany. Although many low-molecular-
weight uremic toxins have been identified, little is known about the
chemical nature of higher molecular-weight uremic toxins. Some of the
experimental difficulties for the preparative isolation of these fractions
have been solved as follows: the hemofiltrate (20 to 30 liters) of patients
with end-stage renal failure is first desalted and concentrated by
reversed osmosis (40 bars) using membranes with a nominal cutoff of
500 daltons. The retentate, after lyophilization, is fractionated on a
cooled macrocolumn of Sephadex G-15 in a volatile buffer (2 m x 5cm;
5 g per run) yielding 17 to 20 fractions. In addition to some lower
molecular-weight fractions, the fractions near the exclusion limit of the
gel inhibit the 3H-thymidine incorporation into rat bone-marrow cells in
vitro. Rechromatography of these toxic fractions on different conven-
tional Sephadex gels gives poorer separations compared with ultrogel
AcA54 (LKB). Preparative rechromatography on ultrogel AcA54 yields
subfractions in the middle and higher molecular weight range (about
10,000 daltons) as has been shown by rechromatography on different
calibrated columns. The higher molecular weight fractions were not
dialysable using visking tubes in vitro, resulting in a simple alternative
procedure for their isolation. Using ion-exchange chromatography
(detection at 206 nm, double column technique, preparative scale) as
well as thin-layer chromatography and isoelectric focusing, these toxic
fractions have been shown to be heterogeneous. Whether these higher
molecular-weight solutes are of clinical relevance or not, cannot be
decided with these in vitro experiments. This combination of methods
enables the isolation of large amounts of subfractions from hemofiltrate
or even from dialysate, thus enabling the chemical and biological study
of fractions with a wide range of molecular weights.
Effect of PTH on human parotid and submandibular saliva. M. T.
Coroneo, H. Maier, J. Juskowa, J. G. Schindler, M. Schmitt, and A.
Heidland. Department of Nephrology, Medical University Clinic, Ju-
lius-Maximilians University, Wurzburg, West Germany. Elevated calci-
um, magnesium, and phosphate concentrations in parotid saliva and in
sweat of patients with chronic renal failure (CRF) have previously been
reported. Increased parotid salivary calcium and phosphate concentra-
tions have been reported in patients with primary hyperparathyroidism.
In some studies, the administration of PTH caused increased salivary
calcium concentration, but serum calcium concentration was also
elevated. In healthy fasted male volunteers, submandibular (N = 9) and
parotid (N = 7) saliva was evoked by pilocarpine (0.15 mg/kg, s.c.). In 7
volunteers, bovine PTH (50 U bolus i.v. then 2 U/mm infusion) was also
given 10 mm after saliva collection began, and saliva from both glands
was collected for 40 mm. Blood was taken during the course of each
experiment. Blood and saliva collection was under anaerobic condi-
tions, and ionized calcium concentration was measured using an ion-
selective electrode. PTH induced significant elevations in parotid
salivary total and ionized calcium concentration (phosphate concentra-
tion was unchanged), submandibular salivary ionized calcium and
phosphate concentration (total calcium concentration was unchanged),
and a significant fall in submandibular protein. Serum total calcium
concentration remained unchanged but ionized calcium concentration
fell significantly after PTH. PTH did not alter salivary pH or flow rate.
As a model for the handling of calcium or phosphate by salivary glands
does not exist, it is difficult to speculate as to the site of action of PTH.
There is some evidence for ductal reabsorption of calcium, and PTH
could inhibit this. An elevation only in submandibular salivary ionized
calcium concentration and not total calcium concentration might be
explained by a PTH-induced alteration in calcium-protein binding as
seen in serum in some cases of primary hyperparathyroidism. PTH
seems to exhibit a direct effect on salivary epithelia and may be
responsible for alterations seen in exocrine secretion in CRF.
Nephroptosis and idiopathic edema in women. W. Cremer, M. Anlauf,
W. Jammers, and J. G. Moormann. Hospital of Barmherzige Brüder,
Trier, and Department of Hypertension and Renal Disease, Klinikum
Essen, Germany. The syndrome of the "idiopathic" edema is to be
studied first in women. An interesting observation has been made by
Mimran et al, that with the converting-enzyme-inhibitor Captopril
therapy, the "idiopathic" edema disappears. We have examined 12
women with "idiopathic" edema, aged between 33 and 56 yr. In all
patients, we discovered a nephroptosis: in 10 patients, in the right
kidney; in 2 patients, the left; and in one patient, both. All patients were
examined, when they were in the supine and upright positions, by
means of an i.v. urogram, '31J-o-hippurate clearance, and for plasma
aldosterone and plasma renin-activity. The 24-hour aldosterone excre-
tion was determined. We also estimated the day/night urine exretion of
sodium and potassium. From patients on whom a nephropexy was
carried out, we took tissue samples for histologic examination. In all
patients, we found significant reductions of blood flow in the ptotic
kidney estimated with the '31J-o-hippurate clearance in sitting position.
Also we observed a hypokalemia and a stimulated renin-angiotensin-
aldosterone-system; in addition, the excretion ratio of sodium and
potassium were found to be significantly higher during the night than
during the day. Of the 12 patients, 5 underwent a nephropexy. Four of
these patients stated that after the operation no edema was observed,
one patient declared an improvement. The blood flow in lying and
sitting position had been improved and/or regulated after the operation.
In our opinion, nephroptosis, a failure frequently observed in women,
might play a role in the pathogenesis of "idiopathic" edema of women.
This disease might be caused by an inappropriate stimulation of the
renin-angiotensin-aldosterone system during the circadian rhythmic
cycle and when renal blood flow in orthostatic position is worse.
Fresh renal artery embolism: Disobliterative treatment. P. Deeg, K.
W. Schneider, W. Gattenlöhner, A. Räckel, and H. Hennemann.
Medical University Hospital Wiirzburg, Wurzburg, Germany. A 50-
year-old female patient, who had mitral valve stenosis, suffered from a
cerebral embolism with a transient paresis. Some days later, she
became anuric. The aortography showed a complete thromboembolic
occlusion of the left renal artery and an incomplete obstruction of the
right renal artery. Thrombolytic therapy was contraindicated for the
cerebral embolism. Because of the poor general condition of the
patient, an operation seemed to be too risky. Therefore, the thrombo-
embolic material was sucked off both renal arteries by means of a
catheter. A subsequent selective control angiography demonstrated a
free right renal artery and a partially disobliterated left renal artery.
After this treatment, diuresis set in again with a daily quantity up to 1
100 ml, and hemodialysis was still necessary. Eleven days later, the
patient expired because of a bleeding complication. In our opinion the
embolus-aspiration seems to be an alternative treatment of renal artery
embolism, if operative or thrombolytic therapy are impossible. The
procedure is harmless and can be done quickly. The technical and time
expense are small. The patient tolerated the catheter very well.
Renal excretion and clearances of amino acids after physical exercise. J.
H. H. Ehrich, F. Kru/l, H. G. Foellmer, G. Hahn-Deinstrup, H.
Deeken, and J. Brodehl. Kinderklinik der Medizinischen Hochschule,
Hannover, W. Germany. Several reports dealing with renal involve-
ment during physical exercise have stated that transient kidney dys-
function can occur and that the changes in glomerular and tubular
function are dependent on the intensity and duration of exercise. The
aim of the present study was to determine plasma concentration,
urinary excretion, and clearance of amino acids (AA) following physical
exercise of two different grades. Plasma and urine AA of 16 untrained
men were investigated before and during a 15- and 25-km march. AA
were measured by column chromatography. For characterization of
partial tubular function, AA clearance and the percentage of tubular
reabsorption were calculated. The plasma concentration of the AA
(Thr, Pro, Gly, Ala, Val, Met, lIeu, Lys, Arg) decreased significantly
after IS and 25 km; this effect was more pronounced after 25 km.
Urinary AA excretion (Thr, Gly, Ala, His) fell significantly. AA
clearances and percentage of tubular reabsorption were unchanged
during the march, as was creatinine clearance. These data support the
results of Refsum et al who showed that prolonged physical exercise is
accompanied by a change of free AA metabolism, leading to a decrease
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in AA plasma concentration and urinary AA output. In addition, the
present work shows that renal AA clearances remain unchanged—a
sign of intact tubular adaptive mechanism—supporting the hypothesis
that physical exercise leads to adaptive renal mechanisms rather than
glomerular and tubular dysfunction.
Renal involvement in patients with nonlethal malaria. J. H. H. Ehrich,
R. D. Horstmann, C. Withycombe, and H. G. Foellmer. Kinderklinik,
Medizinische Hochschule, Hannover and Klinische Abteilung des
Bernhard-Nocht-lnstituts für Schjffsfund Tropenkrankheiten, Hamburg.
The pathogenesis of renal involvement associated with nonrenal infec-
tions is heterogeneous. In the present study, 76 patients with malaria
were investigated prospectively to evaluate renal function 1, 2, 4, and 7
days after their admission to the hospital. Twenty-eight percent of 29
patients with falciparum malaria showed an increase in serum creati-
nine of more than 115 moles/liter; the rise was irreversible in 13%
during the period of observation. Serum urea was above 7.5 mmoles/
liter in 15% of the patients. Of all patients, 44% showed an increased
proteinuria (more than 150 mg/24 hr and 1.73 m2 of body surface or
more than 110 mg/liter) to a maximum of 5 g/24 hr. SDS-polyacrylamide
gel electrophoresis showed two independent patterns of proteinuria:
first, there were patients with an increase in albumin and high molecu-
lar-weight proteins in the urine; second, some patients excreted low
molecular-weight proteins in addition to albumin and high molecular-
weight proteins. The pattern of proteinuria was independent from that
of serum creatinine. Only 2 out of 47 patients with tertian malaria
showed an increase in serum creatinine and urea. A reversible rise in
protein between 110 and 700 mg/liter urine appeared in 36% of all
patients. The appearance of albumin and low molecular-weight proteins
was documented by electrophoresis. In both malaria infections, there
was no correlation between the degree of proteinuria and the height of
fever, thus casting doubt that fever per se is a major cause of
proteinuria. These data show that patients with tropical malaria may
suffer from both transitory glomerular and tubular damage, whereas
patients with tertian malaria may suffer from tubular dysfunction only.
Influence of renal function on urinary and plasma kallikrein activity.
H. Feltkamp, M. Viaho, and K. A. Meurer. Medical Polyclinic and
Medical Clinic of the University of Cologne, Germany. Twenty-two
patients with chronic renal failure (serum creatinine, 6.6 3.1 mgldl
and endogenous creatinine clearance 15.9 14.3 mI/mm) and 20 normal
persons were evaluated for 24-hour kallikrein excretion and plasma
kallikrein activity. Kallikrein activity was measured by means of
chromogenic substrates (S-2266 and S-2302, Kabi Stockholm). The
cause of renal disease was chronic pyelonephritis, polycystic disease,
and analgesic nephropathy. Patients with chronic renal failure had a
significantly (P < 0.001) decreased kallikrein excretion (3.0 1.8 U/24
hr) compared to normal persons (14.9 9.7 U/24 hr). Plasma kallikrein
activity was lower in normal persons (1.2 0.3 U/liter) than in patients
with kidney disease (1.6 0.4 U/liter, P < 0.01). There was a
significant positive correlation for urinary kallikrein excretion versus
endogenous creatinine clearance (r = 0.647; P < 0.01) and a strong
negative correlation for 24-hour urinary kallikrein versus serum creati-
nine (r =
—0.765; P < 0.001) in patients with renal failure. Our results
suggest that the diminished urinary kallikrein excretion may reflect the
loss of intact nephrons and the diminished formation of renal kallikrein
in patients with chronic renal failure. It has been reported in previous
studies that kallikrein is involved in essential hypertension; our obser-
vation may suggest too that a deficiency of the kallikrein-kinin system
may play a part in the systemic hypertension of patients with kidney
disease, because urinary kallikrein excretion is much more decreased
than in essential hypertension. Our findings that patients with very low
renal kallikrein have elevated plasma kallikrein levels might favor the
hypothesis of an interplay between plasma and renal kallikrein system.
Clearance and micropuncture studies of cortisol handling in the rat
kidney in situ and during isolated perfusion. H. Franke, H. U. Gutsche,
J. P. Albert, and F. Hartmann. Dept. of Internal Medicine, University
of Kiel, Germany. It is well known that large amounts of the filtered
cortisol are reabsorbed in the renal tubular system. However, it is still
not clear whether in the mammalian kidney a specific transport system
exists for cortisol. These experiments were carried out to analyze the
cortisol handling by the kidney using micropuncture techniques in situ
as well as the isolated kidney preparation perfused with a modified
Krebs-Henseleit buffer containing substrates and HES. During isolated
perfusion, an almost constant relationship was observed between the
tubular cortisol load and the cortisol excretion: At a GFR of 0.98 0.04
ml/g x mm, 59.3 2.6% of the filtered cortisol was excreted when the
load was varied by different cortisol concentrations in the perfusate
(between 0.7 and 38 .i.g/dl). By micropuncture analysis of different
segments of the nephron, that is, the proximal tubule, the loop of Henle,
and the total nephron where the concentration range of the perfusate
was varied between 0.12 and 50 p.g/dl, similar results were obtained:
Most of the perfused cortisol was reabsorbed by the proximal tubule
and the loop of Henle (>95%), a minor fraction by the distal tubule and
the collecting ducts. Both the isolated kidney preparation as well as the
micropuncture analysis showed a close relationship between fractional
water reabsorption and cortisol efflux from the intratubular space.
Increasing the proximal flow rate during micropuncture experiments
from 15 to 30 nI/mm was followed by a decrease of fractional cortisol
reabsorption by the proximal nephron (including the loop of Henle)
from 64 2 to 56 3%. Correspondingly increasing the GFR in the
isolated perfused kidney from 0.98 to 1.66 ml/g x mm was followed by
a decrease of fractional cortisol reabsorption from 40.7 2.6 to 24.2
3.6% of the load. These results exclude the existence of a specific
transport system for cortisol in the rat nephron.
Hydrocortisone-induced potentiation of the effect of parathyroid hor-
mone on the reabsorption of inorganic phosphate in the rat. A. Frick and
I. Durasin. Department of Physiology, University of Munich, Munich,
Fed. Rep. of Germany. To examine a possible interaction of parathy-
roid hormone (PTH) and hydrocortisone in the renal inorganic phos-
phate (Pi) transport in vivo, we performed clearance experiments in
normal and parathyroidectomized (PTX) rats. Adult female Sprague-
Dawley rats (260 to 300 g of body wt) kept on a standard diet (Altromin)
and tap water ad lib were anesthetized with mactin i.p. (110 mg/kg of
body wt), tracheotomized, and prepared for the clearance studies.
Parathyroidectomy was performed 3 hr before the collection periods
were begun. All animals were infused with a modified Ringer solution at
a rate of 0.15 mI/mm throughout the experiments, the doses of PTH
(Lilly) and hydrocortisone (Hoechst) were 10 USP units and 1,875 mg/











































Mean values SD. P values are for PTH group vs. PTH + cortisone
group. Thus hydrocortisone decreased the Pi reabsorption in the
presence of controlled parathyroid activity. It is concluded that hydro-
cortisone potentiated the effect of parathyroid hormone on the reab-
sorption of inorganic phosphate.
Conservative treatment of advanced chronic renal insufficiency with
ketoanalogues of essential amino acids. Peter T. Frohling, R. Schmicker,
I. Kaschube and K, Vetter. Research Clinic of Nutrition, Potsdam-
Rehbrhcke, GDR, and Clinic for Internal Medicine, University of
Rostock, GDR. Forty-two patients with advanced renal failure (creati-
nine 1105 177 p.moles/liter) were treated with low protein diet (daily
protein intake, 0.4 g/kg of body wt) and keto analogues (KA) corre-
sponding to 0.5 g N per day for 3 to 18 months. Results were compared
with the results of 40 patients under the same protein intake with
substitution of EAA. BUN, creatinine, hemoglobin, base-excess, inor-
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ganic phosphate, transferrin, plasma amino acids (including trypto-
phan), PTH and the N-balance served as control parameters. A
decrease of PTH was observed (1.69 —* 0.99 ng/ml) under KA treat-
ment. A marked decrease of inorganic phosphate and an improvement
of the base excess were also observed. We explain both effects as a
consequence of the PTH-suppression by KA. The N balance improved
significantly after the change of KA treatment and was better in the
long-term tolerability test in comparison with the N balance of the EAA
group. The improvement of the AA pattern was confirmed. All patients
were well rehabilitated during the observation period. No complications
were observed when the therapy had to be changed to the dialysis
treatment.
Estrogen as a risk factor for the vascular system? J. Girndt, H.
Kreuzer, D. Seidel, and F. Scheler. Departments of Nephrology,
Cardiology, and Clinical Chemistry, University Medical Clinic GOt-
tin gen, Germany. Plasma estradiol and plasma testosterone concentra-
tions were measured in 44 men suffering from coronary heart disease
proven by angiography or from peripheral arterial disease. A further
group comprised 28 men with renal insufficiency of different origin and
degree. The control group consisted of 66 men without signs of vascular
disease. Patients with coronary heart disease and peripheral arterial
occlusion demonstrated significantly higher estradiol concentrations
compared to the controls. The testosterone concentrations were not
different from those found in the control group. Patients with impaired
renal function also showed significantly higher estradiol values, but in
this group significantly lowered testosterone values were found. Not
only in the patient groups but in the healthy control group as well, a
relation could be demonstrated between the concentration of estradiol
on one hand and the glucose tolerance, the ratio of beta to alpha
lipoproteins, and the blood pressure on the other hand. Thus, estradiol
in males could indicate a risk constellation for vascular lesions.
Perhaps, however, elevated estradiol concentrations in males are not
only the indicator but the cause of dyregularities of carbohydrate and
lipid metabolism, which lead to hypertension and degenerative vascular
lesions.
Electron microscopic findings concerning early forms of glomerular
amyloidosis: A correlation between structure and function. H. v. Gise*
and A. Bohie. Institute of Pathology, University of Tilbingen, GFR.
The following findings were obtained from electron microscopic studies
of kidney specimens from 25 patients with glomerular amyloidosis in
the early phase. The first alterations in the glomerular tufts, detectable
only with electron microscopy, are zones of loosening in the mesangial
areas facing the capillary lumen and focally in the subendothelial and
subepithelial portions of the glomerular capillary wall. The density of
the fibrillar deposits of amyloid increase in direct proportion to the
increase in the size of the zone. All specimens from patients with a high
protein excretion and/or the nephrotic syndrome show regionally
limited subepithelial amyloid foci, sometimes with detachment of
epithelial cells. In all cases examined, alterations of the glomerular
epithelial cells were observed only when subepithelial loosening or
subepithelial deposits of amyloid were present. The regeneration of the
basement membrane through the epithelial cells was disturbed in the
region of the zones of loosening and over the beginning amyloid
deposition. The regeneration of the basement membrane was not
disturbed in all of the epithelial cell, but rather only in those regions of
the capillary exhibiting these specific structural alterations. After the
cause of the disease has been eliminated and the healing stage has
begun, regeneration of the basement membrane can be observed above
the amyloid masses in the process of being resorbed. The circumscribed
lesions of the basement membrane and the epithelial cells result in
markedly increased permeability of the glomerular capillary walls for
proteins with high molecular weights. At the onset of proteinuria, IgG-
positive storage of protein in hyaline droplets within the tubular cells
can be demonstrated with the PAP-method, Based on these findings, we
concluded that a flooding of preamyloid substances provokes a local
cell reaction, which then leads to the extracellular formation of fibrallae
and subsequently to predominently mechanical damage to the local
cells. This damage to the local cells extends from the absence of the
local regenerative capacity of the basement membrane to total detach-
ment of portions of epithelial cells and, as a result, to increased
permeability of the glomerular capillary wall.
Pressor effect of 8-arginine-vasopressin in man: Interrelation of hemo-
dynamic and hormonal factors. K. GlOnzer, B. Pruj3ing, R. Dusing, and
H. J. Kramer. Medizinische UniversitOts-Poliklinik Bonn, West Germa-
ny. Previous investigations suggest that in a normotensive organism the
vasopressor effect of 8-arginine-vasopressin (AVP) is very effectively
buffered by cardiovascular reflex systems. The relative importance of
hemodynamic and hormonal factors in this regulatory system, however,
is not clear. In the present study we infused AVP in two different doses
(30 pmoles and 160 pmoles/min) in seven healthy volunteers. Maximal
plasma AVP concentrations (41 1.7 and 207 43.7 fmoles/ml,
respectively) were reached at the end of the I-hour infusion period.
During the early phase of the AVP infusion, only a very small and not
significant increase in blood pressure (BP) was observed. BP returned
to preinfusion values after 20 mm despite continuing AVP infusion.
Cardiac index (CI) measured by impedance cardiography decreased 1!
and 22%, respectively, during the first 10 mm of the AVP infusion,
mainly due to a decrease in stroke volume ( SV, —3.3%) and heart rate( HR, —9.3%). All hemodynamic parameters returned to preinfusion
values within 20 mm despite continuing AVP infusion. At this time,
maximal plasma AVP levels were not yet reached. To determine the
role of endogenous vasoactive substances, we measured plasma renin
activity (PRA) and prostaglandin (PG) synthesis inhibited with indo-
methacin prior to AVP infusion. AVP suppressed PRA from 1.49 0.77
to 0.87 0.43 nglml/3 hr. Pretreatment with indomethacin did not
influence magnitude and time course of the hemodynamic changes (
CI, —14%; z SV, —13%; BP, +2%). Our results suggest that the
vasoconstrictor effect of AVP is antagonized in the early phase of the
infusion via the cardiovascular reflex system. In the second phase other
hemodynamic, nervous, or hormonal counterregulations must be postu-
lated. An important role of the endogenous PG system in modulating
the pressor effect of exogenous AVP seems unlikely.
Effect of dopamine on the glucose release of the rat kidney in vivo. J.
Greven and F. J. Charl. Abteilung Pharmakologie, Medizinische Fakul-
tOt, Technische Hochschule Aachen, Aachen. Renal cortical slices and
isolated renal tubules of the rat have been widely used to study the rate
of gluconeogenesis under various experimental conditions. It has been
found that these preparations produce glucose from several substrates,
the gluconeogenetic capacity being even higher than that of the liver. In
addition it has been shown from this laboratory that the kidneys of the
rat release glucose in the blood in vivo. It could be further shown that
the renal glucose release was enhanced by stimulation of the 3-
adrenoceptors. In the present study, the effect of dopamine on the
glucose release of the intact functioning kidneys of rats was determined.
Glucose concentrations were measured in arterial and renal venous
plasma, and the renal glucose release was estimated by simultaneous
determination of renal blood flow (RBF) (electromagnetic flowmeter).
Net renal glucose release was found in control experiments. Dopamine
(7.8 x l0 moleskg'-min' i.v.) increased RBF, glucose concentration
in arterial plasma, and renal glucose release. The glycogen content of
the kidneys was found to be too small to account for the observed renal
glucose release by glycogenolysis. These in vivo data therefore indicate
enhanced renal gluconeogenesis after dopamine. The rise of renal
glucose release and of arterial glucose concentration could be antago-
nized by propranolol (3.9 x l0 moles-kg1min1 iv.) but not by the
specific dopamine antagonist haloperidol (7.8 x l0- moleskgmin
iv.) which only abolished the dopamine induced increase in RBF. It is
suggested that dopamine interacts with a specific receptor in the renal
vascular bed, whereas the increase in renal glucose release is mediated
through 3-adrenoceptors.
Determinants of hyponatremia in experimental syndrome of inappro-
priate antidiuretic hormone secretion. P. A. Gross. Dept. Med., Univ.
Colorado Health Sci. Ctr., Denver, Colorado, U.S.A. Factors that may
determine the severity of hyponatremia in the syndrome of inappropri-
ate antidiuretic hormone secretion (SIADH) have not been rigorously
examined. We therefore studied hyponatremia in response to intravas-
cular infusions of DDAVP and hypotonic fluid over 5 days in conscious,
unrestrained, pairfed rats. Controls (C) and experimental rats (E)
received 0.22% saline at 3.0 ml/hr, and DDAVP at 0.112 gig/hr was
added after 24 hours in E. Plasma sodium fell progressively until 72
hours in E, after which stable hyponatremia (E, 124; C, 145 mEq/liter, P
< 0.001) and escape from the hydroosmotic effect of antidiuretic
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hormone occurred. Urinary sodium excretion was no different between
E and C, and thus hyponatremia in E was caused by water retention
alone. To evaluate the roles of exogenous and endogenous factors in
this hyponatremia, we studied variations in fluid uptake, prostaglandin
secretion, and plasma aldosterone in additional groups of animals. To
determine, whether the rate of fluid uptake influenced hyponatremia,
we reduced infusion flow rates to 1.5 mI/hr of 0.22% saline, keeping the
dose of DDAVP constant, (Ei). Hyponatremia was abolished by this
variation (Ei, 143; C, 145 mEq/liter, P = NS). To study the effect of
solute excretion on hyponatremia, we increased and decreased solute
excretion rates by infusion of 0.9% saline (F2) and distilled water (E3) at
flow rates and DDAVP doses comparable to E. In E2, no hyponatremia
occurred (C, 145; E2, 143 mEq/liter, P = NS), whereas hyponatremia in
E3 was enhanced (F3, 111; E, 124 mEq/liter, P < 0.01). Since prosta-
glandins are known antagonists of antidiuretic hormone and urinary
prostaglandin £2 excretion rate (PGE2) increased after the start of
DDAVP in E (E, 4300; C, 2100 pg/hr; P < 0.01), we determined their
influence on water retention by prostaglandin inhibition with low dose
indomethacin (1.7 mg/kg/day) in a further group of animals (E4).
Hyponatremia was enhanced under these conditions (E, 125; E4, 120
mEq/liter, P < 0.05). Although plasma aldosterone (Aldo) was no
different between C and F at 120 hours (C, 32; F, 30 mg/dl, P = NS),
neither DOCA (500 nor infusions of an aldosterone inhibitor,
SC-l4266 (0.8 mg/day), influenced the degree of hyponatremia. We
conclude that the rate of fluid uptake and the osmolalities of infusate
modulate the degree of hyponatremia in SIADH. PGE2 also has an
important role in water retention, whereas aldosterone was unimpor-
tant.
Distribution of hexokinase and phosphoenolpyruvate carboxykinase
along the rabbit nephron. W. G. Guder, A. Vandewalle, and G.
Wirthensohn. K/in. Chem. Inst., Stádt. Krankenhaus München-
Schwabing, Munich, FRG, and INSERM U2 Hopital Leon Bernard,
Limeil-Brevannes, France. The role of glucose as a metabolic fuel of the
mammalian kidney has not been evaluated, because arteriovenous
differences are hard to measure in vivo. This is caused by the
simultaneous occurrence of gluconeogenesis and glycolysis in the
kidney. To get insight into the intrarenal distribution of the respective
pathways, we have measured the distribution of typical enzymes of
glucose metabolism (hexokinase; HK) and gluconeogenesis (phospho-
enolpyruvate carboxykinase; PEPCK) in single microdissected seg-
ments of the rabbit nephron. Tubules of 0.5 to 2.0 mm in length were
dissected on collagenase-treated kidney. After measuring tubular length
by photography, the segments were permeabilized by freezing on dry
ice. HK activity was determined by measuring '4C02-formation from
[U)4C]-glucose. Incorporation of [-y-32P]-GTP into phosphoenolpyru-
vate was taken as a measure of PEPCK activity. All results were related
to tubular length (pmoles/minlmm). The following results were ob-
tained:
Structure HK PEPCK HK/PEPCK
PCT 1.11 3.55 0.3
PR 1.23 1.50 0.8
TDL 0.65 0.14 4.6
MAL 3.03 0.13 23.3
CAL 2.56 0.14 18.3
DCT 5.44 0.20 27.2
CNT 4.93 0.15 32.9
CCT 3.52 0.11 32.0
MCT 4.33 0.12 36.0
From this study it can be concluded, that in the rabbit nephron, the
proximal tubule is the only structure performing gluconeogenesis. In
contrast, the distal segments have the enzymatic equipment to metabo-
lize glucose to a major extent.
Pathogenesis of the dialysis-induced symptoms. H. Hampl, H.
Paeprer, I. Resa, C. Fischer, T. Ryzlewicz, R. Schiller, and M. Kessel.
Department of Nephrology, Free University of Berlin, Germany. The
circulatory response during different treatment procedures like single-
pass acetate dialysis (HDA; N = 10 patients), single-pass bicarbonate
dialysis (HDB; N = 6 patients), acetate-recirculation dialysis with
venous bicarbonate buffering (RD; N = 5 patients), hemofiltration with
lactate (HF; N = 5 patients) has been examined regarding a correlation
of certain acid-base changes. We made an intraindividual comparison of
the arterial acid-base values between HDA/HDB (N = 5), HDA/RD (N
= 5), HDA/HF (N = 5) over a treatment time of 4 hours every 15 mm.
The following parameters were measured: cardiac output (CO; thermo-
dilution), heart rate (HR), total peripheral vascular resistance (TPR),
blood pressure (BP), arterial acid-base values: pH, Pco2, standard-
bicarbonate (SBC), base excess (BE), Po2, 02-saturation (SAT). Statis-
tics: circulatory values (paired t test); acid-base values (unpaired i test).
Stable circulation during RD, HF, HDB versus unstable circulation
during HDA was explained by a significant increase of the TPR (pre to
240 mm; RD: HDA, P < 0.0125; HF: HDA, P < 0.005; 1-1DB: HDA, P
< 0.005) while no significant changes of BP and HR occurred. CO
decreased significantly (RD, P < 0.0125; HF, P < 0.0025; HDB, P <
0.0025). In comparison, HDA showed circulatory instability because of
an insignificant increase of the TPR and a significant HR increase (P <
0.025). In correlation to the circulatory stability, we found well-
balanced arterial acid base values during RD, HF, HDB versus HDA:
SBC (HDB, P <0.0005; RD, P <0.01; HF, P <0.0025); BE (HDB, P
<0.0005; RD, P <0.01; HF, P <0.0025); Pco2 (11DB, P <0.0005; RD,
P < 0.01; HF, P < 0.0025). But no remarkable differences in Po2 and
02-SAT could be found (Bohr-effect insignificant). We consider the
significant decrease of Pco2 during HDA as a possible reason for
circulatory instability. A certain milieu, depending on Pco2 and/or pH
could be decisive for adequate vasoconstriction during treatment. A
sudden arterial Pco2 decrease with an irregular change of pH leads to an
altered stage of consciousness, headache, tiredness, blood pressure
decrease, and arrhythmia.
Influence of the acid-base metabolism on the circulatory stability:
comparison of single-pass dialysis with acetate to bicarbonate. H. Hampl,
I. Resa, C. Fischer, T. Ryzlewicz, R. Schiller, H. Paeprer, and M.
Kessel. Department of Nephrology, Free University of Berlin, Germa-
ny. We examined the question, whether there are differences in the
adaption of the total peripheral vascular resistance (TPR) under fluid
loss between dialysis with acetate (HDA) (N = 10 patients) and with
acetate (HDB) (N = 6 patients) and whether these correlate to
significant differences of arterial acid base values. The following
parameters were measured: cardiac output (CO; thermodilution), TPR,
central venous pressure (CVP), blood pressure (BP), heart rate (HR),
arterial acid-base values: pH, Pco2, standard bicarbonate (SBC), Po2.
Statistics were by circulatory values (paired I test: P < 0.05k; p <
0,005,P < 0.0025k + 1. Acid-base values: intraindividual compari-
son of HDA/HDB (N = 5) (unpaired t test: P < 0.0005).
CO TPR CVP BP HR pH Pco2 SBC P02
pre 5.1 1561 5.4 142/76 78 7.295 32.9 16.6 95
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The results show, that the circulatory values are remarkably more
stable during HDB compared to HDA because of a significant increase
of TPR. This correlates with well-balanced arterial acid-base values:
normalization of Pco2 and consequently of pH and SBC. But we found
during HDA a significant Pco2 decrease with irregular pH changes.
Contrary to this, we obtained intraindividually different P02 values. We
consider the significant decrease of Pco2 during HDA as a possible
reason for the circulatory instability. A certain milieu, depending on
Pco2 and/or pH could be decisive for the effect of the catecholamines
and therefore responsible for a suitable vasoconstriction.
Blood pressure regulation in essential hypertension: Comparison be-
tween saluretic and beta-blocking therapy. S. Hanke, U. Litmeyer, W.
Daniel, M. Hilfenhaus, and H. Liebau. Hannover Medical School,
Hannover, West Germany. To compare the antihypertensive effects of
saluretic and 3-blocking agents, with particular regard to blood pressure
regulation during exercise, we studied 18 patients with essential hyper-
tension and normal renal function. Following a control period of at least
14 days without any antihypertensive treatment, all patients received 3
x 5 mg/day Pindolol (P) combined with 10 mg/d Clopamid (Cl) for 2
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weeks. Subsequently, patients were divided into two groups: for
another period of 2 weeks 9 patients were treated with 3 < 5 mg/day F,
and 9 patients with 10 mg/day Cl alone. Blood pressure (BP) at rest and
under exercise (bicycle ergometer), blood volume (By), exchangeable
sodium (Na,3, plasma renin activity (PRA), and body weight (BW)
were measured at the end of each treatment period. Results. BV and
BW showed no significant changes under the different therapeutic
regimens. Naex increased during Cl therapy alone. PRA showed a high
increase after Cl treatment, only a slight increase under combined Cl
plus P therapy, and was slightly lowered following P treatment. BP
reduction at rest reached a similar degree under all three therapeutic
regimens; under exercise, however, BP increased by only 15% under P
and 19% under P plus Cl as compared to 27% under Cl and 28% in the
control period. Conclusions. In hypertensive patients a further increase
of BP due to exercise is much better controlled by 3-biocking agents
than by saluretics while the resting BP is lowered to a similar degree by
both therapeutic regimens. The antihypertensive efficacy of P and/or Ci
does not correlate significantly with changes of PRA, By, and Na5.
Control of correct 24-hour urine collection by measuring creatinine
excretion in milligrams per kilogram of lean body mass. E. Hecking, H.
Verhaag, W. Prellwitz. 1st Medical University Clinic, Mainz, FRG.
Twenty-four-hour urine specimens are routinely used for measurement
of creatinine clearance or urinary excretion of numerous substances.
According to the literature 30 to 50% of those collections are not
complete, but there exists no simple method to exclude incorrect urine
collections, Quantitative excretion of creatinine is often used but it is
not well defined. The aim of our study was to give limits of quantitative
creatinine excretion for calculating the correct collection of 24-hour
urine specimens. Ten times, the total 24-hour urine was exactly
collected from 14 healthy colleagues of our clinic, aged to 22 to 59
years. Creatinine excretion was different for the 7 females (1099 220
mg/24 hr) and the 7 males (1904 162 mg/24 hr) also if related to body
weight or body surface area. The variation coefficient of repeated
laboratory analysis amounted to 6.9%. As expected, the variation
coefficient of creatinine excretion of the same person on different days
rose to 5 to 16%. Since creatinine excretion depends on muscle mass,
lean body mass was measured using whole body counter and 40K
method (females, 35.0 6 kg; males, 59.4 4.5 kg). Creatinine
excretion and lean body mass correlated highly significant (r = 0.983).
Related to lean body mass, females and males had statistically identical
creatinine excretion per kilogram of lean body mass (30.8 2.3 and 31 .8
1.6 mg/kg of lean body mass respectively.) These data were con-
firmed by 433 urine specimens collected over 24 hr of 45 young control
persons. The measurement of lean body mass in all 59 persons proved
the same accuracy using more simple anthropometric methods (upper
arm circumference, triceps skinfold thickness, body weight) as well as
by use of the whole body counter (mean error, +4 to —8%). As
confidential limits, the median and 2.5-fold standard deviations of the
complete creatinine excretion per 24 hr were found to be 31 5 mg
creatinine per kg kilogram of lean body mass, not depending on sex.
Therefore with simple anthropometric measurement of lean body mass
the creatinine excretion per kilogram of lean body mass allows to
control complete collection of 24-hr urine specimens.
Effect of bradykinin upon impaired glucose tolerance in the uremic
patient on regular hemodialysis. R. Heidler, G. Dietze, M. Wicklmayr. 4.
Med. Klinik des Klinikums und Instituts für Nephrologie, Nurnberg, 3.
Med. Klinik (Stoffwechsel und Endokrinologie) des Akademischen
Lehrkrankenhauses Schwabing der Universität und Forschergruppe
Diabetes, München, Germany. Immediately after dialysis glucose toler-
ence (GT) was often reported to be reduced in the uremic patient on
regular hemodialysis (UPRH). This was supposed to be due to insulin
resistance of the peripheral tissues (IR). Since IR occurring during the
early postoperative period was improved by the application of bradyki-
nm (BK), the following study was designed. Intravenous GT tests
(IGTT) were performed in 30 UPRH before and after dialysis. In 10 of
them, BK was infused (150 kg/hr) during the IGTT after dialysis.
Dialysis significantly reduced GT (before K1 = 1.34 0.17, afterwards
K2 = 0.70 0.09; P < 0.01, 2aired t test). K2 was improved by BK
(1.89 0.31; P < 0.005, paired t test). Conclusions. BK improves
reduced GT after dialysis in UPRH. This is probably due to the ability
of kinins to augment insulin sensitivity of muscle tissue.
Quantitative evaluation of human kidney tubular damage by enzymatic
and immunologic image analysis device. G. Heinert, J. E. Scherberich,
W. Mondorf, and W. Weber. Z. Chirg., Dept. Urology and Dept.
Nephrology, ZIM, Univ. Frankfurt, Germany. Since previous studies
have shown the excretion of tubular proteins in patients with kidney
diseases, the tissue patterns of specific-marker proteins of the proximal
tubule such as Ala-aminopeptidase (AAP), alkaline phosphatase (AP),
and maltase (Ma) were studied under normal and pathologic conditions
using a quantitative image analysis device (Microvideomat II, Zeiss). In
addition, image analysis of Goldner and PAS stains as well as of specific
immunofluorescence applying antisera directed against brush border
AAP were carried out. The signals obtained from 10 to 15 tissue areas,
each of 1.54 mm2, were determined. The following profile was found in
normal human kidneys: AAP, 790 109.1 units (U) (N = 17); AP,
222.0 59.0 U (N = 10); Ma, 484.3 7.3 U (N = 7). The
concentrations of AAP as an antigen of the brush border surface,
measured by specific immunofluorescence (IF) were: 240 33.6 U (N
= 12). Image analysis after Goldner stains was 599.1 47. 3 U (N =
11). In contrast to these findings, a statistically significant decrease
(Mann-Whitney test 2a <0.01 to 0.001) in the concentration of marker
proteins was found in pathologically changed kidneys (hydronephrosis,
interstitial nephropathy, ischemia, chronic allograft rejection crisis).
The following pattern, found under such conditions, emerged: AAP,
410.3 53.6 U (N = 21), AP, 35.9 21.2 U (N = 39); Ma, 242.9
133.9 U (N = 23);AAP-IF, 115.3 42.4 U (N = 18); Goldner, 355.7
149.4 U (N = 24). The most striking difference, compared to normal
kidney (2a < 0.001) in marker protein profils was found in kidney
tumors (renal adenocarcinoma): AAP, 88.7 146.9 U (N = 33); AP,
31.2 61.0 U (N = 43); Ma, 22.0 30.7 U (N = 36); AAP-IF, 43.2
9.7 U (N 24): Goldner, 449.9 205 U (N = 65). Furthermore,
kidney tissue adjacent to the proliferation zone of the carcinoma
revealed a significant loss of tubular indicator enzymes (e.g., AAP 2ce <
0.001). Quantitative evaluation of proteins, specific for a defined part of
the nephron, appears to be a tool in monitoring the degree of structural
damage, and might be of potential relevance for diagnostic and prognos-
tic purposes.
Changes in amino acid concentrations in brain areas involved in blood
pressure regulation in rats with spontaneous hypertension. K. Hempel,
M. Pröstler, M. Palkovits, A. Heidland, and G. Schmid. Inst. f. Med.
Strahienkunde & Medizinische Klinik d. Univ. Wflrzburg and First
Institute of Anatomy, Medical School Budapest. The amino acid
concentrations in 19 brain regions from spontaneously hypertensive
(SH) rats, strain SHR OKAMOTO, and normotensive (N) rats, strain
WISTARJKYOTO, were compared. Amino acids were determined
fluorometrically in brain areas isolated by the punch technique. Brain
samples from SH rats (Table) had a higher content of Glu and Gin and
taurine than those from normotensive animals, whereas the concentra-
tion of the other amino acids, especially of GABA and glycine, amino
acids that might play an inhibitory role in brain, were lower. The
alterations are not restricted to regions connected with the baroreceptor
reflex arc.
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Invoiced in BP regulation
I 8.3 13.9+ 43.3 52.8 19.2 12.2+ 33.3 24.0+ 9.9 6.5
2 2.6 3.2 16.4 14.4 4.8 2.2+ 12.5 8.3+ 3.3 1.0+
3 3.9 5,9 24.7 28.4 8.4 5.4 20.7 17.2 4.5 1.4+
4 8.3 16.2+ 43.7 77.2 34.7 29.9 26.6 18.6+ 8.8 3.1 +
5 27.2 28.1 87.5 92.6 nd. 18.1 13.9 9.1 5.8
6 8.4 11.1 + 24.7 43.1 + 24.5 19.1 + 13.0 7.7+ 4.6 1.9+
7 7.8 28.2+ 35.2 108.4+ 15.3 29.7+ 11.3 17.8+ 5.6 1.3
8 6.4 9.7 27.3 28.9 15.8 12.4 10.3 4.8 4.2 1.4
9 9.3 11.5 38.5 51.1 nd. 13.3 6.0+ 6.0 1.8+
10 22.0 29.9 nd. nd.
Not involved in BP regulation
26.7 11.6+ 12.5 4.2
II 6.7 9.5 40.4 46.4 14.4 8.6+ 29.6 19.6+ 11.4 2.3+
12 4.6 6.2+ 24.8 26.8 8.2 5.2 18.6 16.5 5.5 1.2+
13 1.9 2.9+ 6.8 13.8+ 3.7 4.0 4.0 2.1 + 1.3 0.4+
14 10.3 14.9+ 18.2 30.0+ 20.3 25.3 11.4 5.2+ 3.9 1.0+
IS 5.0 9.6+ 23.1 37.5+ 21.7 13.0+ 10.3 5.5+ 4.6 1.5+
16 15.5 25.8+ 49.4 76.1 + 33.7 21.4 23.6 14.2+ 9.4 nd.
17 7.7 12.3 nd. 5.2 3.2 2.7 1.7 1.6 1.1 +
18 32.7 16.8 132.0 181.0 nd. 26.4 32.7 16.8+ 18.2 6.4+
19 nd. nd. nd. 4.1 1.9+ 2.4 0.9
Data are expressed in nmoleslmg wet tissue (N = 3 to 5). + P< 0.05. 1 n. tract. solitarii, 2 n.
reticularis lat., 3 formatio reticularis, 4 locus coeruleus. 5 amygdala. 6 n. hypothalamicus post.,
7 median basal hypothalamus, 8 n. paraventricularis, 9 n. hypothalamicus ant., 10 n. interstialis
striae terminales, ii oliva inf., 12 n. traCtus spinalis N. trigemini, 13 central gray. 14 substantia
nigra. l5 corpus mammilare, 16 habenula, 17 hippocampus, 18 cingulum. 19 cortex frontalis.
150 Abstracts
Evaluation of adrenal venous blood catecholamines in the diagnosis of
pheochromocytoma. M. Hilfenhaus, R. Grote, and H. Liebau. Hanno-
ver Medical School, Hannover, West Germany. In a hypertensive
patient with suspected pheochromocytoma of the left adrenal gland
(borderline elevation of urine and plasma catecholamines on several
occasions, enlargement of the left adrenal gland documented by com-
puted tomography) high catecholamine concentrations were found in
the venous blood of the left adrenal gland (adrenaline [A], 8566 pg/mI;
noradrenaline [NA], 3196 pg/mI). Leftsided adrenalectomy was per-
formed; the diagnosis of a pheochromocytoma, however, was not
confirmed by histology, and hypertension persisted postoperatively.
Since normal values of catecholamines in adrenal venous blood are not
known, A and NA concentrations in the adrenal venous blood were
measured in 6 hypertensive patients (without pheochromocytoma)
during diagnostic renal vein renin studies. The concentrations of A
(1957 to 118,350 pg/ml) and NA (940 to 16,880 pg/mI) in the left adrenal
venous blood showed a large scatter, the range even exceeding the
values found in an additional patient with proven pheochromocytoma of
the left adrenal gland (A, 47,920 pg/mI; NA, 1100 pg/mI). Our results
suggest that the determinations of catecholamine concentrations in the
blood of the adrenal vein are of limited value in the diagnosis of
pheochromocytoma; high amounts of catecholamines may be liberated
from an unaffected gland by catheter manipulations.
Biopsy of the transplanted kidney in early and late rejection crises:
Prognostic value and therapeutic consequence. G. Hillebrand, J. M.
Gokel, G. Thoenes, L. A. Castro, W. Land, and H. J Gurland. Med.
Klinik u. Chirurg. Klinik GroJ3hadern, Patholog. Institut u. Med. Klinik
lnnenstadt der Universitdt Miinchen, Germany. In 47 out of 162
transplanted patients, 54 biopsies were performed. Indications were (1)
nonfunctioning graft > 3 weeks p.o., (2) therapy resistent and/or
repeated rejections, (3) suspected symptomless late rejection, (4) sus-
pected recurring or de novo glomerulonephritis. Thirty-one biopsies (25
patients) were performed in early rejection crises (RC) ( 8th week
p.o.), 23 biopsies (22 patients) in late RC (> 8 weeks p.o.). All biopsies
were done with local anesthesia with the TruCut® needle (Travenol).
Histologic examination revealed cellular transplant reactions (CTR),
vascular changes (VC), as well as glomerular lesions (GL). The
histologic findings were classified into three groups: (I) predominantly
CTR, (II) combination of CTR/VC (GL), (III) predominantly VC. In the
majority of the cases (see Table) the rejection crises were treated with
methylprednisolon pulses and ALG if no contraindications for an
additional immunosuppressive medication existed. The correlation be-





Patients RC, no. Successful Unsuccessful
Group I
EarlyRC 7 9 7 2
LateRC 11 9 6 3
Group II
EarlyRC 5 5 2 3
LateRC 5 2 I
Group III
EarlyRC 13 13 2 11
LateRC 6 2 1
The results achieved can be interpreted as follows: (1) The expected
good therapeutic response in predominantly cellular transplant reaction
in the early phase is confirmed; moreover treatment seems to be
promising even in the late phase. (2) The unsatisfactory response of
group II might be explained by the simultaneous presence of humoral
and cellular forms of RC. (3) In severe vascular rejection crises it seems
to be justified to refrain from an additional immunosuppressive therapy
even in the early phase.
Legionnaire's disease following renal transplantation: Favorable out-
come in an immunosuppressed patient. G. Hillebrand, L. A. Castro, W.
Land, G. KOnig, G. Ruckdeschel, and H. Dobbe/stein. Med. Klinik I,
Chirurg. Klinik, Klinikum GroJ3hadern, Max-v .-Pettenkofer Inst it ut für
Hygiene u. med. Mikrobiologie der Universität München, Krankenhaus
der Missionsbenediktiner, Tutzing. Acute rejection crises require an
increase of immunosuppressive medication. This means a considerable
risk of infection for patients with renal transplants, especially in the
early postoperative phase. Besides bacterial and viral infections, an
infection with Legionella pneumophila in cases of therapy resistent
pneumonia has to be considered. Even in nonimmunosuppressed
patients severe lethal Legionella pneumonias may occur (Philadelphia
epidemic of 1976, 19% fatal outcome, 56% fatalities when treated with
steroids). Although severe Legionella infections with a fatal course
were reported, a favorable outcome in immunosuppressed patients is
observed if a specific antibiotic therapy (erythromycin) is applied. Our
patient (female, 26 yr) developed progressive pneumonia during a
second rejection crisis treated with methylprednisolon pulses and ALG.
Pathogenic organisms could not be detected while repeatedly exam-
ined. Common antibiotic therapy (mezlocillin, gentamycin; later cefo-
taxim) was unsuccessful although immunosuppressive medication was
discontinued, After 2 weeks, an impressive clinical improvement oc-
curred, temperatures raised above 39° C went down, renal function
became almost normal (creatinine, 1.9 mg/dl). Since in chest x-rays
pulmonary infiltrations were still evident, we performed a bronchosco-
py with bronchial lavage. Only minor signs of inflammation were seen.
The demonstration of pathogenic organisms was negative. On the 25th
day after onset of illness, antibody titers against Legionella pneumo-
phila (Philadelphia I) rose to 1:1024, thereafter the patient was treated
orally with 1 g of erythromycin over a 2-week period. The chest x-ray
controls revealed a clear improvement, only minimal infiltrations
remained, antibody titers were now at 1:2048, transplant function was
good (creatinine 1.6 mg/dl). In therapy-resistent pneumonias an infec-
tion with Legionella pneumophila has to be considered since in such
cases a specific therapy with erythromycin is indicated.
Laser nephelometry of albumin in urine by equivalence-point estima-
tion. H. Hobler, M. Keller, and M. Weise. Medizinische Poliklinik der
Universität GieJien. Estimation of albumin in the urine of healthy
subjects requires sensitive methods. The use of laser nephelometry
(LN) by common antibody-excess calibration technic is problematic
because of the heterogeneity of urine. (Predilution of the samples with
buffer is limited by the small albumin content.) Therefore we developed
a method that is independent of pH, ionic strength, and unspecific
background turbidity. Antisera, standard sera, and nephelometer were
obtained from Behringwerke AG (BRD). Native urine is diluted 1:10
with phosphate buffer (pH, 7) and then centrifuged (10 win, 5000 UI
mm). Five serial dilutions (100 jil) of the supernatant are incubated with
200 l of an antiserum-buffer mixture (1:100), and the equivalence point
of the laser nephelometric immune precipitin curve is measured. As in
all cuvettes, the antibody content is equal, the equivalence point refers
to a well-defined antigen concentration, which is measured in an
identical procedure with a standard serum with known albumin content.
By estimation of the equivalence point, for the dilution of the urine
aliquot, the albumin content is read off directly on a logarithmic scale.
Extrapolation is facilitated by the uniformity of the immune precipitin
curve. To judge the reliability of the results, we compared three
methods: (1) laser nephelometry with common antibody-excess calibra-
tion, (2) laser nephelometry with equivalence point estimation, (3)
radioimmunoassay. By method I only 70% of the compared samples (N
= 100) were measurable. Thirty percent showed a too elevated back-
ground turbidity or did not accomplish simple quality control criteria as
reproducibility of the results when the urine samples were prediluted.
Method 2 had unlimited applicability. Antibody consumption of meth-
ods 1 and 2 is equal. Because of the high antibody dilution of method 2
we prefer a 12 hr incubation time. Sedimentation effects are eliminated
by shaking (vortex) the cuvettes before laser nephelometric measure-
ment. The sensitivity of methods 1 and 2 is 0.05 mg/dt. The results range
from 0.6 to 12 mg/24h. A comparison of LN (2) and RiA (3) showed a
good accordance (r> 0.9, N = 100).
Respiratory alkalosis reversibly abolish the phosphaturic effect of
parathyroid hormone, calcitonin, and dibutyryl cyclic AMP in rats. A.
Hoppe, B. Kalinowska, and S. Angielski. Department of Clinical
Biochemistry, Institute of Pathology, Medical Academy Gda,isk, Po-
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land. We have previously shown in a preliminary report that respiratory
alkalosis (RA) results in an increase of phosphate (Pi) reabsorption and
prevents the phosphaturic effects of PTH. We therefore evaluated if RA
could abolish already increased Pi excretion induced by PTH, calcito-
nm (CT), and db-cAMP and if the effect is reversible. Rats were kept on
normal Pi diet (0.8% Pi) except that the db-cAMP group was fed with a
high Pi diet (1.4% Pi). Parathyroidectomy (PTX) was done 90 mm prior
to clearance experiments, and then rats were infused with bovine PTH
(1—34, 20 U/kg prime, 0.5 U/kgmin), salmon CT (1 U/kg, 0.2 U/kg.min)
and db-cAMP (1 mg/kg and 0.04 mg/kgmin). Three collections were
made during 1 hr of normal ventilation, 1 hr of RA induced by
hyperventilation and 1 hr of recovery from hyperventilation.
TPTX Normal ventil. Hypervent. Recovery
%
Control 0.4 0.4 0.6 0.6
PTH 0.9 12.3 39* 14.3
CT 0.5 4.5 1.1* 10.6
db-cAMP 14.5 30.0 12.4* 26.8
(Values are the mean, asterisk denotes P < 0.01.) RA ab.olished the
PTH-, CT-, or db-cAMP-induced phosphaturia, which reappeared
during recovery period. The RA did not change the tissue Pi content but
resulted in a decreased ATP level from 2.19 0.06 to 1.48 0.12
moles/g of wet wt of the kidney. Since RA released the inhibition of Pi
reabsorption induced not only by PTH or CT but also by db-cAMP, we
conclude that RA acts on a step beyond the cAMP formation. The effect
is seen only as long as RA exists. The RA increase Pi reabsorption,
possibly via enhanced ATP turnover, which cannot be overcome by the
inhibitory effect of PTH, CT, or db-cAMP on Pi reabsorption.
Comparative studies on the renal elimination of B2-microglobulin and
alanine aminopeptidase and their potential nephrotoxicity. G. Jaques, M.
Keller, M. Weise, and A. W. Mondorf. Zentrum der Inneren Medizin
Giessen and Frankfurt. Cephalosporins, aminoglycosides, their combi-
nation, and plasma-expanders were investigated in therapeutic dosages
for their nephrotoxicity. Therefore B2-microglobulin (B2m), alanine
aminopeptidase (AAP), trichloracetic acid-precipitated protein, albu-
min, and the usual routine renal function parameters were estimated.
Thus, these parameters were investigated in 24-hour urine samples of
healthy informed volunteers (N = 59) 2 days before, during the 3 days
of drug administration, and for a further 3 or 4 days. The plasma-
expanders were infused only once. There was evidence that the effects
of the cephalosporins (cefotaxim, 6 g/day) on the proximal tubule were
totally indifferent, there was no marked increase in the B2m- and AAP-
elimination, while the aminoglycosides and their combination with
cephalosporins (cephalotin, 8 g/day, plus tobramycin, 3 mg/kg/day)
showed a typical pattern of elimination for AAP, which was partly
identical to the B2m elimination. In a study with the aminoglycoside
ribostamycin (15 mg/kg/day) a clear divergence between the AAP- and
B2m-elimination could be found. While in this case B2m showed only an
increasing tendency (105 —* 158 g/24 hr), the elimination of AAP was
significantly increased (2565 —* 7766 mU/24 hr). We can assume that
there is no remarkable functional change of the whole tubular apparatus
in spite of a possible injury of the membrane. The administration of the
plasma-expanders showed, after the infusion of the oxypoligelatine (500
ml, 55 g/liter) a significant increase of the B2m-elimination (0.096 — 118
g/min), but no important change in AAP, while the application of the
dextran (500 ml, 60 g/liter) did not influence the AAP- and B2m-
elimination. Therefore it has to be considered that the gelatine effects a
competitive inhibition of the B2m reabsorption at the tubular mem-
brane. In regard to the clinical relevance, it seems to be reasonable to
measure both parameters for the critical examination of tubular alter-
ations.
Course of hepatitis B infection after renal transplantation. R. font of-
sohn, H. M. Herb, H. Bertold, and B. Schubert. Medizinische Kinik
and Inst. für Virologie der Universität Freiburg, 1. Medizinische Klinik
der Universitát Mannheim. The course and significance of hepatitis B in
250 patients after renal transplantation was studied retrospectively and
prospectively over 6 to 60 months. In 32 patients, a clinical hepatitis B
was detected. These patients were assigned into four groups dependent
on serologic and clinical signs: Group I. HB-antigen-positive, HBE-
antigen-negative, with or without elevated liver enzymes, N = 15
patients. Group II. HB- and HB5-antigen-positive, N = 6 patients.
Group III. HB5-negative, anti-HB-positive, anti-HB5-negative, N = 8
patients. Group IV. HBs-negative, anti-HBc-positive, anti-HBs-posi-
tive, N = 3 patients. In some of the HB5-negative patients (group III)
the persistent HBV-infection could be proved by the demonstration of
immunofluorescence of HB5- and HB-antigen in the liver tissue. Out
of 32 patients, 12 developed liver cirrhosis; 6 of these patients died in a
hepatic coma. Patients of groups III and IV without HB5-antigen had
surprisingly the worst prognosis: 8 out of II patients developed liver
cirrhosis, 4 patients died in hepatic coma. The prognosis of HBV-
infection in kidney transplant patients was significantly worse than in
dialysis patients. Of 44 dialysis patients with HBV-infection, 8 patients
developed a liver cirrhosis, only 2 died in hepatic coma. First clinical
evidence of HBV infection was noted in 15 patients after renal
transplantation. A reactivation of previous infection could be demon-
strated in 10 patients on the basis of the course of the serologic studies.
It would therefore appear that it is a further risk to transplant patients
previously infected with hepatitis B virus.
Biotransformation and elimination of lormetazepam in end-stage renal
disease. D. Kampf, M. Huempel, G. Lerche, and M. Kessel. Depart-
ment of Nephrology', Klinikum Charlottenburg, Free University of
Berlin, and Research Laboratories2, Schering AG, W-Berlin, FRG. In
healthy subjects the new benzodiazepine lormetazepam (LMA) is
extensively metabolized to its glucuronide which is almost exclusively
eliminated by the kidney. For this reason, the effects of renal insuffi-
ciency and hemodialysis (HD) on the disposition of LMA were investi-
gated in 5 patients (mean age, 54 11 yr) on regular HD treatment. All
subjects were studied under HD and in the interdialysis period. LMA
was given as a single oral dose of I mg after an overnight fast. Plasma,
urine, and dialysate concentrations of LMA and LMA-glucuronide
(LMA-GL) were determined using a specific radioimmunoassay. The
semilog plot of LMA plasma concentration and time data showed a
biphasic linear decline in all patients. The mean plasma half-lives (tY2
= 1.3 0.6hrandt'/2. = 13.7 8.6hr)wereinaccordancewiththatof
healthy subjects. 4- to 5-hr HD treatment had no effect on LMA plasma
concentrations or half-lives. No unchanged drug could be detected in
urine or dialysate. LMA-GL plasma concentrations showed a rapid
increase reaching a maximum after about 8 hours. Thereafter, the
plasma levels declined monophasically with a mean tY2 of 80 21 h.
The average urinary recovery of LMA-GL amounted to 3.8 0.7%/48
hr of the administered dose and corresponded to the mean residual
creatinine clearance of 3.6 1.1 ml/min/l.73 m2. The LMA-GL
concentrations from plasma entering and leaving the dialyzer showed
highly significant differences (P < 0.001, paired t test). From these
values a dialyzer clearance of 20 8 mI/mm could be calculated. On the
other hand, 4 to 5 hr HD treatment had no effect on the LMA-GL half-
life. The results show that after a single dose of LMA metabolism is
unchanged by renal insufficiency or HD treatment. On the contrary, its
main metabolite LMA-GL accumulates to a considerable degree. The
consequences of this accumulation after multiple doses remain to be
investigated.
Interaction of nonsteroidal antiinflammatory drugs with antikaliuretic
diuretics: Special reference to the renal prostaglandin-system. J. Kip-
nowski, T. Bininda, R. Düsing, and H. J. Kramer. Medizinische
Universitats-Po/iklinik Bonn, Germany. While the interference of in-
hibition of prostaglandin (PG) synthesis, induced by administration of
nonsteroidal antiphlogistic drugs with the renal actions of conventional
diuretics has been described by several groups of investigators, compa-
rable studies with antikaliuretic diuretics do not exist. The present
study was therefore performed to investigate a possible role of the renal
PG-system in the natriuretic and kaliuretic response to antikaliuretic
diuretics in the absence and presence of indomethacin (I), a potent
inhibitor of PG synthesis. Before the study each of 13 healthy human
subjects (7 females, 6 males) was given a diet containing 150 mEq of
sodium per day. Amiloride (A) and triamterene (T) were given orally in
doses of 5 and 50 mg, three times a day, respectively, while spironolac-
tone was injected iv. as a single dose of 200 mg at 08.15 hours. Each
diuretic drug was given in the absence and presence of PG inhibition
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with indomethacin (50 mg in the evening prior to the study and 50 mg
three times a day on the day of the study). Mean urinary PGE2-
excretion was 529 146 ng124 hr in males and 241 30 ng/24 hr in
females. Administration of S, A, and T was followed by a rise in urinary
sodium excretion of 39% (NS), 77% (P <0.025), and 80%, respectively.
The rise in urinary sodium excretion was accompanied by an increase in
urinary PGE-excretion of 258% (P < 0.025), 165% (P <0.025), and 40%
(NS). A + I, T + I, and S + I resulted in a suppression of urinary
sodium excretion of 24% (P < 0.025) 25% (P < 0.025), and 15% (NS),
respectively. This effect was accompanied by a suppression of urinary
PGE2-excretion of 55% (NS), 70% (P < 0.025), and 90% (P < 0.025).
While urinary potassium excretion was not affected during administra-
tion of T, administration of A and S was followed by a decrease in UKV
of 44% and 31%. Simultaneous administration of I abolished the
potassium sparing effect of A and S and suppressed urinary potassium
excretion in the presence of T (28%). These variable effects of inhibition
of PG synthesis, which also suppresses renin and aldosterone secretion,
may depend on the actual potassium-sparing potency of the diuretics
studied.
Dosage adjustment and elimination of atenolol in renal failure. W.
Kirch, H. Köhler, E. Mutschler, and M. Schafer. I. Med. Univ. Klinik
Mainz and Pharmakologisches Institut für Naturwissenschaftler der
Universitat Frankfurt, Germany. Atenolol, a beta-blocking drug, may
be administered to patients with renal insufficiency for any of the usual
indications, such as coronary heart disease, arterial hypertension or
cardiac arrhythmias, just as in patients with normal renal function. As
atenolol is mainly excreted via the kidneys, application of conventional
doses to patients with renal failure might lead to delayed elimination
and accumulation. Pharmacokinetics of atenolol were obtained follow-
ing acute iv. and chronic oral application in 20 subjects with a GFR
between 5 and 113 nil/mm. Plasma levels of another 5 patients on
hemodialysis dosed iv. were measured. Atenolol concentration in
plasma and urine was obtained by measuring the intrinsic fluorescence
of the drug on thin layer chromatograms. The mean tt/2 of elimination
increases from 5.9 hours in patients with normal renal function (GFR>
90 mI/mm) to 42.1 hours in preuremic patients (GFR < 10 mI/mm)
following a single iv. dose of the drug. The half life of elimination
following chronic oral administration does not differ significantly. Mean
peak plasma concentrations of atenolol increase from 540 ng!ml in
patients with GFR > 90 mI/mm to 1493 ng/ml in preuremic patients
(GFR < 10 mI/mm) following chronic oral doses of 100 mg a day. Mean
0/2 of elimination during a single hemodialysis treatment is 4.3 hours.
Calculation of the daily dose according to Dettli leads to the subsequent
proposition: In patients with a GFR > 30 mI/mm, normal daily dose of
atenolol may be administered; in patients with a GFR between 10 and 30
mi/mm, dose reduction by a half; and in patients with a GFR < 10 ml!
mm, dose reduction by three quarters of the normally applied dose is
recommended. Patients, undergoing chronic intermittent hemodialysis,
should receive 50 mg of atenolol p.o. after every hemodialysis treat-
ment.
Autoregulation of Renin Release and its modilication by renal sympa-
thetic nerves in conscious dogs. H. Kirchheim, R. Gross, H. M.
Hackenberg, E. Hackenthal, and J. Huber. I. Physiologisches Institut
and Pharmakologisches Institut der Universitat Heidelberg, Heidel-
berg, Germany. Aortic blood pressure, renal artery pressure, renal
blood flow (RBF; e.m. flowmeter), renal-venous plasma renin activity
(vPRA; renal vein catheter; radioimmunoassay), arterial plasma renin
activity (aPRA; aortic catheter), and renin release (RR = (vPRA-
aPRA)renal plasma flow) were measured in 14 conscious chronically
instrumented foxhounds on a normal sodium intake (4.7 mmoies/kg of
body wt). Activation of the renal sympathetic nerves was elicited by
common carotid occlusion (CCO; carotid cuffs). When renal perfusion
pressure (RPP) was allowed to rise during CCO by 51 6mm Hg, there
was no change in RBF and RR decreased from 92 27 ng Al/mm by 72
22 ng Al/mm (P < 0.05). When RPP was maintained constant at a
level 5 1.8 mm Hg below its initial value (aortic or renal artery cuff),
CCO caused no change in RBF but increased RR from 213 45 ng Al!
mm by 155 60 ng Al/mm; (P < 0.05). This stimulating effect on RR at
a constant RPP was abolished by 3-adrenergic blockade and did not
occur in the denervated kidney. After 3-biockade, a reduction of RPP in
steps (5 mm's duration) caused no change in RBF between 140 mm Hg
(CCO) and 60 to 65 mm Hg. RR increased from 10 19 ng AL/mm to 60
11 ng Al/mm (P < 0.05) between 143 7mm Hg (CCO) and 95 3
mm Hg (resting level). However, when blood pressure was reduced by
as little as 10 mm Hg below this resting level, RR increased from 60
11 ng AL/mm to 421 90 ng AL/mm (P < 0.05). The highest values for
RR were observed at 60 mm Hg (1850 400 ng Al/mm); below this—
that is, below the lowest pressure of autoregulation—no further in-
crease of RR was observed. It is concluded that activation of the renal
sympathetic nerves by CCO can cause an increase of RR by a direct -
adrenergic effect on the juxtaglomerular cells without exerting vasomo-
tor changes. However, this effect is comparatively small at a normal
blood pressure level and is readily offset by the "vascular receptor
mechanism" when associated with a rise of RPP. Within the autoregu-
latory plateau of RBF, the pressure dependent mechanism causes little
change in RR until RPP reaches a "threshold" close to the normal
resting blood pressure.
Comparative study of counter regulatory responses of catecholamine
plasma levels and the renin-angiotensin-aldosterone system induced by
furosemide and piretanide. R. Kirsten, G. Seidel, B. Heintz, K. Nelson,
and U. Smoler. Department of Clinical Pharmacology, University of
Frankfurt, Frankfurt, Germany. One reason proposed for the unsuit-
ability of loop diuretics in treating essential hypertension is that
activation of counter regulatory mechanisms might cancel a decrease in
blood pressure caused by the diuretics. This proposition was examined
by studying the response of the renin-angiotensin-aldosterone system
and catecholamine production provoked by two loop diuretics dosed to
induce comparable urine production in 6 male volunteers, i.e., furose-
mide (p.o. 2 x 40 mg/day) and piretanide (p.o. 2 x 6 mg/day). The
question of whether different application times of two single doses (8
A.M. and 12 noon compared to 8 A.M. and 8 P.M.) might also affect
counter regulatory phenomena was also examined. Furosemide and
piretanide caused a short-lived increase in serum renin concentration,
which reached a maximum 4 hr after application and returned to initial
values after 6 to 8 hr. Normalization was independent of whether the
first dose was followed by a second dose 4 hr later. After 1 week of 8
A.M. to 8 P.M. piretanide application, the serum renin activity was lower
(1.22 0.18 ng/ml!hr) than that following furosemide application (2.98
0.62 ng/ml/hr). The increase in serum aldosterone concentration after
single dose application of the diuretics was delayed compared to the
increase in renin activity. Serum aldosterone concentration following 1
week of 8 AM. to 8 P.M. piretanide application was lower (288 103 pg/
ml) than that following furosemide application (365 79 pg/mI).
Aldosterone excretion in urine increased after furosemide application
(from 13.8 3.3 to 27.3 5.8 ng/24 hr) but remained constant after
piretanide application (from 15.1 2.3 to 16.2 2.3 ng/24 hr). Plasma
epinephnne and dopamine concentrations remained constant after I
week of double application of both diuretics. However, the norepineph-
tine concentration increased after furosemide application (from 2.55
0.56 to 4.5 0.99 pmoles/ml), whereas the norepinephrine concentra-
tion remained constant after piretanide application (from 2.28 0.27 to
2.80 0.24 pmoles/ml). Urine production was larger when the loop
diuretics were applied at 8A.M. and 12noon than when applied at 8A.M.
and 8 P.M. Urine osmolality did not change during the course of
application of both diuretics. These results indicate that counter regula-
tory mechanisms encountered during furosemide application are largely
avoided during piretanide application.
Origin of urinary 6.keto-PGE1a. W. Kitajima, B. Rosenkranz, J. C.
Frolich. Dr. Margarete-Fischer-Bosch Inst it Ut für Klinische Pharmako-
logie, Auerbachstr. 112, Stuttgart, Germany. We have shown previous-
ly that urinary levels of PGE2 reflect renal synthesis and on its iv.
infusion none is recovered unchanged from urine. Until now, it has
been assumed that urinary 6-keto-PGF1, the stable in vitro hydrolysis
product of prostacyclin (PGI2), similarly might reflect renal PGI2
synthesis. However, we found that after infusion of tritium labeled PGI2
or 6-keto-PGF1,,-labeled 6-keto-PGF1, could be detected in urine of
man and dog by use of gas-chromatography mass spectrometry. In man
it represented about 14% of the urinary metabolites after PGI2 infusion
while dinor-6-keto-PGF1, was the most abundant metabolite (21%). Our
results demonstrated that 6-keto-PGF1,, is not the major metabolite of
PGI2 in man, but that it may represent a urinary metabolite of
circulating PG!2. Therefore, we investigated the primary route of renal
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6-keto-PGF1, excretion. 3H-6-keto-PGF1,, (0.5 Ci) and inulin (100 mg)
were administered into one renal artery of the anesthetized dog
simultaneously. Urine was collected in 20-sec periods. The radioactive
material showed the same excretion pattern as inulin. In addition,
excretion of radioactivity was not affected by probenecid pretreatment
(25 mg/kg). This indicates that 6-keto-PGF1, in contrast to PGE2 is not
excreted by the organic acid pathway. In another group of experiments
renal handling of 6-keto-PGF1,, was investigated by use of stop-flow
technique. 6-Keto-PGF1,, was determined by RIA. No increase in 6-
keto-PGF1,, concentration could be detected in the urine fractions
corresponding to the tubular fluid. To determine if renal PGI2 might
contribute to urinary 6-keto-PGF1,,, we stimulated renal P012 synthesis
by infusion of angiotensin II and bradykinin into one renal artery of
anesthetized dogs. Only a small statistically not significant increase in
fractional 6-keto-PGF1,, excretion could be detected. Therefore, we
conclude that in contrast to PGE2 6-keto-PGF1,, is a urinary metabolite
of circulating P012 and does not reflect renal synthesis. It is only
excreted by glomerular filtration and is not secreted into the tubular
fluid.
Further studies on the isolation of a natriuretic factor from the urine of
healthy subjects. D. Kllngmiiller, C. Rietzel, and H. J. Kramer. Med.
Univ. Poljkljnjk, Bonn, W. Germany. In previous studies we isolated
from the serum of salt-loaded rats and healthy human subjects a small
molecular-weight material eluted from Sephadex G-25 column in the
postsalt fraction which is natriuretic in bioassay rats and inhibits
sodium transport of the isolated frog skin as well as renal Na-K-ATPase
activiy in vitro. For further purification and isolation of this natriuretic
activity from the urine of healthy subjects, in the present study various
chromatographic procedures were used. Twenty-four-hour urine sam-
ples were collected during control with ad lib. sodium intake averaging
181 mEq/day and during each 4 days of low salt (35 mEq Na/day) and
high salt intake (350 mEq Na/day). For detection of natriuretic activity
(NA), a bioassay in intact conscious rats was used, and changes in
urinary sodium excretion following injection of samples indicated the
presence or absence of NA. Specific NA was expressed as increase in
urinary sodium excretion per mg of material injected. In the postsalt
urine fraction IV, NA is detected during normal salt intake and
significantly rises with chronic salt loading. When postsalt fraction IV
eluted from Sephadex 0-25 was rechromatographed on Sephadex G-lO
(F IVA) NA appeared in fractions 2 and 3 out of six fractions. While
acetone extraction of F IV only slightly increased specific activity, with
high performance liquid chromatography NA was detected in the early
fractions (F IVB) with a 12-fold increase in specific activity. When
subsequently subjected to reverse phase chromatography a further 7-
fold rise in specific activity (F IVc) was obtained and was significantly
higher in urine fractions obtained during salt loading than during salt
deprivation. Additional ion-exchange chromatography with linear pH-
gradient resulted in highest specific activity in fractions (F IV0) eluted
in the weak acidic pH range (pH, 6.4 to 4.5). Electrophoretic separation
on thin layer plates also suggests that NA is associated with a small
molecular-weight acidic peptide.
Distinction between rheogenic and electrically silent ion transport. H.
Knauf and G. Sachs. Medizinische Universitätsklinik, Freiburg, GFR,
and Laboratory of Membrane Biology, Birmingham, Alabama, USA.
Ion transport across "tight" distally located epithelia may be rheogenic
or electrically silent across antiporters or symporters, respectively. To
estimate the contribution of these components to net ion transport, we
made two technical approaches in the submaxillary duct epithelium,
which resembles the cortical collection duct of the kidney: (1) recording
the electrical PD following one-sided ion substitution experiments for
the determination of the transference numbers t1, partial conductances
g1, and the permeability Pf' of the epithelium to Na, K, Cl, and HCO3;
(2) determination of the apparent permeability of the epithelium P'
according to the Goldman equation by varying luminal ion concentra-
tion. The sequence is: P > P > P > P03. Net ion flux
measurements yielded: Pa > P> P03> P1. In every case is P' >
Pf', which holds particularly for K: P:P = 10:1; gNa:gK = 10:1. Na
depends upon [Na], [K] and [H] in luminal perfusate. Pis significantly
greater in the presence of Na reabsorption than in its absence. It is
concluded that the duct epithelium mainly operates electrically silent
ion transport. In particular, K secretion and Na reabsorption are
interdependent similar to the cortical collecting duct of rabbit kidney.
About 1/3 of net Na Reabsorption is rheogenic. The density of "Na
channels" seems to be regulated by luminal Na, K, H, and amiloride as
in frog skin.
Urinary neutral maltase activity (brush border maltase activity) in
different renal diseases. R. Kochmann, G. Kochmann, W. Pape, F.
Bode* and K. Baumann. Department of Cell Physiology, Institute of
Physiology and *Department of Internal Medicine I, University of
Hamburg, Hamburg, Germany. Human urine contains neutral as well
as acid maltase activity. Neutral maltase activity (brush border maltase,
I ,4-a-D glucoside glucohydrolase EC 3.2.1.20) was determined selec-
tively. Twenty-four-hour urine samples were collected in polythene
vessels in the presence of sodium azide. After addition of bovine serum
albumine and sodium desoxycholate, urine samples were centrifuged
and the supernatants were dialyzed against sodium citrate phosphate
buffer. Only a few urine samples had to be concentrated by ultrafiltra-
tion prior to neutral maltase determination. Neutral maltase activity
was measured at 370 C directly by optical test with hexokinase and
glucose-6-phosphate dehydrogenase as indicator enzymes following
NADPH absorption at 340 nm. Enzymatic activity was determined
under optimal conditions in the presence of 25 m turanose in 15 mM
maltose substrate solution at pH 6.8 in sodium citrate phosphate buffer.
Turanose was used in the test medium to inhibit residual acid maltase
activity completely without effecting neutral maltase activity. Urinary
excretion of neutral maltase activity in 24-hour urine samples of normal
subjects and patients of both sexes is expressed as U/g urinary
creatinine (mean value SD):
Normal subjects (N = 14) 3.9 1.2
Chronic pyelonephritis (N = 12) 6.1 2.0
Diabetes mellitus (N = 14) 10.5 6.0
Kidney transplanted (N = 15) 14.7 8.3
Chronic glomerulonephritis (N = 5) 39.2 23.0
Terminal renal insufficiency (N = 6) 45.2 26.4
Hemodynamic and catecholamine responses to isometric exercise in
hypertensive patients: Effects of combined alpha- and beta-blockade. R.
Kolloch, M. Myers, J. Bornheimer, and V. DeQuatiro. Department of
Medicine, University of Southern Calfornia, Los Angeles, USA, and
Medizinische Universitats-Poliklinik Bonn, FRG. Basal and stress-
induced sympathetic nerve activity (SNA) is elevated in some patients
with essential hypertension (EH). We studied basal (supine) plasma
norepinephrine (NE), epinephrine (E), plasma renin activity (PRA),
blood pressures (BP), heart rates (HR) and their responses to standing,
and 3-mm isometric handgrip exercise (IHE) in 9 hypertensives, age 47
4 years, before and after 4 weeks of treatment with labetalol, an
alpha- and beta-adrenergic receptor blocking agent. IHE increased the
means of BP, HR, NE, and E by 33, 33, 117, and 110%, respectively.
Labetalol therapy was associated with a significant reduction of BP,
HR, and PRA in all conditions. Plasma NE (mean 5EM) was higher
after labetalol in supine (296 24 vs. 349 24 ng/liter, P < 0.08) and
standing (441 25 vs. 545 36 ng/liter, P < 0.02) positions, but was
lower after IHE (638 108 vs. 481 48 ng/liter, P < 0.05) compared to
pretherapy values. During IHE, the reduction of NE when on drug was
related to the decrease of the systolic BP and heart rate responses (P <
0.02 and P < 0.05). The reduced responses of HR, PRA, and of NE to
IHE after drug are probably due to the beta-blocking property of
labetalol. The increase of NE in supine and standing position may be of
reflex origin and is in accordance with findings after both pre- and post-
synaptic alpha-blockade. The attenuated BP, HR, and NE responses to
IHE suggest reduced peak sympathetic nerve activity during labetalol.
Effects of antihypertensive therapy on renal function of refractory
hypertensives: Experience wth minoxidil. R. Kolloch, T. Kern, J. Born-
heimer and V. DeQuatiro, Department of Medicine, University of
Southern California, Los Angeles, USA, and Medizinische Universi-
täts-Poliklinik, Bonn, FRG. Long-term effects of drug therapy, includ-
ing minoxidil (M), a potent vasodilator, on renal function of refractory
hypertensive patients, have not been well characterized. We observed
effects of M therapy of 6 to 52 month's duration (mean 23 month's) on
serum creatinine (Cr), blood pressure (BP) and body weight in 28
hypertensive patients (mean age, 45 years). M in maintenance doses of
5 to 40 mg/day (mean, 22 mg) was given to hypertensives refractory to
154 Abstracts
conventional drugs, Dialysis was required in 10 of 28; 4 of these (group
IV) began dialysis prior to M therapy. The results of M therapy are
analyzed according to pre-M serum Cr.
Creatinine Diastolic BP Body wI/kg
Group N Pre M Mean %/mon Pre M —% Pre M %
1 9 2.Oorless 1.5 .08 1.1 .4 III 5 16 3 73 4 4.0 2.0
II 10 2.1—4.5 3.6 .2 1.7 1.2 120 5 23 4 74 4 0.6 2.0
III 5 4.6—8.0 6.1 .5 5.8 1.9 116 8 23 5 64 5 —4.1 4.0
1 of group IL and all of group III patients required dialysis after 1 to 45
months. Of 19, 8 (42%) of group I and LI patients had improved or no
change in renal function after a mean of 28 months. Cr increased 0.5
0.02 and 7 1% per month in the group I and II hypertensive patients
without and with albuminuria (> 500 mg/day), respectively. The
increase in Cr compared favorably with those of 7 1 and 17 5%/
month in hypertensives not treated with M and with similar diagnoses
and renal function (P < .001, < .05). M reduced diastolic BP to less than
95 mm Hg in all groups. Long-term M therapy lowers BP effectively in
most refractory hypertensive patients and retards the progression of
renal failure in those without albuminuria.
Diagnostic relevance of thermography in nephrology. H. Kopsa, W.
Czech, P. Schmidt, J. Zazgornik, P. Baicke, and E. Deutsch. 1st
Medical Clinic, University of Vienna, Austria, and Central Institute of
Radiodiagnostic, University ofVienna, Austria. Contact thermography
by Tricoire—a noninvasive, quickly available and reproducable meth-
od—may be helpful in pediatric differential diagnosis between glomeru-
lonephritis, pyelonephritis, and inflammatory hydronephrosis. The
kidneys of an adult, however, can not be examined thermographically.
Exceptional cases are superficial processes such as posttraumatic renal
hematoma, bleeding after renal biopsy, perirenal abscess and phleg-
mon, inflammation of polycystic kidneys, or highly vascularized renal
tumors. The most important results of thermography are obtained in
transplant nephrology. Normally surface temperature over the graft
ranges from 310 C to 340 C, being 1° C to 20 C higher than the surround-
ing temperature or over the opposite groin. Renal transplant patients (N
= 106) with 132 transplants were examined by the method of Tricoire
during 3 years at regular 3 to 8 weeks intervals. Forty-four cases with
normal serum creatinine values revealed over the grafted area hyper-
thermia, normal intrarenal vessel structures, and sharp contours of the
kidney. Thirteen recipients with 25 acute rejection episodes and 36
cases with chronic rejection (serum creatinine > 2 mg/dl) showed
superficial hypothermia, hypovascularization or vague contours. Eight
patients with acute urinary tract infection projected pelvic hyperther-
mia to the surface, whereas chronic urinary tract infection did not
influence surface temperature. In 3 cases with transplant ruptures or
subruptures, hot spots were visible on the thermographic film. Superfi-
cial pen- or para-renal changes could be recognized as well. In case of
postoperative oliganuria differential diagnosis between a priori rejected
grafts and those with transient tubular hypoxaemia can now be
achieved without invasive measurements. Thermography gives suffi-
cient information about blood supply in the transplant.
Effects of furosemide on active and inactive renin and on renal venous
cAMP in man. A. Konrads, W. Hummerich, M. Vlaho, V. Hombach, P.
E. Peters, J. Kindler, M. Bulla, W. Bottcher, A. Helber, and K. A.
Meurer. Departments of Medicine and Institute of Radiology, Universi-
ty of Cologne, West Germany. We studied the effects of furosemide (F),
40 mg iv., on active (AR) and acid-activatable, inactive renin (IR) to
investigate the as yet unknown renin activation process in man. In
normal men (N = 9), F within 15 mm increased peripheral venous
plasma AR (P < 0.001), whereas it slightly but not significantly
decreased IR; thus, the proportion of the active renin form (%AR) rose
after F (P < 0.001). In renal venous plasma of hypertensive patients (N
= 7), F had exactly the same effects on AR, IR, and %AR. F raised the
ratio renal/peripheral venous concentration for AR, whereas the effect
on the respective ratio for JR was inconsistent; peripheral venous AR
and IR correspond to the respective values in renal arterial plasma.
Consequently, this ratio may indicate renal secretion pattern. The renal/
peripheral venous JR ratio was > 1 in most but not in all patients. The
concentration of cAMP in renal venous plasma of these patients
increased after F (P < 0.025), but this effect was not significantly
correlated to the stimulation of AR or %AR. In another series, in
anephric patients on chronic intermittent hemodialysis, AR was very
low, but IR was almost 30% the value of healthy persons. F had no
effect on AR or IR in anephric patients (N = 10). The studies show that
F increases plasma AR and %AR in normal and hypertensive man,
whereas it does not affect extrarenal AR or IR in the anephric state.
Thus, these effects of F are bound to the presence of the kidney. It
zannot be concluded from our data that cAMP is involved in the
stimulation of AR or %AR. We speculate that F induces intrarenal
conversion of IR to AR and in addition may influence the secretion
pattern of the kidney for AR and IR.
Prophylaxis and emergency treatment of acute renal failure by means
of the bicarbonate-alkaluria-regimen. K. F. Kopp. II. Med. Klinik &
Poliklinik, Techn. U. München, BRD. Acute iv. bicarbonate loading
under intensive care precautions has proven to be successful to prevent
and reverse acute renal failure (ARF) even in cases in which conven-
tional treatment had failed. The therapeutic regimen essentially consists
in a rapid elevation of the plasma bicarbonate level by means of rapid
i.v. infusion of I M NaHCO3, to a value slightly above 28 mEq/liter or
toward a BE of +6 to +8 mEq/liter. The bicarbonate bolus is immedi-
ately followed by 50mg of ethacrinic acid, iv. A selection of 12 patients
with ARF of different origins are presented to show the essential points
of the procedure which has to be carried out as an emergency treatment
of "renal resuscitation." As a side-result of the experience gathered on
more than 100 cases treated during the last 3 years, a new classification
of high-risk patients has become apparent. Clinically, three groups, A,
B, C, can be defined according to their response of poor, moderate,
good, following prophylactic or therapeutic bicarbonate loading. From
there, it has become clear that an important number of ARF cases could
be prevented prophylactically by means of the bicarbonate-alkaluria
regimen (BAR), whereas a certain group shows a 100% mortality, in
spite of all therapeutic efforts, including dialysis. The therapeutic key
event of bicarbonate loading is the excretion of bicarbonate in the final
urine, which is easily detectable by dipstick measurement of fresh
urine-pH. As a rule, polyuria sets in, simultaneously as soon as the
urine-pH changes from acid over neutral to alkaline. If the urine pH
cannot be converted from acid to alkaline in spite of adequate bicarbon-
ate loading, the kidney cannot be salvaged. Thus urine-pH constitutes
an important guideline and prognostic tool in this treatment of ARF.
Under bicarbonate loading a number of synergistic physiologic mecha-
nisms are involved in the maintenance or in the recovery of renal
function, some of which are still speculative. Preliminary experience
shows that improved results in early kidney function may be obtained
when donor and recipient are conditioned by BAR in kidney transplan-
tation. In conclusion, our experience shows that important progress has
been achieved in the management of ARF through the use of the
bicarbonate-alkaluria-regimen.
Acute hemolytic anemia following malignant hypertension in patients
on routine dialysis therapy. H. Kopsa, P. Schmidt, J. Zazgornik, P.
Baicke, and E. Deutsch. 1st Medical Clinic, University of Vienna,
Austria. In cases of renovascular diseases complicated by malignant
hypertension (MH), acute hemolytic anemia (AHA) may occur in end-
stage renal failure, either transient and moderate or as a life-threatening
event. AHA during RDT as a consequence of MH requires immediate
antihypertensive treatment. The study presents 7 cases with AHA and
excessive blood pressure elevation (RR, more than 250/140 mm Hg).
Clinical findings were sudden onset with chills, fever, nausea, abdomi-
nal pain, pallor, and tachycardia. In 2 subjects, severe AHA was
complicated by shock, 5 patients revealed hypertensive encephalop-
athy. Laboratory diagnosis was established by elevation of LDH,
diminution of hematocrit, normocytic and normochromic anemia with
spherocytes, microspherocytes, and nucleated erythrocytes, leucocyto-
sis (16 to 34 g/liter), thrombocytosis up to 750 g/liter and reticulocytosis
up to 90%. Blood smear revealed shift to the left and numerous myeloid
cells. Intensive therapy comprised administration of antihypertensive
drugs, ion-exchange, frequent hemodialyses, infusion of alkaline solu-
tions and red packed cells. Cases with refractory MH demand urgent
bilateral nephrectomy for avoidance of AHA. Renal transplantation can
be recommended despite possible recurrence of original disease. In our
study, 3 patients on RDT died from causes not related to MH, 3 patients
were successfully transplanted, 2 of them are doing well since 5 and 3
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years, respectively, I died from septicemia 2 years after transplanta-
tion, and 1 patient is still on RDT.
Comparison of the therapeutic effectiveness of S,6-trans-25-hydroxyvi-
tamin D3 and 25-hydroxyvitamin D3 in renal osteodystrophy. D. Kraft,
G. Offermann, and G. Delling. Nephrologische Abteilung, Klinikum
Ste glitz der Freien Universität Berlin, and Pathologisches Institut,
Universitatskrankenhaus Eppendorf, Hamburg. The effect of the 5,6-
cis and 5,6-trans analogs of 25-hydroxy-vitamin D3 was investigated in
14 dialysis patients with histologically documented renal bone disease.
Six patients (A) received the natural cis-analog 25 (OH) D3 and 8
patients (B) the trans analog 5,6-trans-25 (OH) D3 in a daily dosage of
15,000 I.U. for a therapy period of 24 weeks. Whereas in group B this
dosage could be maintained throughout the study, the average daily
dosage in group A had to be reduced continuously to finally 3,000 I.U.
due to hypercalcemic episodes. Iliac crest bone biopsy was performed
before and after treatment. In the majority of the patients of both groups
improvement of renal bone disorders was observed. In 2 patients of
group A a remarkable reduction of bone formation occurred. Calcium
(Ca), inorganic phosphate (P), alkaline phosphatase (AP), and immuno-
reactive parathyroid hormone (iPTH) in serum were measured every 2
weeks. Before and after treatment, intestinal 47calcium absorption
(47Ca) was estimated. In group A, the mean Ca increased from 2.06 to
2.44 mmoles/liter, P from 1.85 to 2.17 mmoles/liter, and 47Ca from 1.90
to 2.73 %/liter, 1PTH decreased from 125 to 41 pmoles/liter, and AP
from 447 to 150 U/liter. In group B, Ca increased from 2.15 to 2.42
mmoles/liter, P from 1.79 to 1.94 mmoles/liter, and 47Ca from 2.00 to
3.21 %/liter, iPTH decreased from 99 to 79 pmoles/liter and AP from 501
to 261 U/liter. We concluded from these findings that the 5,6-trans
analog of 25-hydroxyvitamin D3 is more suitable to treat renal osteodys-
trophy than the cis- form because of its better therapeutic compliance.
In contrast to 25 (OH) D3 (cis-form) hypercalcemic episodes and
negative influences on bone formation were not observed with this
analog.
Effect of parathyroid hormone, calcitonin, and growth hormone on
growth cartilage in experimental uremia. W. Kreusser, 0. Mehls, and E.
Ritz. Department Internal Medicine and Department Pediatrics, Hei-
delberg, Germany, FRG. Impairment of longitudinal growth in uremic
children is due to disturbances in cell proliferation of growth cartilage.
It was the purpose of the present investigation to examine whether the
responsiveness of chondrocytes to various hormones is altered in
uremia. Male Wistar rats (50 g in body wt) were used: bilateral or
subtotal nephrectomy (NX) or sham operation and pair-feeding (CD);
i.v. administration of 1,34 PTH (15 mm), calcitonin (5 mm) or STH (6 hr
before the end of the experiment) were carried out. Mechanical removal
of epiphyseal plate by histologic control was performed with determina-
tion of cAMP and cGMP by RIA. In addition, in vivo incubation with
PTH and CT was performed. Finally, long-term application of STH and
measurement of H3-thymidine incorporation and body weight and
length were done. Basal cAMP content was identical in NX and CO.
PTH caused a significantly lower increment in cAMP in NX than in CO
(40 lU. PTH in vivo: NX, 11.4 1.01 pmoles/mg protein; CD, 24.0
2.55; P < 0.001) without changing cGMP increase (NX, 2.87 0.16;
CD, 2.63 0.14). However, the cAMP increase after CT in vivo and in
vitro was significantly greater in NX. cGMP remained unchanged after
CT in NX, but fell significantly in CO. STH was without effect on
growth cartilage cAMP or cGMP content. However, significantly
stimulated increase in longitudinal growth (NX-solvens, 29.8 1.4 cm;
NX-STH, 31.1 1.6) and body weight. Our results clearly demonstrate
an altered hormonal responsiveness of growth cartilage in experimental
uremia. cAMP content is lower after stimulation with PTH and higher
after CT in NX. Chronic administration of STH significantly improves
impairment of longitudinal growth without change in cyclic nucleotides.
Our findings may help in understanding the disturbances of growth in
uremic children and may be of relevance for future therapy.
Nephrotoxicity of cefotaxime and tobramycin alone and in combination
in men. J. Kuhlmann, G. Seidel, H. GrOtsch, W. Zilly, L. Munch, and
F. W. Schembra. Medizinische Universiiiitsklinik Wurzburg, Med. Abt.
Hoechst, Frankfurt. The treatment of serious infections often requires
the concurrent use of more than one antibiotic. Controversy continues
to surround the question as to whether or not cephalosporins, especially
cephalothin, potentiate the nephrotoxicity of aminoglycosides, princi-
pally gentamicin. Thus, it was the purpose of this study to determine in
a prospective clinical trial if the combination of cefotaxime (C), a new
very active cephalosporin, plus the aminoglycoside tobramycin (T) is
more nephrotoxic than C or T alone. The studies were carried out in 30
patients with serious infections and normal renal function. Groups,
each of 10 patients, received 2 g C, 1 mg/kg of body wt, T or C + T in
the same dosage every 8 hr i.v. for 7 to 8 days. Plasma levels of C and T
were assayed by agar diffusion. Serum creatinine and creatinine clear-
ances were determined before, during and 5 days after administration of
the antibiotics. Alanine-aminopeptidase (AAP) in 24-hour urine was
determined photometrically at the same time. None of the patients
treated with C alone showed a rise in serum creatinine, AAP excretion,
or reduction of creatinine clearance. In contrast, T and T + C treatment
caused a significant rise in enzyme activity up to 5 to 6 times greater
mean values than before starting antibiotic therapy. Some of these
patients showed pathologic changes in serum creatinine and creatinine
clearance. The differences in the rise of the AAP activity before and
during treatment with T or T + C are statistically significant, whereas
there were no significant differences between the rise of AAP during
treatment with T and T + C. Three to five days after stopping antibiotic
therapy, AAP decreased to values similar to those measured before
starting therapy. The plasma levels of C and T show no differences if
given alone or in combination. Thus, treatment with high doses of C
seems not to potentiate the nephrotoxicity of T as assessed by serum
creatinine, creatinine clearance, and renal AAP excretion in patients
without impaired renal function, and the nephrotoxicity of this combi-
nation is due to the aminoglycoside alone.
Arteriosclerotic renovascular stenoses in patients with peripheral arte-
rial obstructive disease. U. Kuhlmann, J. Steurer, W. Vetter, E.
Schneider, and W. Siegenthaler, Department of Medicine, University
Hospital Zurich, Switzerland. Since introduction of percutaneous trans-
luminal dilatation of renovascular hypertension, the therapeutic concept
of this disease has changed especially in the elderly. To determine the
incidence of atherosclerotic renal artery stenoses with or without
concomitant hypertension, retrograde abdominal aortography was per-
formed in 110 patients (mean age, 63 yr) with symptomatic peripheral
arterial obstructive disease. In 20 of 110 patients (19.8%) an unilateral
(13 patients) or a bilateral (7 patients) renal artery stenosis of more than
30% was found. Of these 20 patients, 12 (60%) were hypertensive
despite antihypertensive treatment(RR, 171 33 over 94 16mm Hg).
Eight patients with renal artery stenoses had normal blood pressure
without antihypertensive treatment (147 18 over 84 Il mm Hg). On
the other hand 30 of 90 patients (33%) without renal artery stenoses
were suffering from essential hypertension (RR, 178 13 over 95 10
mm Hg with antihypertensive treatment, RR 158 19 over 92 9 mm
Hg in patients without therapy). Our results indicate that in some
patients significant renal artery stenoses may occur without concomi-
tant hypertension. However, in our patients, the incidence of hyperten-
sion was markedly higher in the subground with renal artery stenoses.
Therefore, routine abdominal aortography is recommended in patients
with peripheral arterial obstructive disease and hypertension. If a renal
artery stenosis is found, percutaneous transluminal dilatation should be
performed, because this procedure is unexpensive, effective, and
relatively simple.
Analgesic abuse and chronic renal failure. H. E. Kuntziger, F. Ortola,
and F. Schneider. Renal Unit, Centre Hospitalier and Institut d'Hy-
giène et de Sante Publique, Luxembourg, Luxembourg. Analgesic
associated nephropathy as a common cause of end-stage renal disease is
controversial. To determine the incidence and features of analgesic-
associated nephropathy, a potentially preventable cause of end-stage
renal disease, 3 studies were performed in Luxembourg, a small
European country of 350,000 people. (1) The experience of the Centre
Hospitalier's Renal Unit, a major referral Center for end-stage renal
disease, is reviewed from 1977 through mid 1980. Nineteen patients
with excessive intake of analgesics (>1 g /day for 3 years or >3 kg total
of index drug) are identified. Sixty-eight percent are females, age ranges
from 36 to 71 yr. Clinical features comprise: chronic renal failure, 100%;
headache, 95%; anemia, 95%; high blood pressure, 74%; gastrointesti-
nal symptoms, 42%; urinary tract infection, 42%. Urinary tract infec-
tion occurs in all 7 patients subjected to urological procedures, but in
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only one of 12 who are not. Three patients have end-stage renal disease.
(2) A country-wide inquiry is carried out through a questionnaire
circulated to 349 physicians. Twelve more cases of analgesic-associated
nephropathy are identified, 4 having progressed to end-stage renal
disease. Thus, in this country, 7 of a total chronic dialysis population of
58 patients have analgesic-associated nephropathy. (3) A systemic
screening for salicylates and paracetamol is performed on urine samples
submitted for routine analysis. Among 506 samples, 17 (3.4%) are
positive. To conclude analgesic abuse is a public health problem in
Luxembourg; 12% of chronic dialysis patients have analgesic-associat-
ed nephropathy, which is higher than that reported for the whole of
Europe.
Correlation between clinical data and morphology in 124 cases of
analgesic nephropathy. H. G. Laberke. Institute of Pathology, Universi-
ty of Tubingen, FRG. Microscopic and morphometric findings for 124
cases representing all stages of analgesic nephropathy (AN) (female-to-
male ratio, 2 : 1; mean age, 47 yr; Ill biopsies, 8 autopsies, 5
nephrectomies) were correlated with the clinical data. The following
results were obtained. (1) The correlation between ingested amounts of
phenacetin and serum creatinine concentrations at the time of histologic
examination in 80 patients with reliable clinical data was statistically
significant (parabolic function, r = 0.5, P < 0.001). The medullary
interstitium in the early phase of AN is wider than the cortical
interstitium. The increase in serum creatinine concentration with the
ingestion of massive quantities of analgesics does not correspond to the
ingestion of smaller amounts. (2) The correlation between widening of
the cortical interstitium (normal, 6 2%) and serum creatinine is
statistically significant in the exponential function (P < 0.001); cases
with papillary necroses and a creatinine concentration of 1.0 to 1.3 mg/
dl support this relationship. The medullary interstitium (normal. 12
5%) and the cortical interstitium react similarly. While medullary
interstitium volume increases, particularly in the early phase of AN,
widening of the cortical interstitium, however, considerably surpasses
that of the medulla in the late phase. With edematous, i.e., "functional-
ly," widened medullary interstitium, the cortical interstitium is not
widened as much as it is with fibrotically widened, i.e., "fixed,"
medullary interstitium (t test, P < 0.05). (3) If the creatinine concentra-
tion exceeds 2.5 to 3.0 mg/dl, the primary disease, even after withdraw-
al of analgesic abuse, is usually progressive, possibly due to a vicious
circle based on the existing damage. These prognostically important
creatinine values correspond to a widening of the cortical interstitium
by a factor of 3.50 to 4.25. (4) Bacterial urinary tract infections (UTI)
are not especially significant for the course of AN. Most dialysis cases
showed no histologic or clinical-anamnestic indications of subsided
UTI. Sterile leukocyturia is a sign of proceeding UTI. The rise in
creatinine after UTI with widening of cortical interstitium abundant in
inflammatory cells is lower than fibrotic widening.
Influence of uremia on the erythrocyte peroxide metabolism. H. W.
Leber, E. Debus, R. Spiegelhalter, and G. Schdtterle. Dept. Internal
Medicine, Univ. Hospital, Giessen, W. Germany. Our earlier experi-
ments have revealed an augmented oxidative hemolysis rate (OHR) of
erythrocytes from uremic patients compared to healthy subjects. To
further elucidate the underlying mechanisms, we incubated blood
samples from uremic patients and from controls in a Warburg apparatus
(hematocrit, 20%; 370 C, 4 to 6 hr) together with known uremic
retention products (urea, creatinine, guanidines, phenols, uremic mid-
dle molecules EMMI) in concentrations typical for the uremic state. The
side well contained either I ml of 30% H202, or saline, The following
parameters were measured: OHR, superoxide dismutase (SOD), gluta-
thione peroxidase (GSH-Px), catalase (Cat), and the amount of glucose
utilized during incubation. In the presence of MM, but not of the other
retention products, H202 caused a significant increase of OHR and a
significant decrease of Cat activity in both erythrocyte populations.
OHR and Cat activity were inversely correlated in the individual blood
samples. Preliminary results indicate a reduced glucose utilization in
the presence of MM. SOD and GSH-Px were not influenced by any
manipulation of the experimental conditions. An increase of OHR was
also observed in the presence of dihydralazine (5 nmoles/ml) or
oxipurinol (1.5 jj.moles/mI). Conclusions. (1) The MM-mediated Cat
inhibition contributes significantly to the increased OHR in uremia. (2)
Probably, a diminished glucose utilization is involved in the underlying
mechanism. (3) Drugs with the potential of Cat inhibition and/or
increased generation of oxygen radicals should be avoided in uremic
patients.
Role of platelets and prostaglandins in kidney transplant rejection. C.
Leithner, H. Sinzinger, K. Silberbauer, and P. Angelberger. 2nd Dept.
of Intern. Med., Univ. of Vienna and Atomic Energy Research Center,
Seibersdorf, Austria. In 30 patients, blood samples were taken, the
platelets isolated, labeled with II 1-indium-oxine, and reinjected. In 14
patients, the plasma levels of thromboxane B2 and 6-oxo-PGF1, the
stable hydrolytic inetabolite of prostacyclin, were estimated by radio-
immunoassay. Acute rejections showed under gamma camera marked
depositions of platelets in renal transplant. This phenomenon could be
observed not infrequently 1 day before any other clinical symptom. In
the majority of cases with chronic rejection platelet, depositions in the
transplant could be demonstrated too, however to a low degree. Some
transplants with stable and good function showed minimal depositions.
This method is of good value for supervision of transplant patients,
particularly during the first 3 weeks after operation and provides a
clinically important help for differential diagnosis. The observation that
platelets are trapped in the transplant particularly in acute rejection, is
supported by elevated plasma levels of thromboxane B2. Before and
during acute rejection episodes, elevations of plasma 6-oxo-PGF10
levels can be observed too. This may be due to a stimulation of
prostacyclin release by the transplant, but particularly by the whole
vascular system. According to the findings of Moncada's group,
synthetic prostacyclin is now under trial for therapy in acute rejections.
Changes of Na-K-ATPase in three segments of the distal rabbit nephron
after increase of mineralocorticoids in vivo. M. Le Hir, U. C. Dubach, B.
Kaissling, and W. Kriz. Medizinische Universitäts-Poliklinik, Base!,
Switzerland, Anatomisches Institut der Universitdt, Heidelberg, West
Germany. The distal convoluted tubule (DCT), the connecting tubule
(CoT) and the cortical collecting tubule (CCT) were dissected out of
freeze-dried kidney sections after identification in parallel PAS-stained
sections. Na-K-ATPase was assayed in single segments weighed on a
quartz fiber balance. On a low K and high Na diet (20 to 27 days), the
aldosterone level was 10 ngldl serum; the activity of Na-K-ATPase in
units/g dry wt was 65 in DCT, 45 in CoT, and 37 in CCT. On a high K
and low Na diet (20 to 27 days), the atdosterone level ranged from 180
to 320 ngldl serum. In comparison with the first diet, specific activity of
Na-K-ATPase was 80% higher in DCT. This increase is not to be
interpreted as increased capacity of transport for Na and K per unit
tubular length, because at the same time the height of the epithelium
was decreased by one half. Thickening of the epithelium in CoT and
CCT was paralleled by an increase of the specific activity of Na-K-
ATPase of 120% and 170%, respectively. Twelve days of treatment with
DOCA with low K and high Na diet produced a marked thickening of
the epithelium in CoT and CCT as well as a rise of the specific activity
of the enzyme by 40% and 210%, respectively. The thickness of the
epithelium and the Na-K-ATPase activity in DCT are similar as without
DOCA. Conclusions. (1) There is a biochemical correlate to the
anatomical segmentation of the distal nephron. (2) Chronic increase of
aldosterone and DOCA treatment raise considerably the capacity for
active transport of Na and K in CoT and CCT, but not in DCT.
Effect of propranolol and atenolol on the glomerular filtration rate in
healthy volunteers. G. Liebau, A. J. G. Riegger, H. Steilner. Medizin-
ische Universitätsklinik Tubingen Abt. III, Tubingen, Deutschland. As
has been shown repeatedly renal blood flow is reduced after beta
adrenergic blockade in normotensive and hypertensive patients. How-
ever the results on changes of GFR after the administration of different
beta blockers are still controversial. The purpose of our study was to
compare the effect of a nonselective (propranolol) and a selective
(atenolol) beta blocker on the GFR when administered orally for a
short-term period. Twenty male healthy subjects were given an identi-
cal diet for 10 days containing 170 mmoles/liter sodium. Twenty-four-
hour collection of urine was performed every day for the determination
of the endogenous creatinine clearance, and blood pressure and heart
rate was measured daily. Furthermore, blood samples were obtained
for the determination of the plasma concentrations of renin, angiotensin
II, ADH (radioimmunoassay) and catecholamines (radioenzymatic
method). After 5 days the subjects were randomized into two groups,
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one taking propranolol, 40 mg three times a day, the other taking
atenolol, 50 mg twice a day. After a washout period of 6 weeks, the
same protocol was repeated crossing over the drugs. In the first period,
the GFR decreased significantly with both beta blockers from 121 10
to 79 9 mI/mm with propranolol and from 123 12 to 85 18 mI/mm
with atenolol. In the second period, the GFR only slightly decreased
from 115 9to 110 11 ml/minwithpropranololandfrom 119 l7to
109 10 mI/mm with atenolol. The changes in blood pressure, heart
rate, and plasma vasopressor hormone concentrations could not ac-
count for this difference in GFR reduction comparing both periods,
since they were rather identical when comparing the effects of the drugs
in the different periods. Our results clearly demonstrate, that both
selective and unselective beta blockers may cause a reduction of the
GFR. This effect is not constant even in the same individual when
taking beta blockers repeatedly even if the decrease in blood pressure
and heart rate is the same.
pH dependence of vasopressin and cAMP-induced changes in hydraulic
conductance of isolated perfused rabbit collecting tubule. M. Lorenzen,
A. Taylor, and E. E. Windhager, Department of Physiology, Cornell
Univ. Med. Coil., New York, N.Y., USA. Studies on the toad bladder
have demonstrated that acidification of the serosal bathing medium
markedly changes the magnitude of the hydroosmotic response to
vasopressin (VP) and to cAMP. It is also known that metabolic acidosis
in the intact rat inhibits the free water clearance after administration of
VP. To obtain direct information on the effect of peritubular acidosis on
the response to VP in the mammalian kidney, experiments were
performed on isolated perfused cortical collecting tubules of the rabbit.
For this purpose the hydraulic conductance, L, after VP or cAMP
administration was measured at different H concentrations in the
bathing medium. Tubules were perfused at 37° C with dilute P04
buffered Ringer's solution (290 mOsm/kg H2O). ADH (20 U/mI) or
CIPheS-cAMP (l0— M) was added to the bath. pH in the bath was
continuously monitored and was varied from 7.5 to 6.6. In VP experi-
ments when bath pH was changed from 7.6 to 7.2, or from 7.6 to 6.7, by
raising bath CO2 from 5 to 15% or 5 to 40% at constant HCO3 of 25 mM,
mean L changed from 249 32 to 199 23 (N = 5; P < 0.01), and
from 231 38 to 201 36 (N = 5, NS). Changing bath pH from 7.6 to
6.7, by increasing CO2 from 0.5 to 5% at 2.5 mrs HCO3, resulted in a
decline in L from 212 19 to 133 24(N = 5; P <0.05). In a series of
experiments with cAMP, bath HCO3 was kept constant at 2.5, 8.5, and
21.5, respectively, while CO2 was varied from 0.5 to 40%. However, at
any given (HCO3), increasing Pco2 lead to an increase in cAMP-
stimulated L (cm . atm sec 10). Linear regression lines for 2.5
mM HCO3: L = 789 to 78, pH, (N = 16, NS); for 8.5 mr'i HCO3: L1, =
1316to144pH,(N=4l,P<0.03);andfor2l.5mMHCO3;L= 1804
to 204 pH (N = 44, P < 0.003). Thus, steeper increases in L occurred
at higher total (CO2 + HCO3). In contrast, there was no significant
effect on L when CO2 was kept constant at 2.5, 5.0, and 10% while
HCO3 was changed and pH varied from 7.5 to 6.7. An S-shaped curve
was obtained, when L is plotted as a function of %CO2 with L values
rising steeply between 2.0 and 13%. Further increases in CO2 had little
effect on cAMP-induced water movement. In sum, lowering pH in the
bath inhibits the hydro-osmotic response to VP. This inhibition is
prevented by a high CO2 concentration in the bath. The hydroosmotic
response to cyclic AMP is enhanced by elevation of the CO2 tension in
peritubular fluid. The magnitude of the cAMP response did not corre-
late with either bath pH per Se, or bath bicarbonate concentration, but
rather with bath CO2 tension. These results suggest that changes in
intracellular CO2 content and/or changes in intracellular hydrogen ion
and bicarbonate concentration play a role in regulating the response to
cAMP of the cortical collecting tubule.
Increase of plasma prostaglandin E2 following hemodialysis against 130
mEq of sodium per liter. M. Maiga, G. Schuitze, D. Kraft, W. Oelkers,
andM. Molzahn. Medizinische Kiinik und Poiiklinik, Klinikum Stegiitz,
Freie Universität Berlin, Germany. Several authors have influenced the
release of prostaglandin £2 (POE2) by alteration of sodium intake.
Parallel to the release of renin, a low sodium administration is suggested
to stimulate the release of PGE2. Other authors have contradicted this
concept, all the more since a negative sodium balance has often been
initiated by diuretics. In the present study, we have investigated the
influence of a direct change of plasma sodium by hemodialyses against
140 or 130 mEq/liter Na on the plasma concentration of PGE2, PGF2,,,
and renin activity (PRA) in patients with terminal renal insufficiency
with both kidneys in situ. The prostaglandins have been determined
radioimmunologically according to the method of Dray et al. Determi-
nations were performed in plasma samples before and after hemodialy-
sis in 16 patients. Patients underwent hemodialysis once against 140
mEq/liter Na and twice against 130 mEq/liter Na. Before dialysis, PGE2
and PRA were influenced by varying body weight (i.e., hydration) in
such a way that lower body weight was followed by increased plasma
levels of POE2 and PRA. After dialysis against 140 mEq/liter Na, POE2
was, in contrast to PRA, in several cases (8 of 16) lower (1.22 pg/mI
before HD, and 0.96 pg/mI after HD). After dialysis against 130 mEq/
liter Na, PGE2 was in most cases (22 of 31) higher (3.29 pg/mI before
HD, and 3.95 pg/mI after HD). The PRA was increased by a mean of
30% after dialysis with low sodium. The changes of PGF2. were not
uniform. It remains to be discussed whether or not the stimulation of
prostaglandin release has a hemodynamic effect in cases of dialysis with
low sodium.
Filariasis (Loa Loa) associated with membranous glomerulonephritis:
Demonstration of ifiarial antigen. S. T. A. Malik, M. McHugh, A. R.
Morley, J. Ngu, M. Qureshi, and R. Wilkinson. Departments of
Nephrology and Pathology, Freeman Hospital, Newcastle upon Tyne,
England, and Cuss University of Yaounde, Cameroons. Infection with
the nematode Loa Loa is endemic in areas of the Cameroons. The
disease is mild and characterised by subcutaneous (Calabar) swellings.
Microfilaria are found in the blood, and adult worms migrate to the eye.
Renal involvement is rare. Reports of nephrotic syndrome are sparse,
but in two published reports membranous glomerulonephritis has been
found. Filarial antigen in epimembranous glomerular deposits has not to
our knowledge been demonstrated. A 57-year-old African was known to
have had basis in childhood. In 1976 a diagnosis of severe hypertension
was made; BP 210/110, which was controlled with difficulty. Fundi
showed typical hypertensive changes. In March 1979, unselective
proteinuria of 5 g124 hr was discovered. Significant results included
blood urea of 14.3 mmoles/liter, Creatinine of 350 moles/liter and
creatinine clearance of 24 ml/min. Serum albumin was 22 g/liter
hemoglobin, 12.6 glliter and eosinophils, 58%. Numerous microfilaria
with the characteristics of Loa Loa were seen in the blood. Filarial
immunoglobulin was filarial antigen titer positive, 1/128. Circulating
immune complexes were detected by Clq binding assay. Renal biopsy
revealed severe hypertensive nephrosclerosis, and membranous gb-
merulopathy with deposits of IgG and C3 demonstrated by immunoper-
oxidase techniques. Rabbit antisera against adult Brugia Malayi was
localized to the glomerular depoits. Antisera to filaria are group-,
rather than species-specific, suggesting that our antiserum against
Brugia malayi is detecting an antigen common to a wide range of Filaria.
The present results strongly suggest that Filarial antigen is present in
the basement membrane deposits in loal membranous glomerulonephri-
tis. Further tests of the specificity of the antisera will be reported.
Pringle-Bourneville syndrome with renal insufficiency. L. Marosi, J.
Zazgornik, P. Schmidt, H. Kopsa, P. Balcke, K. Mach, and G. Syré.
1st Medical Clinic, University of Vienna, Austria. We report about a 38-
year-old female patient suffering from epilepsy since childhood. She
was admitted in status epilepticus. The routine examination showed a
terminal renal insufficiency. Above all, a striking dermatologic status
was found: fine, wartlike lesions predominantly in a butterfly distribu-
tion over the nose, cheeks, chin and forehead. The individual adenomas
vary in size from 0.1 to 1.0 cm and are elevated and pinkish or pinkish
yellow in color. Furthermore the patient has papillomatous gingival
vegetations and finger and toe nail fibromas (so-called "Koenen tu-
mors"). The diagnosis of "Pringle-Bourneville disease" was based
upon these dermatologic findings. This rare disease, also called tuber-
ous sclerosis, of dominant inheritance (one of the patient's sons is also
suffering from the same disease), is manifested by the clinical triad of
convulsive seizures, progressive mental deficiency, and adenoma seba-
ceum. The lesions of the skin are pathologically fibromas, the brain
lesions consist of areas of malformed cortex. To clarify the renal
insufficiency, surgical exploration and biopsy were performed: macro-
scopically a very small kidney could be seen dotted with whitish solid
tumors. Histologically, a leiomyoangiolipoma of the kidney was diag-
nosed. The following additional investigations are presented: optical
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immunfluoreszence, electronic microscopy, biochemistry, and cytoge-
netics. Because of chronic renal failure, regular dialysis treatment was
instituted.
Pathophysiology of the deeper lying regions of the kidney after tempo-
rary renal ischemia. J. Mason and J. Welsch. Physiology Instil ute,
University of Munich, FRG. Experiments were performed on rats to
further clarify the nature of the functional disturbance which follows 45
mm of renal arterial occlusion. Micropuncture investigations showed
filtration rate in the superficial nephrons to be 12.7 0.6 following 45
mm of ischemia and at least 60 mm of reperfusion, compared to 13.1
0.5 nl/min/100 g body wt in control kidneys. However, whole kidney
filtration rate was lowered to 0.21 0.05 after ischemia, compared to
0.38 0.02 ml/min/lOO g body wt in controls. The relatively well-
maintained superficial nephron filtration rate in the face of poor whole
kidney filtration suggested that the cause of the functional disturbance
may lie in the deeper lying juxtamedullary nephrons. Macroscopic
examination of the kidney following ischemia revealed the outer
medullary region to be dark red in color, the degree of redness reflecting
the extent of the functional impairment. Vascular filling with silicone
rubber confirmed that the outer medulla was extremely poorly perfused
with blood, indicating that a stagnation of blood in this region may be
involved in postischemic renal failure. To examine the function of the
deeper nephrons following ischemia, the Hanssen technique was em-
ployed. A 50-jil bolus of saturated sodium ferrocyanide was injected
into the aorta, a little above the renal arteries, and the kidneys were tied
off and shock-frozen 6 sec later. Individual tubules were dissected from
macerated pieces of the renal tissue after precipitating the ferrocyanide
at Prussian blue, and the distance from the glomerulus to the dye-front
was measured. In normal kidneys, bolus velocity was the same in all
nephron populations, 388 6 in surface, 307 30 in other superficial
nephrons, 293 19 in middle, and 340 35 jim/sec injuxtamedullary
nephrons. Following 45 mm of ischemia and 60 mm of reperfusion,
bolus velocity was 239 40 in surface, 113 9 in other superficial
nephrons, 102 16 in middle and 61 8 jim/sec in juxtamedullary
nephrons. This reduction in bolus velocity in all nephrons, but most
predominantly in the juxtamedullary nephrons, indicates that filtration
rate is depressed most in this population. It is concluded that superficial
nephron function is well preserved after 45 mm of ischemia, so that
investigation of these nephrons gives little information regarding the
pathogenesis of ischemic renal failure. The functional impairment
seems to be confined to the deeper nephrons, particularly the juxtame-
dullary nephrons, which are more difficult to examine experimentally.
A possible cause for the functional disturbances may lie in the vascular
congestion seen in the outer medullary region after ischemia.
Hypercatabolism and muscle wasting in experimental uremia. 0.
Mehls, E. Ritz, and H. D. Bundschu. Dept. Pediatrics and Intern.
Med., Univ. of Heidelberg, and Caritas-Krankenhaus, Bad Mergen the-
im, Germany. Muscle wasting is a common problem in patients with
renal failure. This phenomenon was studied in an experimental model of
chronic renal insufficiency. Methods. Sprague Dawley rats (40 g each)
underwent 2-stage subtotal nephrectomy (NX) with irradiation of renal
parenchyma. Controls underwent shamoperation and were pairfed
(CO). Metabolic cages were used. Diet was 13.8 kJ/g and 17.5% protein.
Measurements were made of longitudinal growth; weight gain; nitrogen
balance (Kjeldahl of diet feces, urine and total animal after removal of
intestine); organ weights; and quantitative histochemical analyses were
made of muscle biopsies taken from m. quadriceps and the diaphragm.
Results. Longitudinal growth and weight gain were significantly dimin-
ished in NX as compared to ad-lib-fed and sham-op CO and pairfed
sham-op. At identical dietary intake of nitrogen (and correcting for
spillage), the gain of dry mass and whole body nitrogen (N) was
significantly diminished in NX. Reduced N retention was paralleled by
an increase of urinary loss of N substances (urea, alpha-amino-N,
protein, and creatinine); urea-N was: NX, 64 17.4 mg/12 hr; CO. 51
12.6. In parallel, dry weight of one reference muscle (triceps surae) was
significantly reduced in NX as compared to pairfed sham-op CO (NX,
139 24 mg dry wt.; CO, 166 13). In the diaphragm, cross-sectional
areas of type I, II, and III fibers were significantly reduced. Histologic
and histochemical analyses did not show the pattern of neuronal
damage. In contrast to skeletal muscle, heart muscle was increased in
weight (NX, 1025 57.5 mg; CO, 741 18.6) despite only marginal
elevation of blood pressure (tail plethysmography). Conclusions. The
findings document a hypercatabolic state in chronic experimental
uremia. This is proved by diminished N retention and increased urinary
N excretion at identical levels of N intake. Skeletal muscle, in contrast
to heart muscle, is an important target organ for hypercatabolism.
Histology showed simple muscle wasting without evidence of damage
from polyneuritis, thus validating this model as a model of muscular
hypercatabolism.
Comparative testosterone substitution in chronic hemodialysis patients.
R. Mies, H. Fischer, L. Glôckner, and M. Viaho. II Medical Clinic and
I Medical Clinic, University of Cologne, West Germany. Patients under
chronic intermittent hemodialysis need testosterone substitution, as
basal plasma concentration and peak values after stimulation are
reduced to half the average. Three different methods of substitution
were studied in a group of 10 dialysis patients (group A) and compared
to 10 patients with primary hypogonadism Klinefelter (group B). The
parenteral therapy with testosteronoenanthate (TO) (250 mg every 3
weeks) was compared to two oral therapy schemes. The substitution by
testosteronundecanoate (TU) (120 mg daily) has a substantial lymphatic
reabsorption, whereas mesterolon (M) (120 mg daily) is rapidly trans-
ported via the portal vein to the liver and is metabolized there. The
parenteral substitution by TO leads to sufficiently high testosterone
plasma levels in both groups; there are, however, substantial fluctua-
tions and decreases during dialysis. The oral therapy by TU gave
constantly high plasma testosterone values in group B, a result only
occasionally seen in group A. Oral M therapy caused no significant
improvements. The gonadotropic hormones LH and FSH in plasma
showed an inverse pattern to testosterone changes. Prolactin remained
unchanged. Summary. The parenteral treatment is better suited for
those dialysis patients in need of substitution.
Tumors of the urinary tract in phenacetin abusers. M. J. Mihatsch and
C. Knüsli. Institute of Pathology, University of Base!, Basel, Switzer-
land. The investigation is based on 29,226 autopsies of adult inhabitants
of Basel performed between 1953 and 1977. Four hundred nine patients
had urinary tract tumors (UTT, i.e., papilloma and carcinoma) and 513
were clinically known abusers of phenacetin-containing analgesics
(PA). Of the PA users, 8.6% (N = 44) had a total of 50 UTT. whereas
the frequency of the control group was only 1.27% (Fischer's test P <
0.001). Tumors of renal pelvis, the ureter, and the urinary bladder, as
well as multiple tumors of the urinary tract, were statistically more
frequent in PA than in non-PA users. Out of the 50 UTT in PA users,
52% were located in the urinary bladder, 6% in the ureter, and 42% in
the renal pelvis. Compared with the control group, these figures show a
pronounced increase in tumors of the renal pelvis in PA users. The
induction time of UTT in PA users is 28 years for urinary bladder
tumors and 21 years for tumors of the renal pelvis. The daily dose of
phenacetin is nearly twice as high in PA users with tumors of the renal
pelvis than it is in those with tumors of the urinary bladder. PA users
with UTT die 5 to 10 years earlier than do patients with spontaneous
urinary tract tumors. Among PA users, females predominate (d : =
1.75). In PA users, papillomas are more frequent in the urinary
bladder whereas carcinomas predominate in the renal pelvis. The
frequency of metastases was equal in PA as in non-PA users. Analgesic
nephropathy is present in 53% of PA users and nearly as frequent in
woman as in man, but more frequently associated with tumors of the
renal pelvis (70%) than with those of the urinary bladder (50%).
Determination of structural proteins of the human kidney in urine for
detection of proximal tubular lesions caused by drugs. A. W. Mondorf, J.
E. Scherberich, T. Stefanescu, and W. Schoeppe. Center of Internal
Medicine, University of Frankfurt, Frankfurt, Germany. Integral con-
stituents of the brush border membrane of the human kidney are
membrane-bound enzymes. These are an alkaline phosphatase, a
gamma-glutamyl-transpeptidase, and an alanine-aminopeptidase
(AAP). The latter is of interest because of the constant behavior in daily
excretion in urine. In the so-called creatinine blind phase of toxic
alterations of the kidney, this enzyme shows very sensitive structural
damage of the brush border membrane. Extensive studies with in-
formed healthy volunteers' reaction pattern of drug effects on the
proximal tubular membrane has been recognized. Enzymatic measure-
ments of AAP in urine and immunologic determination of AAP with
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anti-AAP-antibodies in concentrated urine revealed a different behavior
of AAP elimination according to certain effects of drugs. The mean
values of AAP in females was with 1490 530 mU/24 hr, statistically
significantly lower than in males with 2302 931 mU/24 hr. The
coefficient of variability from day to day ranges between 30 and 38%.
Diuresis-dependent daily fluctuations of AAP were of no influence on
the 24 hour values. The potential toxicity of 10 cephalosporins, 8
aminoglycosides, and 7 combinations of cephalosporins with aminogly-
cosides as well as 2 combinations with cephalsosporins and loup
diuretics were under our investigation with 230 informed, healthy
volunteers. The drugs were given on 3 consecutive days. AAP in 24-
hour urine samples was measured before, during, and after application
of the drug. Of 10 cephalosporins, 2 showed an obviously genetically
ruled elimination pattern, resulting in responder and nonresponder. In
the responder-groups, AAP values reached up to 6000 mU/24 hr. AAP
activities in urine after application of aminoglycosides showed maximal
values up to 18,000 mU/24 hr. There was a cumulative increase after
application of the drugs according to the accumulation in the tubular
cells. After centrifugation of the urine samples at x 100,000g for 1 hour
membrane particles with AAP activity have been found in the pellet.
This was a definite sign of tubular lesions. Cephalosponns revealed no
activity in the pellet. The combination of aminoglycosides with cephalo-
sporins showed no additive or protective effects in those we had under
investigation. AAP elimination has been entirely dependent of the
potential toxicity of the respective aminoglycoside. The combination of
cephalosporins with loup diuretics was not followed by an increase of
AAP elimination and therefore showed no signs of tubular effects.
Adenosine as a mediator of the renal response to acute sodium chloride
loading. H. Osswald, G. Nabakowski, R. Sacher, W. S. Spielman, and
H. Kammermeier. Dept. of Pharmacology and of Physiology, RWTH,
Aachen, West Germany, and Dept. of Physiology and Biophysics,
Rochester, Mayo Clinic, Minnesota, USA. Infusion of hypertonic
saline (HS) into the renal artery of dogs leads to sustained vasoconstric-
tion and marked decrease of renin release. In the present experimental
series, we tested the hypothesis whether the renal response to infusion
of HS may be mediated by intrarenal adenosine formation since
exogenous adenosine leads to changes in renal function similar to that
of HS infusion. In sodium-depleted rats, HS was infused into the
thoracic aorta for 10 mm to elevate arterial plasma sodium concentra-
tion up to 170 to 180 mmoles/liter. Tissue content of adenine nucleotides
was measured by means of high pressure liquid chromatography; and
adenosine was measured enzymatically. Tubular sodium reabsorption
increased from 60 3 to 109 9 imoles/min/l00 g of body wt (±sEM;
N = 7) following HS infusion. Renal ATP tissue content decreased from
2.6 .5 to 1.1 .3 p.moles/g wet wt whereas that of adenosine
increased from 5.7 1.2 to 16.2 3.2 nmoles/g wet wt. In addition,
there was a positive correlation between tubular reabsorbed sodium and
urinary adenosine excretion. In sodium-depleted dogs, HS infusion into
the renal artery lowered RBF and GFR by 14%, and renin release by
77%. Infusion of the adenosine antagonist theophylline into the renal
artery (5 imoles/min) abolished the fall in RBF, GFR, and renin release
due to HS infusion. When adenosine was infused into the renal artery at
a rate of 100 j.moles/min, single injections of adenosine on top of the
continuous infusion no longer cause vasoconstriction. Under this
condition of an adenosine autoblockade, HS infusion induced vasodila-
tation instead of vasoconstrictjon as seen under control conditions.
Conclusion. (1) Acute increase of tubular sodium reabsorption leads to
a fall of ATP tissue levels and enhanced adenosine generation in rats.
(2) Theophylline and adenosine autoblockade prevent the normal renal
response to HS infusion in dogs. (3) Adenosine is thought to mediate the
renal response to acute NaCI loading.
Pharmacokinetics of digitoxin in patients with end-stage renal failure
treated with continuous ambulatory peritoneal dialysis. U. Peters, T.
Risler, and B. Grabensee. Medizinische Klinik A der Universitat
Dusseldorf, NRW. The study was performed in nine patients (ages: 51.3
16.2 yr) with end-stage renal failure, who were treated with CAPD
and had to be on a digitalis medication because of heart failure. The
kinetics of digitoxin were studied under steady-state conditions in
patients on CAPD and compared with the results of a control group on
equal medication but treated with hemodialysis. The patients, who were
on a daily dosage of 0.1 mg of digitoxin, received 4 times 2 liters
(glucose content: 1.5%) and once 2 liters of a hypertonic dialysate
(glucose content: 4,25%) per day. The mean voiding volume was 10.6
1.3 liters/day, containing 19.2 11.2 g protein/day. We measured
digitoxin in serum and dialysate using our specific radioimmunoassay.
The digitoxin protein binding as well as the protein unbound fraction
were determined with a ultracentrifugation method. Results. In nine
patients, we measured a mean serum digitoxin concentration of 14.3
6.1 ng/ml which was significantly (P < 0.005) lower than in the control
group (22.8 8.1 ng/ml). Although the serum protein binding of
digitoxin was significantly smaller (94.7 1.5%) in patients on CAPD
compared to those on hemodialysis (96.2 1.3%), the unbound fraction
of digitoxin was similar in both groups with 0.8 0.3 and 0.9 0.3 ng/
ml. The amount of digitoxin being excreted via peritoneal dialysis was
13.4 6.2 g/day, and this was similar to the amount excreted by the
kidneys of patients suffering from renal failure (creatinine clearance, 10
to 30 mI/mm). None of the patients presented symptoms of a digitalis
intoxication, which is in accordance with the measured unbound serum
digitoxin fraction, which remained in normal limits despite a reduced
digitoxin protein binding. Thus, our results prove the need to treat
patients on peritoneal dialysis with the common maintenance digitoxin
dosage of 0.1 mg/day despite a reduced protein binding.
Clinical course of vascular rejection in human renal allografts. W.
Pommer, G. Offermann, P. H. Krause, and M. Molzahn. Medizinische
Klinik und Poliklinik Klinikum Steglitz u. Institut für Pathologie,
Klinikum Charlottenburg, Freie Universität Berlin, Germany. In 25
patients with cadaver kidney transplantation, histologic findings of
renal allografts and clinical outcome were investigated for predictive
significance of vascular rejection (VR). 54 percutanous graft biopsies
performed during clinical signs of rejection were studied by light
microscopy, immunofluorescence and, in some cases, electron-micros-
copy. The following clinical data were recorded: allograft function
(serum creatinine), blood pressure behavior, time and number of
rejection periods, infections. According to the histologic findings of the
vessels, we divided the patients into two groups: group I (N = 8) with
complete unchanged vascular structure in renal allografts (predominant
interstitial rejection), group II with vascular rejection (fibrinoid wall
necrosis, intimaproliferation). Ten patients of the latter group still retain
their life-sustaining graft after a period of 12 to 30 months (group LIa),
but eight grafts failed within a period of 1 to 5 months (group lib).
Group I showed serum creatinine values of less than 120 moles/liter at
the end of the observation period (12 to 18 months), one patient with
recurrence of primary oxalosis showed serum creatinine of about 200
moles/liter. In comparison with that, serum creatinine levels of group
ha were normal in one case only; seven patients had values between
120 and 150 jimoles/liter, two patients between 250 and 400 moles/
liter. In group lib, minimal serum creatinine values before complete
failure were between 190 and 600 moles/liter. Seven patients of group I
and nine patients of group ha were normotensive; one of each group
showed elevated blood pressure. Severe hypertension developed in
seven patients of group lIb. Number and time of clinical rejection
periods did not differ within groups I and IIa; in group Hb rejections
resisted steroids. Number and type of infections seemed to be quite
similar in each group. Our findings suggest that (1) VR in renal allografts
indicates poor prognosis in comparison with purely interstitial rejec-
tion, (2) depending on the clinical course, there is a normotensive group
with restricted but life-sustaining function and, on the other hand, a
hypertensive group with irreversible damage of graft function, (3)
hypertension in VR seems to be of predictive and possibly causative
value.
Effects of captopril on severe hypertension in advanced renal insuffi-
ciency. E. Quellhorst, B. Schuenemann, H. Hildebrand, and G.
Mietzsch Nephrolog. Zentrum Niedersachsen, Muenden, FRG. Capto-
pril is an orally active converting enzyme inhibitor, the antihyperten-
sive activity of which having been proven in essential and renovascular
hypertension. There are only few reports, however, concerning the
influence of this new drug on hypertension in advanced renal failure
which may be caused by sodium and water retention or by an imbalance
between total body sodium and renin secretion. Eighty-one patients
(pats) with chronic renal insufficiency (CR!) being classified according
to the degree of renal impairment into 5 groups were treated with
captopril in doses of 25 to 600mg daily during a period of 5 weeks. After
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this phase, 40 to 120 mg of furosemide daily were administered to 16
nonresponders whereby the number of responders could be increased
from 65 to 75 pats (= 92.6%). Nonresponders to this combined therapy
exclusively belonged to the groups with severe renal insufficiency
(GFR, 30 ml/min) and very high mean arterial pressure at the start of
treatment. During captopril treatment, generally a slight increase in
pulse rate could be observed. In both normoreninemic and hyperrenin-
ernie pats a correlation existed between dosage of captopril and its
maximum effect on blood pressure. In hyperreninemic pats, however, a
certain dose of captopril was more effective in reducing blood pressure
than in normoreninemic pats (normoreninemic: y = —0.99 + 0.04x, r =
0.50, hyperreninemic: y = 16.35 + 0.05x, r = 0.67). In the course of
treatment, mean OFR showed a transient decrease in all groups of pats,
being more distinct in groups with mild and less pronounced in groups
with severe CR1. In hemofiltration experiments, total body sodium and
water were influenced independently of each other by partial substitu-
tion of ultrafiltrate by hypotonic (Na, 130 mEq/liter), isotonic (Nat,
145 mEq/liter) or hypertonic (Nat, 160 mEq/liter) diluting fluids. The
early effect of captopril on blood pressure could be enhanced by
removal of Na alone or in combination with water, resulting in an
isotonic volume depletion. On the other hand, the antihypertensive
effect of captopril was markedly reduced when total body sodium was
kept constant by partial substitution of the ultrafiltrate by a hypertonic
diluting fluid. Side reactions were observed in 12 pats (nausea 5, skin
reactions 3, tachycardia 2, transient loss of taste 2).
Diminished noradrenalin sensitivity of resistence vessels in chronic
uremia: Are prostaglandins involved? W. Rascher, A. SchOmig, and E.
Ritz. Department of Pharmacology & Dept. of Intern. Med., Univ. of
Heidelberg, FRG. Sympathetic function and specifically vascular re-
sponsiveness to noradrenalin (NA) was examined in rats with chronic
uremia. Male Sprague Dawley rats (250 g) were used and underwent:
subtotal nephrectomy (NX); sham-op and pairfeeding of controls (CO);
experiments 5 weeks after (NX); radioenzymatic (DaPrada) measure-
ment of plasma NA, adrenalin, and dopamine, measurement of neuro-
nal (cocaine blockade, 30 M) and of extraneuronal (corticosterone
blockade, 100 p.M) uptake in the isolated perfused heart; determination
of tritiated NA metabolites in the perfusate and effluent after Graefe et
al; and measurement of the response of the isolated perfused hindlimb
preparation to NA and vasopressin according to Folkow et al. Results.
Plasma NA levels were elevated in NX rats (242 22 vs. 184 16 pg!
ml, P < 0.05). However, neuronal uptake of NA was reduced in hearts
of NX rats (50.9 5.45 vs. 85.1 13.5 pM/mm/heart, P < 0.05).
Extraneuronal uptake did not differ. Blood pressure was only marginal-
ly elevated, but heart weight was increased and heart NA content
diminished. In the isolated perfused hindlimb, the dose response curve
to NA was shifted to the right (ED50, 4.28 0.37 vs. 2.68 0.18 M; P
0.01) with and without cocaine blockade. Maximal vasodilatation and
maximal contraction were unchanged. Dose-response curves to vaso-
pressin were unchanged. Pretreatment with indomethacin (2 x 1 mg/kg!
day) restored ED30 of NX to CO values. Conclusions. In chronic
uremia, plasma NA is elevated, but reuptake is reduced, suggesting
increased spillover of NA into circulation. NA sensitivity of resistance
vessels is diminished, and this defect is normalized by indomethacin.
Consequently, prostaglandins may be involved in altered NA respon-
siveness.
Activity of so-called middle molecules from hemodialysates in biological
systems. H. Rautenstrauch, G. Bovermann, and G. Jung. Abteilung fur
Nephrologie am Zentrum für Innere Medizin des Robert-Bosch-Kran-
kenhauses, Stuttgart, and Chemisches Inst itut der Universitiit Tubing-
en, Deutschland. The preparative isolation of toxic middle molecule
fractions from freeze-dried hemodialysates of several uremic patients is
reported. The gel filtration techniques in combination with ion-ex-
change chromatography reported so far were found to be unsuitable.
Better results were obtained by elution with 0.01 N acetic acid on
Sephadex G-l5. Fractions inhibiting the proliferation of lymphocytes
were separated by reversed phase chromatography on silica gel RP-8
with methanol/water (20:80) as eluent, yielding various pepitidic frac-
tions. Lyophilized probes of hemodialysates contain only about 0.1%
(w/w) of the most active fraction containing an amount of 10% peptides.
Amino acid analyses deviate strongly from data published so far;
however they confirm the presence of peptides consisting of 10 to 11
amino acids. Fractions obtained from preparative isolations were
subjected to analytical high-pressure liquid chromatography on silica
gel Si -60, silica gel RP-8, and bondagel whereby a further separation
into several components could be accomplished. Inhibitory activities in
several test systems were not seen, if isolated fractions were better
cleaned.
The attack complex of complement in epimembranous and antibase-
ment membrane antibody glomerulonephritis. E. W. Rauterberg, T.
Gehrig, and P. Kohl. Institut für Immunologic, Universität Heidelberg,
Germany. The pathogenetic role of the complement (C) system in the
various types of glomerulonephritis (ON) is not yet fully elucidated.
Glomerular deposits of C components have been visualized by immuno-
fluorescence microscopy (IF) indicating a local C activation. A com-
plete C activation may result in the formation of a lytic attack complex
(C59), which has the potency to alter the membrane function of
nucleated cells. Thus, the C-attack complex could possibly participate
in the initiation and maintenance of glomerular dysfunction by irritating
the endothelial or epithelial cells. However, even the IF detection of
tissue bound CS, C6, C7, C8, or C9 cannot indicate their assembly to
the lytic attack complex (C59). The assembly of the late C components
C5 to C9 to the attack complex results in the expression of neoantigens,
which cannot be detected on the native molecules. In the present study
anti-C59-neoantigen antibodies were used to demonstrate the C attack
complexes in the tissue by IF. Cryostat sections of 25 kidney biopsies
with epimembranous ON (N = 19) and antibasement membrane anti-
body GN (N = 6) were examined by direct or indirect IF using
antibodies against IgG, IgA, 1gM, Clq, C4, C3b, C3d, factor B, CS, C6,
C8, C9, and the C59 neoantigen. The fluorescence intensity of the
glornerular deposits was classified semiquantitatively. In all cases with
epimembranous ON (EON), fine to coarse granular IgO deposits were
detected along the peripheral basement membrane. In all biopsies with
antibasement membrane antibody ON (ABM-GN), "ultrasharp" linear
IgG deposits were observed along the glomerular basement mem-
branes. The following table gives the results for a fluorescence intensity
of++ and +++:
IgO IgA 1gM Clq C4 C3bC3d B cs Co co C9 Neo
EON (N = 19) 19 8 10* 9* 4* 17 18 14* 17* 17' 10' 8' 17'
ABM-GN (N 6) 6 2 3+ 2+ I 4+ 6+ I 6 6+ 4+ 6+
— --
6+
= additional tnesangial granular deposits; + = additiotmi gtanulat deposits).
The C59-neoantigen of the C-attack complex was observed in 17/19
cases of EON with an identical distribution as IgG and was found in all
six cases of anti-BM antibody ON with an ultralinear distribution. In
some cases additional mesangial C59-deposits were visualized. Our
findings indicate, that (I) the complement cascade is completely activat-
ed up to the formation of the C-attack complex, and (2) the C59-
complex is bound to the immuncomplexes or the basement membrane
by a yet unknown mechanism.
Liver gluconeogenesis in acute uremia: Abnormal hormonal response.
W. Riegel, J. Stepinski, W. Horl, and A. Heidland. Medizinische
Universitätsklinink, Wurzburg, BRD. Available data suggest that hyper-
glycemia and glucose intolerance in renal failure are due to stimulation
of glycogenolysis and gluconeogenesis, as well as inhibition of glyco-
neogenesis and glycolysis. Additionally, abnormal carbohydrate metab-
olism in uremia is complicated by unexpected hormonal responses,
uremic toxins, electrolyte disturbances, and metabolic acidosis. The
aim of our study was to investigate the effect of hormones and pH on
gluconeogenesis (GNO) in liver cells of acutely uremic rats. Acute renal
failure (ARF) was induced by: uranyl nitrate injection (5 mg/kg) (UN);
bilateral nephrectomy (BN); ureterligation (UL) and unilateral nephrec-
tomy accomplished by 1 hour of ischemia of opposite kidney (IS).
Normal (CO) and sham-operated (SO) rats were used as controls. Liver
cells were prepared 48 hours after operation and 24 hours after
starvation using collagenase method. Hepatocytes were incubated in
Krebs-Ringer-bicarbonate buffer (pH, 7.1; 7.4; 7.6). Substrates (10 mM)
and hormones were used: pyruvate (PYR), Di-OH-aceton (DiOH), I-
serine (SER); glucagon (28 nM), insulin (17 nM), adrenalin (10 .LM), and
db -cAMP (0.1 mM). Glucose was measured by enzymatic method and
expressed in nmoles/mg of proteinl30 mm. Results. Glucose synthesis
from PYR, DiOH, and SER in SO (pH, 7.4) was: 86 14, 167 27, 29
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12, respectively, High stimulation of GNG was observed only in the
presence of SER: UN (+131%), BN (+147%), and UL(+116%). The
pH didn't significantly change GNG in all tested groups. Glucagon
stimulated GNG from DiOH in SO (+ 11%), UL (+30%) and IS (+30%).
No stimulation was observed in BN. Adrenalin and db-cAMP have had
similar effects. Insulin inhibited GNG only in BN (— 12%) and UL
(— 10%). Antagonistic effects of insulin and propranolol were observed
in all experimental groups. Conclusions. Our data indicate that in ARF,
SER seems to be one of the most important substrate for liver GNG. No
responses to cAMP-mediated hormones were observed in ARF without
kidneys, while higher effects have been seen in all other types of
uremia. The inhibitory effect of insulin depended on the severity of
ARF. We can therefore assume that different types of experimental
ARF induce different gluconeogenic abilities of liver.
Successful treatment of oligoanuric patients with rapidly progressive
glomerulonephritis by plasma exchange. A. J. G. Riegger, G. Liebau, H.
Steilner, and K. Kochsiek. Medizinische Univ.-Klinik, Abt.III, Tubing-
en, FRG. Immune mechanisms play a major role in the pathogenesis of
rapidly progressive glomerulonephritis (RPGN) through the deposition
of soluble immune-complex activation of complement, kinin, and
coagulation factors like fibrinogen. Plasma exchange in combination
with immunosuppressive therapy has proved to be beneficial by remov-
ing these reactants from the circulation. In 3 patients with clinically and
histologically confirmed RPGN, with extensive crescent formation and
oligoanuria, 6 plasma-exchanges (4.51) were performed using a hollow-
fiber filter (Asahi), and a hemopröcessor (Sartorius), and a concomitant
immunosuppression with prednisolone (1 mg/kg/day), azathioprine (2
mg/kg/day), and in one patient cyclophosphamide (2 mg/kg/day). In all
patients a close coincidence between the plasma exchange and the
clinical improvement was observed with a striking increase in urine
production, sufficient enough to stop regular hemodialysis or hemofil-
tration. In 2 of them a remission up to 5 months until now was achieved
even under continuous reduction of immunosuppression. Plasma ex-
change produced a rapid and substantial reduction of IgG, IgA, and 1gM
as well as of the complement factors C3 and C4, which could be reduced
to about 30% of their initial values.
Morphometric studies of exogenous kaliopenic nephropathy. Thomas
Riemenschneider and Adalbert Bohie. Institute of Pathology, Universi-
ty of Tubingen, FRG. Morphometric studies using light microscopy
were carried out on 39 kidney biopsy specimens from 37 female and 2
male patients. The mean serum potassium concentration at the time of
hospitalization was 2.59 mg/dl. Causes of potassium depletion were
abusive use of laxatives (34) and diuretics (16), anorexia nervosa (14),
psychogenic vomiting (6), and renal potassium loss (5). The duration of
the nephropathy at the time of biopsy was between 1 and 35 years.
Serum creatinine concentration, on the average, was 1.51 mg/dI.
Quantitative evaluation, compared with 35 normal kidney biopsy speci-
mens, yielded the following results: (1) vacuolization in the cytoplasm
or basal labyrinth of the proximal and distal tubules in 17.97%; (2) a
significant reduction of the glomerular capsule spaces and capillary
convolutions of 17.50%; (3) a significant increase of the mesangial
matrix per glomerulus of 25.64%; (4) a pronounced hyperplasia of the
juxtaglomerular apparatus of 173.00%; (5) PAS-positive, argyrophilic
granules in interstitial cells of the renal medulla in 2 of 10 tissue
cylinders containing portions of medulla; (6) predominantly circum-
scribed lymphocytic infiltration of the renal cortex (only 5 diffuse) in 30
of the 39 biopsy specimens; and (7) an increase in interstitial volume of
the renal cortex of 102% due to sclerosis. Of all the morphologic-clinical
correlations, the relationship between relative interstitial volume and
serum creatinine concentration at the time of biopsy was highly
significant. The morphologic picture of exogenous hypokaliemic
nephropathy therefore has several new aspects: The vacuolar degenera-
tion of the renal tubules, which up to now has been considered
pathognomonic, is not essential for the diagnosis. By comparison, the
combination of extremely enlarged juxtaglomerular apparatus, dimin-
ished glomerula with markedly increased mesangial matrix, and intersti-
tial fibrosis with circumscribed interstitial nephritis (correlated to the
high serum creatinine concentration) appears to be characteristic for
kaliopenic nephropathy.
Treatment of therapy-resistant hypertension with captopril. A. Rockel
and A. Heidland. Med. Univ. Klinik, Wurzburg, BRD. The antihyper-
tensive effects and side-effects of the converting-enzyme inhibitor
captopril were studied in 26 outpatients with "therapy-resistant"
hypertension (diastolic blood pressure > 110 mm Hg under therapy
with 4 to 6 antihypertensive drugs). Captopril (I x 6.25 to 3 x 150 mg/
day) caused (mostly in combination with diuretics, a- and 3-receptor-
blockers, vasodilators and/or central a-receptor-stimulators) a normal-
ization of the blood pressure in 3 out of 7 patients with essential, in 7 out
of 7 with renovascular, in 1/5 with renoparenchymal hypertension, and
in 4 out 7 hypertensive patients on regular dialysis treatment. Initially,
in most patients a good control of blood pressure could be attained.
During the course of the treatment, however, a loss of efficacy in
patients with essential and renoparenchymal hypertension was ob-
served. During therapy with captopril, the following side-effects were
noted: hypotension (N = 5), angioneurotic edema (N = I), skin rash
and pruntus (N = I), leukopenia (N = 2), increase of plasma creatinine
concentration, stronger as expected by the course of the underlying
disease (N = 5). Moreover captopril might have caused abdominal
cramps (N = 3), duodenal ulcers (N = 3), a reduction of pulmonal CO-
transfer/alveolitis (N = I), and disturbances of the taste (PTH blindness)
(N = 3). The experience so far available seems to indicate that captopril
may be an effective antihypertensive drug in "therapy-resistant" hyper-
tension, particularly in hypertension with stimulated RAS. Unfortu-
nately the ascribed side-effects prevent a wider use of this agent.
Clearance of low molecular-weight plasma proteins by hemofiltration.
A. Röckel, G. P. Dragoun, U. Gilge, B. Oh!, A. Liewald, A. Heidland.
Med. Univ.-Clinic, Department of Nephrology, Wurzburg, FRG. Ure-
mic symptoms (anemia, osteopathy, myopathy, disturbances of the
metabolism of carbohydrates, fat, and proteins) may be partly caused
by an accumulation of low molecular-weight proteins (Mr, 10,000 to
60,000 daltons) in patients on regular dialysis therapy. The aim of the
study was to test the cut-off of the Gambro high-flux, Duoflux, and
Hospal 7 + 8 hemofilters using trace proteins as marker substances.
Clearances of f32-microglobulin (32-MG, 118,000 daltons), lysozyme
(LZ, 15000), retinol-binding protein (RB F, 21,000), 32-glycoprotein I
(132-GP, 40,000), a1-antitrypsin (a1-AT, 54,000), praealbumin (PA,
61,000), albumin (A, 69,000), and transferrin (TF, 90,000) was calculat-
ed during a 4-hour hemofiltration (20 liters of ultrafiltrate). The proteins
were analyzed by immunodiffusion or laser nephelometry. Results were









p2-MG 40.1 10.9 37.2 11.6 23.7 13 50 23 37.9 1.3
LZ 52.5 11.8 36.5 14.7 30 7.6 26.2 7 33.9 7.5
RBP 0.6 0 3.7 1.7 1.3 0.4 5.3 32 7.4 4.4
s2-GP I 0.1 4.5 1.2 — 4.2 2.7 5.9 2.8
a1-AT 1.85 0.07 2.1 1.1 — 2.1 0.9 2.2 0.5
PA — 4.2± 1.1 — — —
A 0.89 0.7 1.3 0.8 0.19 0 1.4 0.9 1.4 0.6
TF 0.7 0.14 1.3 0.6 — 2.2 1.1 1.6 0.6
The tested hemofilters were well permeable up to a mol wt of 15,000
daltons. Compared with the Hospal 7 + 8 and Gambro FH 102, in the
mol wt range of 20,000 to 40,000, Duoflux and Gambro-Highflux
showed significantly higher clearances. Long-term studies will show if
and in how far the uremic symptoms might be favorably influenced by
membranes with a higher cut-ol.
Supported by the BMFT
Pharmacologic Influences on parotid salivary kallikrein concentration
in rats. A. ROckel, H. Zenglein, A. Preissler, J. VOlker, G. Hem, A.
Heidland. Med. Univ. Klinik, Wurzburg, BRD. In human essential
hypertension, an enhanced parotid salivary kallikrein concentration
(PKC) was established previously. To evaluate this phenomenon, the
effect of various pharmacological agents on salivary kallikrein secretion
was investigated in rats. Intravenous administration of dibutyryl-cAMP
(200 g/kg/min) as well as theophylline (250 g/kg/min) caused an
increase of PKC. Blockade of sodium channels of the duct system by
amiloride (100 jig/kg/mm) resulted in a reduction of PKC. On the other
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hand, an enhanced intracellular Na-shift induced by the Na-iono-
phore monensin (140 g/kg/min) caused a rise of PKC, The Ca
antagonist verapramil (90 j.glkg/min) and the Ca + ionophor A 23187
(100 gIkgImin) had no effect on the PKC. Bradykinin (100 i.g/kgImin)
as well as inhibition of the kininase II with captopril (10 mg/kg/mm)
caused a decrease of PKC. A low dose of angiotensin 11(1 p.g/kg/min)
resulted in a decrease; a high dose (10 p.g/kg/min) resulted in an increase
of PKC. The latter effect was abolished by saralasin (10 p.g/kg/min). a-
Methyl-norepinephrine, norepinephrine (each, 10 g/kg/min), and orci-
prenaline (150 g/kg/min) caused an increase of PKC; norfenephrine (40
gIkg/min) did not influence significantly the PKC. Propranolol (30 g/
kg/mm) caused a decrease, and phenoxybenzamine (160 p.g/kg/mmn) an
increase of PKC. The kallikrein secretion in the parotid duct system
seems to be mediated by cAMP. Moreover, interactions with the local
Na/K transport are assumed. Alterations of the Ca + transport in the
duct system had no influence on the enzyme secretion of the parotis.
The decrease of PKC, observed after administration of bradykinin,
suggests a negative feedback-mechanism in the kallikrein kinin system.
Corresponding to the effects on urinary kallikrein excretion, angioten-
sin II causes a dose-dependent divergent kallikrein secretion in parotid
saliva. The PKC of parotis seems to be enhanced by a- and 13-
receptor—but not by a1-receptor-stimulation; the reduced PKC after 3-
receptor blockade supports this view. The increase of PKC after a-
receptor blockade might be due to a counterregulatory stimulation of 13-
receptors.
Nephrotoxicity of water-soluble contrast media in renal angiography.
R. Rohrbach and D. Weingard. Dept. of Pathology and Radiology,
University of Freiburg, Freiburg, Germany, The present studies were
conducted to help clarify the morphologically demonstrable damage to
the kidney due to contrast media used for angiography. To obtain
clinically relevant results, we attempted to improve different experi-
mental conditions by selection of the laboratory animals, the amount of
contrast material and the procedure of tissue collection and prepara-
tion. Morphologically visible damage of kidney tissue may be induced
by: (1) a toxic damage of contrast substance, (2) a reduced blood flow
caused by erythrocyte aggregation, (3) the method of tissue prepara-
tion, and (4) a high osmolality of the contrast medium. Twelve 6-month
old Gottinger minipigs were used as test animals because of their short-
looped nephron similar to that of man. Diatrizoate, ioxithalamate, and
metrizamide were chosen as contrast media of different osmolality and
administered by angiography. Kidney needle biopsies were harvested 2,
12, 24 hr, and I week after angiography. Tissue alterations were
investigated by light and electron microscopy. The most pronounced
renal tubular cell changes were yielded after the contrast media with the
highest osmolality. Only 2 hours after angiography, tubular cells
revealed a hydropic swollen and granulated cytoplasm. Focal glomeru-
lar loop necrosis could be observed at that time, too. Most extensive
degenerative and necrotic tubular cell damage were observed 24 hr
later. Similar but quantitatively and qualitatively less pronounced
tubular cell changes were observed in animals treated with a contrast
medium of lower osmolality and the slightest signs of tubular cell
damage were seen after plasma-isotonic contrast medium. Electron
microscopy also reveals heavily damaged tubular epithelial cells 12 and
24 hr following the application of hyperosmolar media. An increasing
number of hydropically swollen mitochondria and cyst-shaped lamellat-
ed cytoplasmatic bodies together with focal epithelial cell necrosis
indicate a hypoxemic or hyperosmolar cell damage. Already 2 hr after
angiography, some endothelial cells exhibited an immense cytoplasma-
tic edema. Twenty-four hours later, endothelial cells reveal a cell
hypertrophy with swelling and arcade formation of the nuclei as well as
cytoplasmatic vesicles. Single endothelial cell necrosis were observed.
Nearly all cellular changes were negligible after plasma isotonic media.
Partial isolation and characterization of an urine protease from a
patient with nephrotic syndrome. K. Scheidhauer, W. H. HOrl, J.
Stepinski, and A. Heidland. Department of Nephrology, Medical
University Klinik, Wurzburg, West Germany. HUrl et al. recently
demonstrated for the first time the existence of free proteolytic activity
in the urine of a patient with posttraumatic renal failure. The aim of the
present investigation was the isolation and characterization of an urine
protease at patients with nephrotic syndrome. After a 12-hour collec-
tion of urine from a 21-year-old patient with serious nephrotic syndrome
(initial daily proteinuria up to 55 g/24 hr max.), one urine protease was
isolated as follows: fractional precipitation of the urine with ammonium
sulfate, subsequent gel chromatography with Sephadex G 100 and G 50.
The proteolytic active fractions were identified with azocasein as
substrate. For characterization of the protease, these fractions were
incubated with phophorylase kinase, isolated from rabbit muscle.
Subsequently, the samples were separated by SDS-gel-electrophoresis
(5% gels). The densitometric valuation was made with cytochrom c as a
standard. Results. Twenty microliters of the 10-time diluted protease
fraction showed, after incubation with 20 l of phosphorylase kinase
(1.5 mg/mI), the following proteolytic digestion of its three subunits




(mol wt 75,000)Alpha Beta Gamma
mm p.g/ml p.g/ml
0 170 199 102 25
30 23 135 80 132
60 11 88 39 75
240 0 39 33 53
Over 4 hours, the subunit alpha (mol wt, 135,000 daltons) was digested
completely, with partial proteolytic degradation of the subunits beta
(mol wt, 120,000 daltons) and gamma (mol wt, 42,000 daltons), while the
structure of the enzyme was unchanged after a 24-hour incubation with
control urine. One fraction X (mol wt 75,000 daltons) seems to be the
proteolytic degradation product.
Excretion of specific tubular antigens as an indicator of kidney damage
in patients with malignant monoclonal gammopathy (plasmocytoma). J.
E. Scherberich, H. Basting, F. Waither, W. Mondorf, P. Mitrou, and
W. Schoeppe. Dept. of Nephrology, Dept. of Haematology, University
Frankfurt, FRG. To evaluate the possibility of an association between a
nephropathy (paraneoplastic) developing during the course of a system-
ic disease and the excretion of kidney antigens, we studied urinary
proteins of tubular origin in 26 patients (l6, 10 ,mean age 62.7 yr)
suffering from plasmacytoma (PC) (lymphoplasmocytic immunoblas-
toma). Tubular markers such as alanine-aminopeptidase (EC 3.4.11-),
-y-Glu-transpeptidase (EC 2.3.2.2), and alkaline phosphatase (EC
3.1.3. 1), as well as membrane antigens of the proximal tubule, were
determined by quantitative enzymatic and immunologic methods apply-
ing specific brush-border antisera. Diagnosis of PC was established by
histocytologic, radiologic, clinical, and biochemical criteria. The fol-
lowing immunoserologic pattern of paraproteins emerged: IgG (, N =
10; a, N = 3), IgA(, N = 2; a, N = 5), light chain PC (, N = 2;a, N
3), nonsecretory PC, N = 1. Eleven patients were undergoing
cytostatic therapy (Vcr, Adr, Pred, End), while 15 patients received no
cytostatics. As compared to normal persons (N = 44), 24/26 patients
with PC exhibited a significant increase in tubular indicator enzyme
concentration in their urine, which was correlated with the elimination
of the major brush-border surface antigen (R5 = 0.77; 2a <0.001). This
antigen, excreted only under pathologic conditions, was characterized
as a protein of 156,000 daltons containing glucose, galactose, and N-
acetylglucosamine on its surface. The concentration of kidney proteins
found in the urine of PC patients was independent of the time following
PC diagnosis. In addition, no correlation was found between the
creatinine concentration in serum and histuria of tubular antigens (6/26
PC: creatinine > 1.2 mg/dl). Excretion of kidney proteins was signifi-
cantly higher in PC patients under cytostatic treatment as compared
with that for PC patients receiving no cytostatics (2a < 0.001).
Furthermore, 16 patients with Bence-Jones paraproteinuria (free light-
chain concentration, 18 to 505 U/24 hr) had significant higher outputs of
tubular membrane antigens than patients where no L-chains (free
Bence-Jones L-chains 4 7 U/24 hr) could be detected in urine (2a <
0.001). This association was independent of whether or not PC patients
were under a cytostatic regime. Kidney antigens, excreted under
pathologic conditions, were isolated from the urine by specific immuno-
sorption. FITC-labeled antisera directed against these purified urinary
kidney antigens gave a specific immunofluorescence over kidney sec-
tions which was restricted to the plasma membranes of the proximal
tubule. From these results we conclude: (1) that patients with PC
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excrete tubular membrane antigens at an increased rate, which might be
due to a nephrotoxic effect of free L-chains; whether infiltration of the
renal interstitium by the plasmocytoma might play a role remains open
to question. (2) that administration of cytostatics to PC patients might
enhance preexisting tubular damage due to the underlying disease.
Antihypertensive effect of diazoxide and labetalol on acute hypertension
during hemodialysis treatment. H. Schiffi, G. Keusch, and U. Bins-
wanger. Section of Nephrology, University Hospital, Zurich, Switzer-
land. We compared the antihypertensive effect of the peripheral vasodi-
latator diazoxide (D) in 13 patients with the alpha-beta adrenoceptor
blocking agent labetalol (L) in 12 patients on 23 acute hypertensive
episodes during hemodialysis treatment (HD). At the beginning of HD,
the blood pressure was 171 6/102 4 (sCM) mm Hg in the D-treated
group and increased to 191 3/117 3mmHg 117 6mm after HD; in
the L-treated group the blood pressure was 180 4/101 3 mm Hg at
the start of HD and increased to 192 4/108 3 mm Hg after 125 17
mm of HD. Pretreatment mean arterial blood pressure (MBP) and heart
rate (HR) and the response to 150 mg of D or 50 mg of L, 5, 10, and 30
mm after injection as well at the end of HD were the following: In 7 D-
treated hypertensive episodes, a second dose of 150 mg was given 60
11 mm after the first injection and in 6 L-treated hypertensive episodes
a second dose of 50 mg was given 41 9 mm after the first injection.
D treatment
(N=23) L treatment(N=23)
MBP Z%MBP HR MBP Z%MBP HR
Pretreat 141 2 82 4 135 2 77 3
5mm 116±5** —19±3 86±4 121±3** —10±2 79±3
10mm 1l7±4** —18±3 84±3 119±3** —12±2 81±3
30 mm 114 3** —20 2 85 3 117 3** —14 2 82 2*
End of HD
*p< 0.0025;
109 3** —23 2
** < 0.0005
85 4 113 3** —17 2 86 2
The reduction in MBP 5, 10, and 30 mm after injectionwas greater withD (P < 0.05); at the end of HD both groups showed a comparable
decrease in MBP. HR remained unchanged with D treatment and
increased slightly with L after 30 mm. Postdialysis orthostatic fall in
MBP was similarly low in both groups (—0.8 4 and —4 2 mm Hg).
These results indicate that acute hypertension during HD may be
adequately controlled either by D or L; D did not increase significantly
HR.
Catecholamines, sodium, and renin in unilateral renal hypertension in
man. H. Schiffi, P. Weidmann, W. H. Ziegler, Z. Glflck, A. Meier, and
G. Keusch. Medizinische Poliklinik, University of Berne, Switzerland.
The relative roles of plasma or urinary norepinephrine (NE) and
epinephrine (E), exchangeable sodium, blood volume, and plasma renin
(PRA) or aldosterone in the pathogenesis of unilateral renal hyperten-
sion were evaluated. Ninety-nine normal subjects and 33 age-matched
untreated hypertensive patients with unilateral renal parenchymal dis-
ease (RPD, N = 18) or renal artery stenosis (RAS, N = 15) were
compared. Underlying lesions in RPD included unilateral small kidneys
due to pyelonephritis and/or hypoplasia (N = 10), hydronephrosis due
to pyeloureteral obstruction (N 6), and renal tuberculosis (N = 2).
Measurements were repeated following operative treatment in 23
patients. Plasma and urinary NE orE, exchangeable sodium, and blood
volume were comparable between normal and untreated subjects with
RPD or RAS. Both patient subgroups had increased blood pressure and
supine PRA (P < 0.001); these abnormalities were milder with RPD.
Plasma aldosterone and upright PRA were significantly elevated (P <
0.05) in RAS only. Operative treatment of RPD and RAS caused
decreases in blood pressure (—18 and —28%) and PRA; they correlated
significantly in RPD (r = 0.56; P< 0.05). In RPD and RAS, exchange-
able sodium, blood volume, and NE or E values remained unchanged
following operation, except for mildly increased upright PNE in RAS.
These observations suggest that the sympathetic system plays no major
role in unilateral renal hypertension in man, However, the "normal"
body sodium-volume state in RPD or RAS may be inappropriate
relative to coexisting hypertension. In addition to its established role in
RAS, mild activation of the renin-angiotensin-system may be also
important for the pathogenesis of hypertension caused by unilateral
RPD.
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Effect of pig and rat insulin on sodium reabsorption in the isolated
perfused rat kidney. E. Schlatter and H. J. Schurek. Zentrum Innere
Medizin, Medizinische Hochschule Hannover, Hannover, FRG. Sodi-
um reabsorption in the isolated perfused rat kidney can be increased by
glucose and even more by substrates feeding the malate-aspartate
shuttle; the increase in sodium transport is followed by an increase in
GFR up to the normal in vivo range. The aim of this study was to reveal
whether insulin further stimulates the tubular sodium uptake and
whether the different AA sequence of rat and pig insulin exhibits a
different stimulating effect. Isolated rat kidneys were perfused in
recirculation mode using a sterile, substrate enriched Krebs-Henseleit
bicarbonate buffer (including ADH) which contained 50 g/liter predia-
lyzed bovine albumin. Chromatographically pure pig (p) and rat (r)
insulin were used. The effects on sodium transport were studied in a
steady state period between the 30th and 70th mm of perfusion.

















I; ** < 0.001/p/r-insulin.
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Results. (1) Fractional sodium reabsorption was significantly increased,
when pig insulin had been added. (2) Addition of homologous rat insulin
stimulated sodium uptake even further. Sodium concentration in the
final urine dropped from 112 to 73 mmoles/liter at a comparable GFR in
the normal in vivo range. Conclusions. The different AA-sequence of
rat and pig insulin exhibit a different stimulating effect on sodium
reabsorption. The decrease of the sodium concentration in the final
urine, especially when homologous insulin is used can be attributed to
distal nephron segments, ascending limb of Henle, and collecting ducts.
Conservative treatment of chronic renal failure: A study of 5822
patients. R. Schmicker, I. Handschuk, H. Klinkmann. Department
Internal Medicine, W.-Pieck-University, Rostock, GDR. In Rostock
county (pop. 870,000), 5822 patients with varying degrees of renal
failure are observed and treated by means of a coordinated medical
network. Patient followup is undertaken at all levels, ranging from the
general practitioner to highly specialized renal clinics at kidney centres.
Of the 5822 patients, 72.8% suffered from chronic urinary tract infection
(UTI), 11.7% from chronic glomerulonephritis (GN), and 15.5% from
other chronic nephropathies. Six hundred eighty-two (11.7%) already
developed chronic renal failure (CRF) and 122 of them demonstrated
serum creatinine levels of more than 5 mg/dl. Patients with serum
creatinine > 5 mg/dl are supervised in renal clinics with attached
dialysis units. This study includes data obtained from 165 patients with
CRF,62 of whom had already a serum creatinine > 5 mg/dl. The general
therapeutic regime consists of treatment of the underlying disease,
dietary managements, and symptomatic drug-treatment. Moderate low
protein diet (0.6 g/kg body wt) was given to patients with serum
creatinine of 4 to 8 mg/dl. Patients with a serum creatinine > 8 mg/dl
received 0.4 g of protein/kg body wt with additional substitution of
essential amino acids or keto acids, respectively. Hypertension, cardiac
insufficiency, and renal osteopathy were main reasons for symptomatic
drug therapy. The clinicalfollowup of these groups was up to 10 years.
Out ofthe observed 165 patients with CRF, 95 (57.6%) worked fulltime,
36 (21.8%) part-time. In 41 patients (mean serum creatinine, 10.1 1.9
mg/dl), the onset of dialysis therapy could be postponed for 7.5 months.
It is an open question, however, whether the delay in initiating RDT has
any adverse effects on the clinical course and prognosis when the
patient eventually enters on RDT program.
Glandular adenylate cyclase system in genetic hypertension of rats:
Age-dependent changes of sensitivity of catecholamines. G. Schmid, A.
Heidland, and K. Hempel. Medizinische Universitdtsklinik, Inst. of
Med. StrahlenJ3unde, Wurzburg, FRG. In earlier investigations in man
and rats, we showed that the cAMP output of parotid glands reflects the
3-adrenergic activity, In in vivo experiments, parotid saliva of rats was
collected continuously using a technique elaborated in our laboratory
and cAMP excretion was measured by radioimmunoassay. In normo-
tensive rats, cAMP excretion rate in parotid saliva averaged about 20 to
30 fmoles/min when salivary flow was stimulated by pilocarpine (0.045
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x kg' x min' i.p.). Salivary cAMP excretion increases immediate-
ly when isoproterenol (20 g x kg" x min' i.v.) was administered.
This increase in salivary cAMP output is slightly but not significantly
pronounced in younger animals (6 to 8 weeks) than in older ones (16 to
18 weeks). In genetic hypertensive rats, the young animals show a
significantly exaggerated response (+ 19%) to isoproterenol administra-
tion as compared to the control rats of the same age, indicating an
increased sensitivity and/or number of the adenylate cyclase complex.
In contrast, adult genetically hypertensive rats are less sensitive to
catecholamines than their controls (—49.7%). The results indicate that
young genetically hypertensive rats are more sensitive to catechol-
amines than normotensive control rats. On the other hand, adult
genetically hypertensive rats show a subsensitivity to catecholamines
due to a subsensitivity of the adenylate cyclase complex and/or a
decreased number of receptors. Our results suggest that the sympathet-
ic system is involved in initiating the hypertensive state in genetic
hypertension, whereas common mechanisms of blood pressure regula-
tion seem to maintain hypertension.
Evidence that PTH level determinates Ca-flux during extracorporeal
blood purification in chronic renal failure patients. H. Schneider, E.
Streicher, and H. Schmidt-Gayk. Katharinen Hospital, Stuttgart, and
University Hospital, Heidelberg, GFR. Calcium (Ca) balance studies
have been undertaken in 10 patients on a chronic hemofiltration
program (HF). HF was carried out 3 times weekly with Pan 15
hemofilters and a mean plasma water exchange of 23.5 liters. The
purpose of the study was to test the interrelationship of serum levels of
ionized, ultrafiltrable, and total Ca, PTH, 25-OH-D, P04, and plasma
water exchange volumes on Ca mass transfer rates with reference to
different Ca concentrations in the substitution fluid. From former
examinations, it has been concluded, that Ca intake was correlated to
the individual plasma water balance merging zero with negative fluid
balance exceeding approximately 5 liters. Taking 4 mEq/liter Ca in the
substitution fluid, a mean positive Ca balance of 100 mg was achieved
per treatment with a mean negative fluid balance of 3.5 liters. The
regression analysis showed a positive correlation (r = 0.638249). If Ca
balances are plotted individually against fluid balance, extraordinarily
high differences are found in Ca intake when matched for the fluid
balance. Group I patients (N = 3) showed a positive Ca balance of 13.87
3.38 mEq/treatment; group II patients (N = 3) were found to have a
negative Ca balance of —0.04 2.76 mEq/treatment despite of a
comparable fluid balance (group I, —3.79 1.08 liters; group II, —3.76
0.58 liters. Total protein, hematocrit, P04, and AP were not
significantly different in both groups. Ionized Ca, ultrafiltrable and total
Ca were found to be significantly different (group I: Ca" 1.84 0.14;
CaUF, 2.61 0.17; Ca,0,, 4.05 0.23 mEq/liter; group II: Ca''", 2,14
0.27; CaUF, 2.95 0.16; Ca,0,, 4.88 0.56 mEq/liter). The significantly
differing PTH levels (group I, 152 45; group II, 325 109 pmoles/
liter) seem to be the major determinant, as 25-OH-D levels showed no
significant difference in both groups, yet tending to be lower in group II.
We conclude from these observations that the individual PTH level has
to be taken into account when estimating the Ca balance under fixed
conditions (for example, dialysate Ca concentration, or Ca concentra-
tion in the substitution fluid) because of the influence on CaUF levels. If
parathyroid stimulation has exceeded a certain degree, Ca intake will
diminish and be hardly influenced by increased Ca donation in the
extracorporeal circuit.
Mechanisms of autoregulation of nephron filtration rate in the subnor-
mal pressure range. J. Schnermann and J. P. Briggs. Physiologisches
Institut der Universitdt München, Mflnchen, Germany. Experiments
were done to identify and quantify the mechanisms which contribute to
the maintenance of single nephron GFR (SNGFR) during reductions of
arterial blood pressure. Following surgery all rats received harvested
rat plasma (1.5 to 2.5 ml) to reduce arterial hematocrit which had risen
from an initial value of 42.0 0.58 to 47 0.65. SNGFR was
determined at four different levels of arterial pressure with and without
tubuloglomerular feedback (distal vs. proximal collection sites) and in
the absence and presence of the angiotensin II antagonist saralasin (1
p.g/kg/min). The results are summarized in the following table (means
5EM):
Control
Art, pressure, mm Hg 114.6 1.5 97.5 0.8 78.0 0.4 56.0 0.5
SNGFR distal proximal, nI/mm 31.8 1.3
40.8 1.7
31.7 1.6 29.3 .5




Art, pressure, mm hg 113.0 2.5 95.4 0.8 77.0 0.3 56.5 I
SNGFR distal proximal, nI/mm 32.0 1.0
41.6 1.2
30.7 1.6 26.0 1.2
35.8 1.6 27.4 1.2
—
17.6 1.5
By assuming that the change of SNGFR during the pressure step of 77
to 56 mm Hg represents the SNGFR pressure relationship in the
absence of regulatory adjustments, it is possible to calculate that the
completeness of autoregulation with all mechanisms intact (control
distal) was 99% in the upper (11 to 96 mm Hg) and 78% in the lower (96
to 77 mm Hg) pressure range. Contribution of tubuloglomerular feed-
back was derived from the difference of autoregulatory adjustments
between control distal and control proximal collections and was esti-
mated to be 45% in the upper and 30% in the lower pressure range.
During blockade of vascular angiotensin receptors, autoregulation was
still 98% complete in the upper pressure range; however, completeness
of autoregulation had fallen to 55% in the lower pressure range.
According to these data, efferent vasoconstriction subsequent to endog-
enous angiotensin generation does not contribute markedly to autoregu-
lation of SNGFR in the upper pressure range, but is responsible for 30%
of the regulatory capacity in the lower pressure range. The mechanisms
responsible for the remaining half of autoregulation in both pressure
ranges are as yet undefined; it is possible that they may be related to a
truly myogenic, wall-tension-dependent mechanism.
Captopril treatment of renovascular hypertension after renal trans-
plantation. G. Schwietzer, G. Offermann, G. Schultze, W. Oelkers, R.
Ha ring, R. SOrensen, and M. Molzahn. Dept. of Intern. Med., Dept. of
Surgery, Dept. of Radiology, Klinikum Steglitz, Free University of
Berlin, Berlin, Germany. Since 1970, 150 patients underwent renal
transplantation (TPL). In 14 pat. severe hypertension associated with
transplant renal artery stenosis (TRAS) developed 1 to 162 weeks
(mean, 47) after TPL. Before TPL, 6 of these pat. had been normoten-
sive and 8 hypertensive (diast. BP, 90 to 110mm Hg). Immediately after
TPL, BP was normal in 10 and elevated (DBP, 90 to 110 mm Hg) in 4
pat. Graft survival in this group averaged 18 (4 to 81) months.
Creatinine clearance before and after development of severe hyperten-
sion was 74 15 vs. 74 18 mI/mm, respectively. Conventional drug
treatment did not lower BP in 13 of 14 pat. They required additional
therapy: Group I (N = 4) had surgical treatment. Group II (N = 6) had
transluminal angioplasty. Group III (N = 3) had captopril (alone or in
combination with diuretic). Outcome was the following: Group I,
transplant nephrectomy (2), unimproved (1), now normotensive on
captopril, and improved (1), normotensive under B-blocker (I). Group
II, BP lower (2), in I pat BP normal on captopril, 4 pat. required
additional surgery with good success. Group III, normotensive (2),
improved (1). Finally, BP was normal in 10 pat. (4 surgery only, 3 on
captopril, 3 on other drugs) and still elevated in 3 pat. Long-term
transplant function (serum creatinine) was not affected by different
forms of antihypertensive treatment. Conclusion. (1) A broad scale of
methods has to be considered for the treatment of hypertensive patients
with TRAS to reduce the risk of transplant nephrectomy. (2) In our
patients, invasive techniques (surgery or angioplasty) were mainly
useful at the presence of a short and/or proximal stenosis. (3) In
contrast, patients with a long and/or distal stenosis should be treated
primarily with antihypertensive drugs. (4) Captopril has been shown to
normalize BP in patients with TRAS when other antihypertensive drugs
have failed and surgery is not possible.
Reduced GFR in dehydrated rats via tubuloglomerular feedback. G.
Selen, R. Müller-Suur, and A. E. G. Persson. Dept. of Physiology and
Medical Biophysics, and Dept. of Clinical Physiology, University of
Uppsala, Sweden. Since the existence of a feedback mechanism was
demonstrated between the distal tubule and the glomerulus (tubulo-
glomerular feedback; TGF), most interest is now focused on the
physiologic significance of this mechanism. Our group showed earlier
changes in TGF sensivity during variation of plasma colloid concentra-
tion in blood perfusing the macula densa. The present study was
performed to evaluate if such sensivity change can explain the GFR
decrement in dehydrated rats. These rats (24 hours without food and
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water) were studied before and after volume expansion (5% of body wt
by saline). Normal rats were used as controls. Kidney GFR was
decreased in dehydrated rats to 0.96 0.08 mI/mm (1.49 0.09 in
controls) and increased after volume expansion to 1.71 0.08. The
TGF was studied by two different micropuncture techniques: the first
was recording of the proximal tubular stop-flow pressure changes
(SFP%) upstream to a wax block and at different rates of microperfu-
sion through Henle loops with artificial tubular fluid. Moreover, with
this technique we determed the perfusion rate at which 50% of the
maximal SFP decrease was obtained, the so-called turning point (TP).
Dehydrated rats showed increased sensivity of TGF, concluded from
increased ISFP% (36.2 4.0) and decreased TP (16.3 0.4 nI/mm)
compared with controls (25.5 1.8%, 20.7 + 0.8 nI/mm, respectively).
In contast, volume expansion led to a decrease in TGF sensivity since
LSFP% decreased (8.0 3.3%) and TP increased (> 35 nl/min). The
second technique was measuring nephron filtration rate (SNGFR) both
by collection in the proximal tubule (with interruption of flow to macula
densa) and collection in the distal tubule (with physiologic flow to
macula densa). In dehydrated rats, the proximal SNGFR was higher
than the distal (37.5 + 2.6 to 32.2 + 1.9 nl/min), whereas such
differences were not obtained in controls or volume-expanded animals.
The results with the second technique give further evidence for
increased sensivity of TGF in dehydration. Conclusion. The reduction
in kidney GFR that occurs in dehydration is at least in part caused by
the TGF that has gained an increased sensivity during this condition.
The present results are in agreement with our hypothesis that the
pressure-volume conditions of the interstitium surrounding the macula
densa cells modulate the sensivity of the tubuloglomerular feedback
mechanism.
Resistance to acute renal failure by glycerol injection in the recovery
phase of renal blood flow and mesenterica superior blood flow. D.
Seybold, W. Pfaffl, K. Baueref3, and U. Gessler. 4. Med. Klinik des
Klinikums and Inst itut für Nephrologie, Nürnberg, Germany. Animals
recovering from acute renal failure (ARF) are resistant to subsequent
glycerol injections (GI). We investigated whether resistance to ARF
after repeated 01 is related to different hemodynamic reactions. Male,
Sprague Dawley rats, weighing 180 to 200 g, were used. Series I. After
food and water deprivation for 24 hours, the first GI (0.61 mmoles/liter
solution, 10 mI/kg body wt) was done. Arterial blood pressure, renal
artery blood pressure (RBF), and mesenteric superior artery blood flow
(MBF) were measured (flowmeter, Carolina Instr.) from 15 mm before
to 120 mm after GI, while the rats were anesthetized with Inactin.
Series II. After deprivation of food and water for 24 hours, the first 01
was given. Six days later, when serum urea concentration had returned
to normal, the same procedure as in series I was done. Series III.
Plasma renin activity (PRA) was measured before, 30, 60, and 120 mm
after first and second GI. Results. During 5 mm after the first GI, RBF
decreased from 4. 7 0.7 to 3.1 1.1 ml/min/l00 g of body wt (P <
0.001), increased to 3.8 0.6 during the following 30 mm and then
decreased continuously until 120 mm after GI (3.5 0.7 ml/min/lOO g of
body wt). RBF was not significantly lower (3,8 1.2 mI/mm/tOO g)
before the second 01 as compared to the first UI and did not change
significantly after the second GI. MBF decreased identically after the
first and second 01 (from 10.8 2.4 to 7.0 1.4, respectively, and from
11.4 2.7 to 7.0 1.4 mllmin during 120 mm after GI). PRA increased
from 12 1 ng/mllhr before the first GI to 26 2 ng/ml/hr one hour after
01. Before the second UI, PRA was significantly (7 1 ng/ml/hr) (P <
0.005) lower than before the first GI and did not change after the second
01. After first and second UI, intrarenal mechanisms might be responsi-
ble for the absence of renal vasoconstriction, since mesenteric vessel
resistance increased identically. Possibly the lack of appearance of
renal vasoconstriction and ARF after the second GI is related to the
absence of a PRA increase; other intrarenal mechanisms, however,
seem to be involved, since protection against repeated GI is partly
abolished by indomethacin (our unpublished data).
Characteristics of renal tubular reabsorption of "acidic" amino acids.
S. Silbernagl, J. Joost, E. Jarosch**, and H. VOlkl. Depts. of Physiolo-
gy, Urology, and Pediatrics, Univ. of Innsbruck, Austria. The "acidic"
amino acids L-glutamate (L-Glu) and L-aspartate (L-Asp) are reab-
sorbed by a common low capacity/high affinity mechanism. Our recent
investigations showed that D-Asp but not D-Glu, the neutral amino
acids L-glutamine and L-asparagine, and 2-oxoglutarate share this
transport mechanism. In the present study the characteristics of this
reabsorption mechanism were investigated furthermore by clearance
experiments in man and rat and by micropuncture and continuous
microperfusion of single rat tubules in vivo and in situ: Results.
Pyroglutamate (76 p.moles . liter-') is reabsorbed rapidly in the proximal
convolution. The reabsorption is not influenced by I mole 'liter' L-
Glu. Neither do N-methyl-L-Glu (2 imoles . liter-') nor kainic acid (2
pmoles liter-') influence tubular reabsorption of L-Glu (70 moles
l'). N-methyl-D-Asp is reabsorbed very slowly in the proximal convo-
lution: Fractional recovery was found to be about 90% of the filtered
load at a perfusion distance of 2 mm. In loop perfusions, recovery was
about 60%. L--y-carboxyglutamate, whose 'y-carboxylation is a post-
translational vitamin K-dependent step in the formation of prothrombin
and other proteins, was found in its free form in human plasma in a
concentration of about I p.mole liter. Endogenous fractional excre-
tion of L-'y-carboxyglutamate in man was found to be about 30% of the
filtered load. In the rat in which the plasma level has been elevated by
infusion to about 40 ii.moles liter', fractional excretion amounted to
about 50% of the filtered load. Recovery in microperfusion experiments
of single proximal convolutions (perfusion distance, max 1.7 mm) was
found to be > 90%, and in loop perfusions about 70%. Absolute
excretion of -y-carboxy-Glu was approximately elevated five times in Ca
stone-forming patients. The recovery of endogenously filtered L-Glu in
early superficial loops of the distal rat tubule amounted to 6.6 2.4%
(SD, N = 9) of the filtered load. Fractional urinary excretion of L-Glu
was only 0.13 0.02 (SD). Conclusions. The tubular reabsorption
mechanism of L-glutamate and L-aspartate is extremely specific.
Intramolecular ring formation of L-Glu, or N-methylation of L-Glu and
D-Asp abolishes the affinity to the reabsorption system as well as the
ring structure in the "acidic" amino acid kainic acid. -y-Carboxylation
of L-Glu prevents reabsorption of the resulting tricarboxylic amino acid
to a great extent. This nonmetabolizable metabolite of vitamine K-
dependent proteins, therefore, is rapidly excreted by the kidneys. The
fractional reabsorption of 50 to 70% may be explained by (passive?)
reabsorption in the proximal tubule and/or by a relatively higher
reabsorption rate in deeper nephrons, as is mostly likely the case for L-
Glu. Hyperexcretion of --carboxy-Glu in Ca stone-formers needs
further investigation.
Prognostic significance of bioptic diagnosis in impaired renal graft
function. H. P. Spichtin, M. J. Mihatsch, M. Oberholzer, G. Thiel, and
H. U. Zollinger. Institute of Pathology, University of Basel, and
Department of Medicine, University of Basel, Basel, Switzerland. From
1967 to 1979, 148 consecutive renal graft biopsies of 102 patients with
impaired renal graft function were examined. The following morpholog-
ic findings were considered: glomerulopathy, glomerulitis, glomerular
necrosis and thrombosis, vasculopathy (alterative-proliferative and
sclerosing stage), arterial wall necrosis, intravascular coagulation,
interstitial infiltrate, interstitial bleeding and fibrosis, tubular dilatation,
as well as tubular necrosis. The graft failure was defined by a permanent
increase of creatinine over 5 mg/dl or by the need of periodic hemodial-
ysis. The findings were analyzed by plotting survival curves according
to Cutler and Ederer (1958). The crude 5-year survival rate of all grafts
is 39%. Graft survival is significantly worsened by transplant glomeruli-
tis, glomerular necrosis and thrombosis, proliferative vasculopathy,
arterial or arteriolar wall necrosis, intravascular coagulation, interstitial
bleeding, and tubular necrosis. All other criteria are of no prognostic
significance. More than 90% of grafts failed within 3 months after
biopsy in cases with (1) glomerular necrosis or thrombosis and intersti-
tial bleeding, (2) glomerular necrosis or thrombosis and proliferative
vasculopathy, (3) proliferative vasculopathy, arterial or arteriolar wall
necrosis. More than 90% of the grafts failed within the first 6 months
after biopsy in cases with interstitial bleeding accompanied by trans-
plantglomerulitis or tubular necrosis. On the basis of our findings, we
can state that morphology allows a reliable prediction of graft survival.
Measurements of flow velocities in single glomerular loops in the rat.
M. Steinhausen, B. Zimmerhackl, N. Parekh, and U. Ejilinger. I.
Physiologisches Institut der Universität Heidelberg, Heidelberg, Ger-
many. Linear flow velocities in single loops of superficial glomerula in
the kidneys of anesthetized rats were measured with the aid of a new
fluorescent microscopic technique. The passage of intravenously inject-
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ed fluorescent labeled latex particles (1.8 p.m) in single glomerular loops
was traced by single-frame analysis of recordings from a high sensitivity
television camera. The diameters of the glomerular loops could be
determined by using fluorescent labeled dextrans of high molecular
weight. The mean flow velocity and luminal diameter in single glomeru-
lar loops in 25 animals were 781 271 p.m sec and 8.4 1.4 p.m,
respectively. In single glomerular loops with a mean length of 76 p.m. a
decrease in flow velocity along the capillary was observed. In addition
to the reduction in flow velocity from earlier to later capillary segments
of 7.2%, there was a reduction in the capillary diameter. By correcting
for the Fahraeus-Lundquist effect, our data enable local filtration rate in
single glomerular loops to be determined. This method could be verified
by stopping the glomerular filtration using an intratubular paraffin
block. Furthermore, this microscopic technique allows continuous
determination of flow velocity in micropunctured single glomerular
loops. Pressure measurements using the servo nulling device failed to
show a filtration equilibrium in these glomerular loops.
Role of proteolytic enzymes in the pathogenesis of protein catabolism in
acute renal failure. J. Stepinski, W. H. Hörl, C. Gantert, and A.
Heidland. Division of Nephro!ogy, Department of Medicine, University
of Wdrzburg, Wurzburg, West Germany. Despite intensive experimen-
tal and clinical studies, a positive nitrogen balance has not been shown
in patients with acute renal failure (ARF). The important role of
proteolytic enzymes in the induction of protein catabolism during
hypercatabolic ARF is supported by our previous studies. Results.
Using ultrafiltrated plasma, it was possible to verify the existence of
proteolytic activities by digestion of azocasein or phosphorylase kinase
in 6 patients with post-traumatic ARF. In one case, we found, as a
possible cause for proteolytic autodigestion, a protease-antiprotease
imbalance. Alpha-2-macroglobulin values were, after an initial value of
80 mg/dl, too low to be detected. Addition of purified alpha-2-macro-
globulin resulted in a complete inhibition of protein catabolism in vitro.
To determine the tissues that release proteolytic enzymes, we prepared
liver, muscle, kidney cortex, and kidney medulla cytosols from rats
with different types of ARF. Kidney cortex cytosol digests the alpha
and beta subunits of phosphorylase kinase within 12 hours of incubation
at 370 C. Blood coagulation as a source of proteases could largely be
excluded because identical results with ultrafiltrated plasma and ultra-
filtrated serum were found. From patients on routine dialysis, concen-
trated diafiltrates digest the alpha subunit of phosphorylase kinase,
whereas urine fractions degradate the alpha and beta subunits of this
enzyme. Ultrafiltrated plasma predominantly splits the alpha and
gamma polypeptide chains of phosphorylase kinase. Proteolytic active
plasma fractions digest membrane proteins of hepatocytes isolated from
rat liver within 24 hours. Conclusions. Different digestion pattern of
phosphorylase kinase in body fluids may indicate the presence of
different types of proteolytic enzymes in patients with hypercatabolic
renal failure. Our results provide evidence for the key role of proteases
in the participation of protein catabolism in hypercatabolic states.
Long.term course of hepatitis-B infections in dialysis patients. G.
Stiess, R. Jontofsohn, H. Boeckle, G. Schaeffer, H. Vick, and H.
Bert hold. Medizinische Klinik, Abteilung IV, Nephrologie, Univ. Frei-
burg, Germany. Since 1971, routine measurement of HB,-antigen has
been performed in all dialysis patients in south Baden. In the present
study, the long-term prognosis of HB0-AG-positive patients was as-
sessed retrospectively using serologic and clinical parameters. Forty-
four patients with a clinically manifest B-hepatitis were observed over a
period of 1 to 9 years (mean 4.5 years). Two groups were detected: (1)
Those with transitory HB-antigenemia, and (2) those with persisting
HB-antigenemia. Patients in group 1 eliminated HB0-antigen within
10.5 2 months (range, 2 to 42 months). In this group, the rise of anti-
HB. was markedly delayed. In a few patients, HB-antigen-positive and
-negative phases appeared alternately until final HB0-antigen elimina-
tion accompanied by production of anti-HB. The HBV-infection
induced benign liver disease in the marjority of the patients, although
one patient developed liver cirrhosis. In comparison, the patients of
group 2 exhibited a significantly unfavorable prognosis. In spite of an
equivalent age distribution in the groups, in group I no patient died,
whereas in group 2, 7 patients died. Only two of the deaths could be
directly related to the liver disease. In respect to liver involvement,
long-term prognosis was worse in group 2, with 8 patients developing
cirrhosis of the liver. A variable state of immunity must be considered
as a possible cause. Of note is the case of one patient who died
following a sepsis and at autopsy demonstrated an absolutely normal
liver histology despite HB- and HBe-Ag in serum and liver cells. The
prognosis of serum hepatitis virus infections is more favorable in
dialysis patients than after renal transplantation.
Metabolic analyses in recurrent calcium-stone formers. E. Streicher,
H. Schneider, and F. Eisenberger. Katharinen Hospital, Stuttgart,
GFR. In 45 pat. (24 males, 21 females) suffering from recurrent calcium
nephrolithiasis, we studied the renal Ca excretion during a 5-day lông-
term study (LT) under a low Ca diet and a high Ca diet and compared
the results with a short-term test (KT). During KT, determination of Ca/
creatinine (mg/mg) excretion was obtained in a 2-hour urine sample
after an overnight fast and then in a 4-hour collection after a I g oral Ca
load. Blood and urine samples were examined for Ca, P04, uric acid,
PTH, creatinine clearance, and 24-hour uric acid and oxalic acid
excretion. A Ca excretion > 4mg/kg/day was found during LT in 30 pat.
(66.7%); (6.08 1.78 mg/kg/day). Of these stone formers, 13 sustained
their elevated Ca excretion during the low Ca diet period (5.11 0.80
mg/kg/day). During KT, Ca/creatinine excretion was > 0.11 in 19 pat.
(42.2%); (0.25 0.14); after Ca load an elevation > 0.22 was found in
25 pat. (55.6%); (0.39 0.20). Comparison of LT and KT disclosed
disagreement in 10 pat. Hyperoxaluria (> 0.5 mmoles/day) was found in
5 normocalciuric pat. (33.3%) (2,63 2.43 mmoles/day), hyperurico-
suria (> 900 mg/day) was detected in 2 pat. (13.3%), Four hypercal-
ciuric pat. were detected to suffer from prim. HPT, serum Ca values
were 6.15 0.45 mEq/liter, PTH levels 119.50 122.45 pmoles/liter,
serum phosphate values 2.73 0.66 mg/dl. In the 26 pat. with
idiopathic hypercalciuria, serum Ca values were 4.91 0.33 mEq/liter,
PTH was 16.62 13.31 pmoles/liter and serum phosphate was 3.14
0.50 mg/dl. If idiopathic hypercalciuria was classified in absorptive and
renal form according to the results of KT, no significant differences
were found for serum Ca (4.90 0.52 and 4.93 0.27 mEq/liter,
respectively) and serum phosphate (3.21 0.44 and 3.29 0.44 mg/dl,
respectively) whereas PTH levels were highly distinctive (11.29 3.36
and 23,40 13.96 pmoles/liters, respectively) individually, this differ-
ence is hardly applicable because of broad ranges. On the basis of these
results KT alone is not sufficient in the diagnostic procedure of
hypercalciuria and always should be completed by LT.
Does affinity of anti-GBM antibodies correlate to the severity of renal
involvement in Goodpasture-llke syndromes? W. Stuhlinger, P. Konig,
and P. Dittrich. Klinik für Interne Medizin, Innsbruck, Austria. Kidney
tissue and sera samples from 12 patients with progressive and 4 with
nonprogressive Goodpasture's syndrome (GPS)-like diseases were
studied by immunologic methods. Linearly deposited and eluable
immunoglobulins were detected in all cases. Circulating anti-GBM
antibodies were observed by IF methods in 7 of 12 progressive and in all
nonprogressive GPS-like diseases, Circulating anti-GBM antibodies
were also detected in all studied cases by radioimmunoassay (collage-
nase-digested GBM). No difference was found between the antibody
concentration in the progressive and nonprogressive groups. Absorp-
tion experiments on sepharose coupled IgG fractions obtained from
GPS patients with different clinical courses failed to indicate qualitative
differences of basement membrane antigens. Differences in terms of
eluability of deposited antibodies and displacement of labeled basement
membrane antigens from complexes with specific antibodies suggest
that a different affinity of the anti-GBM antibodies causes differing
clinical courses.
Isotachophoresis in renal stone disease. W. Tschäpe and E. Ritz. Div.
of Nephrology, Med. Univ. Klinik Heidelberg, Germany. Isotachophor-
esis (ITP) is a recent chromatographic method which is now widely
accepted as a simple and reliable sensitive method to identify and
measure quantitatively small amounts of unknown substances in biolog-
ical samples. In clinical research it has been successfully applied to
purine and nucleotide metabolism. It was the aim of the present
investigation to develop a new method for determination of urinary
oxalate (ox) and related substances in nonprocessed native urine.
Performance of ITP was determined in the LKB 2127 Tachphor
equipped with the UV and thermal signal. Leading electrolytes were
HCI 5 x i0 M, NaC1 I x 10 M, and 0.4% HPMC. Terminating
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electrolytes were acetic acid, 50 mmoles/liter. Samples (usually 5 p.I of
urine) were injected using Hamilton microsyringes (model AA 701 SN;
teflon and tungsten surfaces) to avoid formation of ox-containing Fe-
complexes, 10 mM ZnCI2 was added to urine samples prior to measure-
ment to assure full recovery. Specificity was tested with oxalate
decarboxylase for ox and with citrate lyase for citrate. Twenty-four-
hour urine samples were examined from 27 healthy adults, 45 healthy
children, and 34 idiopathic renal stone formers. Results. Quantitative
codetermination of oxalate and citrate was possible; orotic acid,
oxaluric acid, and glycolic acid could be identified and separated.
Oxalosis Type I could be diagnosed in two children (ages 11 and 15;
UV0,, 1170 and 1890 p.moles/24 hr). Children excreted significant less
oxalate (292 196 p.moles/24 hr) than did adults (436 176 p.moles/24
hr) or stone formers (471 195 p.moles/24 hr). UV,, was positively
correlated with UV0, (r = 0.66). Ox/Cr ratio was positively correlated
with Ca/Cr in adults, but negatively (r =
—0.33) in children, indicating
different sources of urinary oxalate. Conclusions, LTP is a reliable new
method to quantitate substances involved in renal stone formation. It
can be applied to urine samples without significant pretreatment
procedures and, compared to other methods, offers the distinct advan-
tage of codetermination of a number of other anions important in stone
formation.
Disorders of the urea cycle in the rat liver and in the human leukocyte
in chronic uremia. M. Vlaho. Medical Clinic of the University of
Cologne, FRG. The inborn defects of the urea cycle enzymes lead to
disorders of the protein and amino acid metabolism. The acquired
disorders of the urea cycle enzymes in chronic uremia have been
isolated and reproducible only in animal experiments. Examination of
the urea cycle enzymes in uremic patients are absent. A chronic uremia
was induced in male Wistar rats by performing the so-called 5/6
nephrectomy. The duration of the uremia lasted 6 weeks. Sham-
operated rats served as control animals. We also examined all the urea
cycle enzymes in the leukocytes from normal persons, patients with
renal insufficiency on low protein diet, and dialysis patients. In the liver
of chronic uremic rats was found increased activities of ornithine
carbamoyl-transferase (OCT), arginino-succinate synthetase (ASAS),
and carbamoyl phosphate synthetase (CPS). The activity of arginino-
succinate lyase (ASAL) was no different from the controls. The activity
of the arginase per I g'weight of fresh liver was significantly lowered in
chronic uremic animals. The protein content of the liver in uremic
animals was diminished. In human leukocytes, the activities of the all
five urea cycle enzymes could be measured. Patients with very im-
paired renal function, conventionally treated with a low protein diet,
showed a significant lowering of ASAL and protein content in the
leukocytes, compared to normal persons, In dialysis patients in relation
to normal persons it was observed that the ASAL was significantly
lowered, whereby the activity of ASAS was significantly raised. From
the disorders discovered in measuring the urea cycle enzymes, the
increased amount of guanidino-succinic acid is explainable in chronic
uremia. The results lead also to the interpretation of a number of other
disorder points within protein metabolism in chronic uremia.
Interactions of cysteine/cystine with neutral and dibasic amino acids
during reabsorption in proximal convoluted tubules of rat kidney. H.
VOlki and S. Silbernagi. Physiologisches Institut der Universität,
Innsbruck, Austria. In cystinuria the tubular reabsorption of L-cystine
as well as of L-arginine, L-lysine, and L-ornithine is impaired. The
assumption of a common reabsorptive mechanism for L-cystine and
dibasic amino acids could not be confirmed definitely in previous
studies. Furthermore it could not be clarified whether L-cystine is
reabsorbed as such or is reabsorbed in its reduced form as L-cysteine.
We performed microperfusion experiments concerning these questions
and got the following results: (1) The fractional reabsorption rate (FRR)
of L-cysteine (initial conc., 0.01, 0.53, and 5 mmoles'liter') was about
88% after a perfusion distance of 2 mm. Almost the same reabsorption
rate could be observed for L-cystine (initial conc.: 0.01, 0.08, and 0.4
mmoles 'liter—'). (2) In the presence of the neutral amino acid L-methionine
(10 mmoles1iter') the FRR of L-cysteine (0.53 mmolesliter') dropped
to 60% and the FRR of L-cystine (0.08 mmoles'liter') to 48% after a
perfusion distance of 2 mm. L-cysteine (20 mmoles'liter') reduced
significantly the FRR of L-methionine (0.33 mmolesiiter') and phenyl-
alanine (2 mmolesliter'). (3) Decarboxylated arginine (agmatine) is a
strong inhibitor of L-arginine reabsorption, but did not influence the
FRR of L-cystine (0.08 mmoles'liter') in a concentration of 10 mmoles'
liter'. (4) L-arginine and L-canavanine are strong inhibitors of L-
cystine reabsorption. But these substances (10 mmoles liter') did not
affect the FRR of L-cysteine (0.53 mmoles'liter') in the presence of the
reducing agent 1 ,4-dithioerythrit (DTE) in a concentration of I mmole'
liter'. (5) The FRR of L-cystine (0.08 mmoles'liter') decreased to 60%
after a perfusion distance of 2 mm, when the disulfide bond stabilizing
agent azodicarboxylic acid-bis-dimethylamide (diamide) was added to
the perfusion fluid in a concentration of 10 mmoles'Iiter'. The reab-
sorption of phenylalanine (2 mmoles'liter1) proceeded undisturbed in
the presence of diamide (10 mmoles1iter'). Conclusions. The interac-
tions of cysteine/cystine with neutral amino acids and the lacking effect
of agmatine on L-cystine reabsorption could be an indication that L-
cysteine and L-cystine share a transport system with neutral amino
acids. The observed effects of DTE and diamide could be interpreted as
follows: L-cystine can be reabsorbed only as L-cysteine after a reduc-
tion process separated from reabsorption. The basic amino acids may
block the splitting of the disulfide bond in L-cystine.
Nitrogen balance with free diet in patients on continuous ambulatory
peritoneal dialysis. H. Von Baeyer, G. M. Gahl, R. Averdunk, H.
Riedinger, R. Borowzak, R. Schurig, H. Becker, and M. Kessel.
Nephrologische Abteilung Medizinische Klinik und Poliklinik, Klinikum
Charlottenburg der Freien Universitat Berlin, Berlin, West Germany.
Continuous ambulatory peritoneal dialysis (CAPD) is characterized by
either protein loss and o-glucose absorption through the dialysate, such
that an influence on the dietary intake of nutrients and therefore on the
energy metabolism should be expected. In 7 patients treated with
CAPD over a period of 4 to 12 months, a study of the nitrogen balance
under free diet was performed. The analysis of the nitrogen intake was
accomplished by a daily Kjeldahlometric determination of the nitrogen
content in a duplicate of the diet. The analysis of the nitrogen loss by
dialysate and urine was also determined by Kjeldahlometry. In addi-
tion, the nitrogen fractions of urea, creatinine, uric acid, alpha amino
nitrogen, and total protein were measured. Nitrogen loss by skin and
stool was normalized over body surface and body weight, respectively.
The average daily protein gain was found to be around 0.85 g/kg body
wt. The nitrogen loss in the dialysate is divided into the following
fractions: urea-N, 3.6 g; uric acid-N, 0.14 g; creatinine-N, 0.22 g;
protein-N, 0.142 g, alpha amino-N, 0.11 g. Taking into account the
urinary, skin, and stool losses of nitrogen, no patient revealed over the
period of investigation a negative nitrogen balance despite the fact that
the recommended protein intake of 1.2 to 1.5 g/kg body wt per day was
not reached uniformly. But, in view of possible diseases, the optional
protein intake of these patients seems to be too low. Consequently a
close surveillance of CAPD patients in general is advisable with respect
to their diet.
Measurement of distal tubular function in the differential diagnosis of
Banter's Syndrome. D. Walb, S. Abdelhamid, P. Fiegel, and L.
Thomas. Deutsche Klinik für Diagnostik, Wiesbaden, Germany. A
prostaglandin-independent defect of fractional distal tubular reabsorp-
tion of chloride (Clreb) has recently been shown in 5 patients with
Bartter's syndrome, whereas 5 patients with pseudo-Bartter syndrome
due to vomiting had normal distal tubular function. We measured
CH2O/CH2O + CC! (Clreab) during maximum water-diuresis in 12
volunteers, Clreab was 0.89 0.05 (sEM). Three groups, of 4 volunteers
each, received iv. 20 mg of furosemide, 50 mg of ethacrynic acid, or 50
mg of hydrochlorothiazide. The table shows the results in the different
groups of CH2O/CH2O + CC! (±sEM):
Furosemide Ethacrynic acid Hydrochlorothiazide
Before 0.87 0.06 0.92 0.02 0.9 0.06
After 0,36 0.05 0.29 0.09 0.58 0.07
In 4 patients with pseudo-Banter's syndrome, due to vomiting and/or
laxative abuse CLa, was between 0.87 and 0.98. In 2 patients Clrab was
decreased to 0.69 and 0.65, respectively; in both the final diagnosis is
not yet established. Conclusion. If Bartter's syndrome is considered in
the differential diagnosis of unclassified chronic hypokalemic alcalosis
(U HA), measurement of Clreab might be helpful. In 4 of 6 patients with
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UHA, Clrab was normal; they were later shown to have pseudo-
Bartter's syndrome due to secret vomiting and/or laxative abuse. In
UHA with decreased Clreab, abuse of diuretics must be considered,
since this may mimic Bartter's syndrome.
Radioimmunoassay studies on erythropoietin in uremic patients: Influ-
ences of severe anemia and hypertransfusion and the kinetics of reticulo-
cytes. A. J. Walle, J. F. Garcia. Dept. of Internal Medicine, University
Clinics Kiel, FRG, and Donner Laboratory, Berkeley University,
Calfornia, USA. The role of erythropoietin studied by radio-
immunoassay (EP-RIA) in chronic uremic anemia could best be eluci-
dated by the demonstration of an operative feedback control between
EP-RIA and the hematocrit (Hct). We tested this interrelationship by
forcing a strong stimulating and a strong suppressive impact upon the
erythropoiesis of 15 patients kept on chronic intermittent hemodialysis
for different periods of time (2 to 81 months). They were run on low Hct
of 16% for 1 week, then they were transfused twice with 500 ml of
washed erythrocytes (1st and 2nd ERY) in order to exert stimulant or
suppressive effects on their erythropoiesis, respectively. Low pretrans-
fusion (PRE) Hct's of 16 2% were associated with EP-RIA of 75 (9 to
598) mU/mi serum (normal subjects, 23 4 mU/mi). The EP-RIA
responses to hemoglobin (hgb) increases to 164 24% of PRE levels
within 12 hr after the 1st ERY consisted in sharp rises to 170 41% of
PRE levels, and subsequent declines to 45 28% of PRE levels 2 days
later. The RC's showed parallel patterns of responses. The 2nd ERY,
resulting in HGB elevations to 240 62% of PRE levels, provoked
another increase in EP-RIA during 12 hr after the ERY. Thereafter, EP-
RIA values were further reduced to minimum levels of 38% (3 to 89%) of
PRE levels. This second increase in EP-RIA, however, was recorded
mainly in patients with low PRE EP-RIA values. Again, this EP-RIA
reaction was reflected by positively correlated courses of the RC
counts. By days 9 to 11, none of the patients (except for the one with the
lowest PRE EP-RIA) had resumed his PRE EP-RIA level. Conclusions.
(1) Low, normal, or high EP-RIA values were recorded in association
with an average Hct of 16 2% in 15 patients. (2) EP-RIA levels were
conversely correlated with the HGB. (3) EP-RIA was positively corre-
lated with the kinetics of the RC. (4) Evidence suggested the existence
of an operative feedback control between HGB levels on the one hand
and EP-RIA and the bone marrow activity on the other hand in
response to anemia and hypertransfusion. (5) The POST shortlasting
and significant increases in EP-RIA levels remain unexplained to date.
Impaired prostaglandin-biosynthesis in patients with nephropathy and
hypoaldosteronism. G. Wambach, H. Kuppers, A. Helber, and E.
Schnurr. Med. Klinik KOln-Merheim und Med. Poliklinik, Lehrstuhl fur
Innere Medizin II der Universität Koln, und Med. Klinik A der
Universitat Düsseldorf, Dusseldorf Germany. Hyperkalemia in pa-
tients with nonacidotic chronic renal insufficiency is often caused by
decreased biosynthesis of aldosterone. The reason for the hypoaldos-
teronism is unknown. Recently, the syndrome of isolated hypoaldoster-
onism with hyperkalemia was observed in patients with glomerulone-
phritis (GN) during the administration of indomethacin. We therefore
examined the urinary excretion of POE2, PGF2,. and thromboxan B2 in
4 patients (2 male, 2 female, age 16 to 68) with nephropathy (2 patients
with GN, I with diabetic nephropathy, and 1 with analgesic nephrop-
athy; serum-creatinine, 1.49 0.29 mg/dl), hyperkalemia (5.5 1.2
mEq/liter) and hypoaldosteronism (aldosterone excretion, 2.1 2.0 ig/
24 hr, normal range 8.3 3.7 g/24 hr). In 2 patients urinary POE2 was
undetectable. Values for PGE2 were low in the remaining 2 patients
with 3.6 and 4.4 nmoles/24 hr (normal range, 8.5 6.9 nmoles/24 hr).
Similarly, thromboxan B2 excretion was decreased in patients with
hypoaldosteronism (1.5 1.7 nmoles/24 hr compared with 6.5 3.8
nmoles/24 hr in normal controls). Urinary PGF2,, excretion, however,
did not differ from the control range in 3 patients and exceeded the
control group in one patient. The data demonstrate an impaired urinary
prostaglandin excretion in patients with nephropathy, hyperkalemia,
and hypoaldosteronism. Low PGE2 synthesis could be related to the
hypoaldosteronism in these patients.
Early detection of diabetic nephropathy by SDS polyacrylamide electro-
phoresis in children with diabetes mellitus. R. Wartha, D. Nebinger, F.
Thanner, and D. Gekie. University Childrens' Hospital, Wurzburg,
Germany. The present studies were undertaken to elucidate the nature
of the early manifestation of diabetic nephropathy in children. Separa-
tion of urinary proteins according to molecular weight with the SDS
polyacrylamide electrophoresis (SDS-PAGE) permits the differentation
between glomerular and tubular proteins. Forty children with diabetes
without proteinuria according to Albustix and with a duration of
diabetes between I and 11 years were examined. The glomerular-
tubular protein-ratio (GTPR) in normal children (14) was about I. In
diabetics with less than 2 years of diabetes we found a normal GTPR.
After 2 years, there was the beginning of a significant decrease of the
GTPR according to an increase of tubular (low molecular weight)
proteins. We found a good correlation between the duration of diabetes
and the GTPR. Children with a diabetes more than 8 years had a GTPR
< 0.71 in 88%. The dominent excretion of low molecular-weight
proteins reflects an impaired tubular reabsorption according to a very
early manifestation of diabetic nephropathy.
Effect of lysin-vasopressin on the secretion of renin by the rat. H.
Winter and B. Lamberts. Abteilung Innere Medizin II der RWTH
Aachen and Knappschaftskrankenhaus Dortmund, Germany. The ap-
plication of physiologic or pharmacologic doses of lysin-vasopressin
(ADH) reduces the plasma renin activity (PRA), even if the macula
densa is eliminated. Therefore some authors suppose a direct influence
of ADH on the juxtaglomerular apparatus (JGA). In vivo experiments,
conducted by us, confirmed the reduction of PRA by ADH. Male
Wistar rats (wt, 400 g) fed on salt-poor diet showed a significant
reduction of PRA (of 34.5% for 105 mm, followed on ascendance to a
level of — 13.3% until 180 mm) after a bolus injection of 0.2 U of ADH in
0.5 ml of glucose solution into the aorta abdominalis (in contrast to
comparable animals, in whom 0.5 ml of glucose solution without ADH-
added was injected). The effect of ADH on the renin secretion of rat
kidney slices was tested in in vitro experiments. The addition of ADH
repeated three times in 10-mm intervals in doses of 50, 40, 25, 10, and
0.05 U/mI incubation-solution showed no significant effect on the renin
secretion compared to the secretion of kidney slices incubated without
ADH addition. After an incubation period of 10 mm, the average level
of ADH in the incubation-solution amounted to 52.3% of the starting
level. The comparison of in vivo and in vitro results leads to the
conclusion that the reduction of renin secretion by ADH is not a result
of a direct effect on the JGA, but of an indirect mechanism.
Indomethacin reduces the hemodynamic and hormonal effects of capto-
pill. H. Witzgall, and P. C. Weber. Medizinische Klinik Innenstadt der
Universität München, Munchen, Germany. Recently published data
indicate the participation of prostaglandins (P0) in the hemodynamic
and hormonal effects of the orally active converting enzyme-inhibitor
captopnl. Twelve healthy men (33 6 years) were investigated under
active orthostasis and an ad iib diet. (1) For 90 mm before and 90 mm
after 100 mg of captopril, urinary aldosterone (Aldo) and PGE2 excre-
tion were measured. Before, and 30 and 90 mm after captopril, plasma
renin activity (PRA) and plasma Aldo were determined. Mean arterial
blood pressure (BP) and heart rate (HR) were recorded every half hour
before and after captopril. (2) The same protocol was performed 8 days
later under PG blockade by Indo (200 mg). (1) 60 mm after captopril, BP
fell from 97 7to88 8mm Hg (P<0.0005), but HR (75 7min')
did not change. PRA increased from 2.5 1.4 to 8.6 9.1 30 mm (P <
0.02) and 9.7 6.7 ng AL/mi/hr 90 mm after captopril. Plasma aldo fell
from 237 73 to 133 38 pg/mI (P < 0.005) 90 mm after captopril
indicating effective All reduction, Concomitantly, Aldo excretion de-
creased from 12.7 5.5 to 8.2 3.5 ng/min (P < 0.05). POE2 excretion
remained constant before (217 65 pg/mm) and after (224 77 pg/mm)
captopril. (2) Under Indo pretreatment, POE2 excretion was significant-
ly lower (72 37 pg/mm, P < 0.05) and remained low after captopril (80
39 pg/mm). Under Indo, BP fell significantly less after captopril from
97 7 to 93 3 mm Hg (P < 0.05). HR was lower than without Indo (70
9 min, P < 0.05) and did not change after captopril. PRA was
significantly reduced under Indo (1.1 0.6 ng Al/mI/hr. P < 0.05) and
increased only to 2.5 2.1 (P <0.02)30 mm and 2.9 1.890 mm after
captopril. This increase was significantly less than without Indo (P <
0.02; P <0.02). As a result of decreased PRA and, hence, All formation
under Indo, plasma Aldo (140 54 pg/mI) was significantly reduced (P
< 0.002) and no further decrease (143 52) followed captopril. Aldo
excretion under Indo was reduced as well and paralleled plasma Aldo:
6.4 2.0 before and 7.4 5.6 ng/inin after captopril. Conclusion. Indo
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reduces to a significant extent the decrease of BP and the hormonal
changes after captopril administration. Therefore, PG's are involved in
the actions of captopril.
Intestinal magnesium absorption: Effect of chronic uremia, calcium,
I,25.DIICC (calcitriol). V. Wizemann, K. Seim, J. Erhart, R. V. Okun,
E.-L. Sattler, and G. Schütterle. Zentrum für Innere Medizin, Strahlen-
Zen! rum, Hessen, FRG. Using an evened sac preparation from intesti-
nal segments of 54 control rats and 54 rats with chronic renal failure
(CRF), intestinal transport of 28Mg and 45Ca was measured. CRF was
achieved by 9/10 nephrectomy. Mean serum urea averaged 254 mg/dl in
the uremic and 38 mg/dl in the control animals. Serum phosphate
significantly correlated with serum urea. We obtained the following
results: (1) CRF significantly decreased intestinal Mg absorption by
50%. (2) In the presence of Ca, magnesium transport was inhibited
dose-dependently. (3) Pretreatment of the uremic rats with calcitriol
resulted in a further decrease of Mg absorption. (4) Ca absorption was
decreased in CRF by 30%. (5) Pretreatment of the uremic rats with
calcitriol normalized Ca absorption. The presence of Mg at the mucosal
side of the intestine leads to a further increase in Ca absorption. (6) In
control rats, calcitriol increased Ca absorption by 70% and did not
influence Mg absorption.
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Folic acid and vitamin B12 concentrations in serum during hemodialysis
and after kidney transplantation. J. Zazgornik, E. Neumann, L. Marosi,
P. Baicke, P. Schmidt, and H. Kopsa. I. Medical Clinic, University of
Vienna, Vienna. In 26 chronic hemodialyzed patients, 52 renal trans-
plant recipients, and 20 healthy controls, serum folic acid level was
determined by folate radioassay kit with 1251. Additional vitamin B12
concentration was estimated by radioassay kit with 57Co. In the
dialyzed patients, serum folic acid level was significantly lower (3.37
1.25 ng/ml) when compared to controls (6.1 1.38 ng/ml) (P < 0.001).
In renal transplant recipients, serum folic acid concentration was 4.09
1.58 nglml and also significantly decreased as in the healthy controls
(P < 0.001). Out of 52 renal transplant patients, 15 (29%) showed serum
folic acid levels lower than 3.0 ng/ml. Diminished serum folic acid
concentrations were found not only in patients shortly after surgery but
also in cases with excellent graft function up to 6 years after transplan-
tation. Macrocytosis was found in 52% of our renal transplant patients.
By comparing renal transplant recipients with (N = 27) and without (N
= 25) macrocytosis we have not found significant differences in serum
folic acid levels, but serum creatinine levels were significantly lower in
cases revealing macrocytosis. Folic acid deficiency does not seem to be
responsible for macrocytosis after renal transplantation. In the dialyzed
patients, serum vit. B12 level was within the normal range, and there
was no significant difference prior to and after hemodialysis. In renal
transplant recipients, serum vit. B12 levels were also normal.
